| PNPLA3 I148 M genetic variant in autoimmune hepatitis characterises advanced disease at diagnosis and reduced survival free of cirrhotic events and liver-related mortality. | Azariadis K, Gatselis NK, Lyberopoulou A, Arvaniti P, Zachou K, Gabeta S, Dalekos GN | 2024-12-01 | Autoimmune hepatitis, Biomarker, Liver-related mortality, PNPLA3 I148 M, Polymorphisms | Journal of translational autoimmunity |
| Non-invasive assessment of severe liver fibrosis in patients with Fontan-associated liver disease: The VALDIG-EASL FONLIVER cohort. | Téllez L, Rincón D, Payancé A, Jaillais A, Lebray P, Rodríguez de Santiago E, Clemente A, Paradis V, Lefort B, Garrido-Lestache E, Prieto R, Iserin L, Tallegas M, Garrido E, Torres M, Muriel A, Perna C, Jesús Del Cerro M, d'Alteroche L, Rautou PE, Bañares R, Albillos A | 2024-09-09 | Fontan, Fontan-associated liver disease, biopsy, liver fibrosis, liver stiffness | Journal of hepatology |
| Reply: Implications of Mycophenolate Mofetil in a reproductive age patient cohort: Maternal Fetal Medicine point of view. | Slooter CD, Stoelinga AEC, Snijders RJALM | 2024-09-07 | | Journal of hepatology |
| Efficacy and safety of infliximab in patients with autoimmune hepatitis. | Efe C, Lytvyak E, Eşkazan T, Liberal R, Androutsakos T, Turan Gökçe D, Terziroli Beretta-Piccoli B, Janik M, Bernsmeier C, Arvaniti P, Milkiewicz P, Batıbay E, Yüksekyayla O, Ergenç I, Arıkan Ç, Stättermayer AF, Barutçu S, Cengiz M, Gül Ö, Heurgue A, Heneghan MA, Verma S, Purnak T, Törüner M, Akdogan Kayhan M, Hatemi I, Zachou K, Macedo G, Drenth JPH, Björnsson E, Montano-Loza AJ, Wahlin S, Higuera-de la Tijera F | 2024-09-06 | | Hepatology (Baltimore, Md.) |
| Percutaneous recanalization of non-cirrhotic extrahepatic portal vein obstruction in children: technical considerations in a preliminary cohort. | Marra P, Franchi-Abella S, Hernandez JA, Ronot M, Muglia R, D'Antiga L, Sironi S | 2024-09-06 | Extrahepatic portal vein obstruction, Meso-Rex bypass, Portal hypertension, Portal vein recanalization, Portal vein thrombosis | European radiology |
| An overweight female with a history of allergies and drug-induced liver injury. | Myoteri D, Grypari IM, Schina M, Lohse A, Tiniakos D | 2024-09-01 | autoimmune hepatitis, centrilobular liver injury, drug-induced liver injury | Journal of hepatology |
| Modulation of Metabolomic Profile in Sepsis According to the State of Immune Activation. | Kranidioti E, Ricaño-Ponce I, Antonakos N, Kyriazopoulou E, Kotsaki A, Tsangaris I, Markopoulou D, Rovina N, Antoniadou E, Koutsodimitropoulos I, Dalekos GN, Vlachogianni G, Akinosoglou K, Koulouras V, Komnos A, Kontopoulou T, Dimopoulos G, Netea MG, Kumar V, Giamarellos-Bourboulis EJ | 2024-08-23 | | Critical care medicine |
| Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome. | Magaz M, Giudicelli-Lett H, G Abraldes J, Nicoară-Farcău O, Turon F, Rajoriya N, Goel A, Raymenants K, Hillaire S, Téllez L, Elkrief L, Procopet B, Orts L, Nery F, Shukla A, Larrue H, Degroote H, Aguilera V, LLop E, Turco L, Indulti F, Gioia S, Tosetti G, Bitto N, Becchetti C, Alvarado E, Roig C, Diaz R, Praktiknjo M, Konicek AL, Olivas P, Fortea JI, Masnou H, Puente Á, Ardèvol A, Navascués CA, Romero-Gutiérrez M, Scheiner B, Semmler G, Mandorfer M, Damião F, Baiges A, Ojeda A, Simón-Talero M, González-Alayón C, Díaz A, García-Criado Á, De Gottardi A, Hernández-Guerra M, Genescà J, Drilhon N, Ferreira CN, Reiberger T, Rodríguez M, Morillas RM, Crespo J, Trebicka J, Bañares R, Villanueva C, Berzigotti A, Primignani M, La Mura V, Riggio O, Schepis F, Verhelst X, Calleja JL, Bureau C, Albillos A, Nevens F, Hernández-Gea V, Tripathi D, Rautou PE, García-Pagán JC | 2024-08-22 | Porto-sinusoidal vascular disorder, idiopathic portal hypertension, natural history | Journal of hepatology |
| Reproductive and pregnancy control in Wilson disease patients in Spain. | Romero-Gutiérrez M, Alonso P, Berenguer M, Olveira A, González-Diéguez ML, Iruzubieta P, Masnou H, Delgado M, Hernández-Guerra M, Lorente S, Lázaro M, Moreno-Planas JM, González C, Fernández-Álvarez P, Cuenca F, Gómez J, García-Villareal L, Rodríguez O, Mariño Z | 2024-08-14 | | European journal of gastroenterology & hepatology |
| Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma. | Stern L, Schmidt C, Kocheise L, Joerg V, Casar C, Walter A, Drenth JPH, Papp M, Gatselis NK, Zachou K, Pinter M, Scheiner B, Vogel A, Kirstein MM, Finkelmeier F, Waidmann O, Weinmann A, Milkiewicz P, Thorburn D, Halliday N, Lleo A, Huber S, Dalekos GN, Lohse AW, Wege H, von Felden J, Schulze K | 2024-08-13 | AIH, AILD, HCC, PBC, TACE, TKI | Annals of hepatology |
| Editorial: Tracking the course of Wilson's disease: Authors' reply. | Burghart L, Reiberger T, Staettermayer AF | 2024-08-09 | | Alimentary pharmacology & therapeutics |
| Clinical significance of transjugular liver biopsy in acute liver failure - a real-world analysis. | Nalbant B, Pape T, Schneider A, Seeliger B, Schirmer P, Heidrich B, Taubert R, Wedemeyer H, Lenzen H, Stahl K | 2024-08-08 | Acute liver failure, Liver biopsy, Liver transplant free survival, Transjugular liver biopsy | BMC gastroenterology |
| Anticoagulation for Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: A Systematic Review and Meta-Analysis. | Chrysafi P, Barnum K, Gerhard GM, Chiasakul T, Narang A, Mcnichol M, Riva N, Semmler G, Scheiner B, Acosta S, Rautou PE, Lauw MN, Berry J, Ageno W, Zwicker JI, Patell R | 2024-08-08 | Anticoagulation, Bleeding, Myeloproliferative disorders, Thrombosis | Journal of thrombosis and haemostasis : JTH |
| Internal medicine in the 21st century: Back to the future. | Gómez-Huelgas R, Dalekos GN, Dicker D, Montano N | 2024-08-02 | Internal medicine, Medical education, Multimorbidity, Subspecialization | European journal of internal medicine |
| Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis - an ELTR study. | van Hooff MC, de Veer RC, Karam V, Adam R, Taimr P, Polak WG, Pashtoun H, Murad SD, Corpechot C, Mirza D, Heneghan M, Lodge P, Oniscu GC, Thorburn D, Allison M, Metselaar HJ, den Hoed CM, van der Meer AJ | 2024-08-01 | Calcineurin inhibitors, Graft survival, Liver Transplantation, Primary Biliary Cholangitis, Survival | JHEP reports : innovation in hepatology |
| Fatigue is a symptom of clinical importance in patients with Primary Sclerosing Cholangitis (SOMA.LIV). | Johannes H, Laura B, Bernd L, Anne T, Christoph S | 2024-07-29 | | Journal of hepatology |
| PLCG2 Mutation in a Patient Presenting with Type 2 Autoimmune Hepatitis. | Gardin A, Gaigne L, Magérus A, Rieux-Laucat F, Jacquemin E | 2024-07-28 | | Journal of clinical and translational hepatology |
| Identification of new correctors for traffic-defective ABCB4 variants by a high-content screening approach. | Lakli M, Dumont J, Vauthier V, Charton J, Crespi V, Banet M, Riahi Y, Ben Saad A, Mareux E, Lapalus M, Gonzales E, Jacquemin E, Di Meo F, Deprez B, Leroux F, Falguières T | 2024-07-24 | | Communications biology |
| Unmet needs in autoimmune hepatitis: Results of the prospective multicentre European Reference Network Registry (R-LIVER). | Schregel I, Papp M, Sipeki N, Kovats PJ, Taubert R, Engel B, Campos-Murguia A, Dalekos GN, Gatselis N, Zachou K, Milkiewicz P, Janik MK, Raszeja-Wyszomirska J, Ytting H, Braun F, Casar C, Sebode M, Lohse AW, Schramm C | 2024-07-22 | autoimmune hepatitis, complete biochemical response, immunosuppression, remission, treatment regime | Liver international : official journal of the International Association for the Study of the Liver |
| Alcohol consumption and liver phenotype of individuals with alpha-1 antitrypsin deficiency. | Fromme M, Schneider CV, Guldiken N, Amzou S, Luo Y, Pons M, Genesca J, Miravitlles M, Thorhauge KH, Mandorfer M, Waern J, Schneider KM, Sperl J, Frankova S, Bartel M, Zimmer H, Zorn M, Krag A, Turner A, Trautwein C, Strnad P | 2024-07-19 | SERPINA1, FibroScan, Pi*Z, alcohol, liver cirrhosis, liver fibrosis | Liver international : official journal of the International Association for the Study of the Liver |
| Association of circulating Z-polymer with adverse clinical outcomes and liver fibrosis in adults with alpha-1 antitrypsin deficiency. | Fromme M, Rademacher L, Amzou S, Cook CD, Zacharias I, Zhang L, Ripollone JE, Strnad P | 2024-07-18 | FibroScan®, SERPINA1, alpha‐1 antitrypsin deficiency, augmentation therapy, liver fibrosis, transient elastography | United European gastroenterology journal |
| Dynamics of liver stiffness measurement and clinical course of primary biliary cholangitis. | Lam L, Soret PA, Lemoinne S, Hansen B, Hirschfield G, Gulamhusein A, Montano-Loza AJ, Lytvyak E, Parés A, Olivas I, Londono MC, Rodríguez-Tajes S, Eaton JE, Osman KT, Schramm C, Sebode M, Lohse AW, Dalekos G, Gatselis N, Nevens F, Cazzagon N, Zago A, Russo FP, Floreani A, Abbas N, Trivedi P, Thorburn D, Saffioti F, Barkai L, Roccarina D, Calvaruso V, Fichera A, Delamarre A, Sobenko N, Villamil AM, Medina-Morales E, Bonder A, Patwardhan V, Rigamonti C, Carbone M, Invernizzi P, Cristoferi L, van der Meer A, de Veer R, Zigmond E, Yehezkel E, Kremer AE, Deibel A, Bruns T, Große K, Wetten A, Dyson JK, Jones D, Levy C, Tanaka A, Dumortier J, Pageaux GP, de Lédinghen V, Carrat F, Chazouilléres O, Corpechot C | 2024-07-15 | Elastography, FibroScan, Liver stiffness, PBC, Prognosis, Time course | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association |
| Detection of polyreactive immunoglobulin G facilitates diagnosis in children with autoimmune hepatitis. | Engel B, Diestelhorst J, Hupa-Breier KL, Kirchner T, Henjes N, Loges S, Yuksel M, Janczyk W, Lalanne C, Zachou K, Oo YH, Gournay J, Pape S, Drenth JPH, Renand A, Dalekos GN, Muratori L, Socha P, Ma Y, Arikan C, Baumann U, Manns MP, Wedemeyer H, Junge N, Jaeckel E, Taubert R | 2024-07-08 | Anti-liver kidney microsomal antibody, Anti-smooth muscle antibody, Anti-soluble liver antigen/liver pancreas, Antinuclear antibody, Huntingtin-interacting protein 1-related protein (HIP1R) | Hepatology international |
| Sirolimus to treat chronic and steroid-resistant allograft rejection-related fibrosis in pediatric liver transplantation. | Quintero Bernabeu J, Juamperez Goñi J, Mercadal Hally M, Padros Fornieles C, Ortega López J, Larrarte King M, Molino Gahete JA, Salcedo Allende MT, Hidalgo Llompart E, Bilbao Aguirre I, Charco Torra R | 2024-07-08 | biliary injury, immunosuppression, mammalian target of rapamycin inhibitors | Journal of pediatric gastroenterology and nutrition |
| Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure. | Semmler G, Alonso López S, Pons M, Lens S, Dajti E, Griemsmann M, Zanetto A, Burghart L, Hametner-Schreil S, Hartl L, Manzano M, Rodriguez-Tajes S, Zanaga P, Schwarz M, Gutierrez ML, Jachs M, Pocurull A, Polo B, Ecker D, Mateos B, Izquierdo S, Real Y, Balcar L, Carbonell-Asins JA, Gschwantler M, Russo FP, Azzaroli F, Maasoumy B, Reiberger T, Forns X, Genesca J, Bañares R, Mandorfer M | 2024-07-08 | | Hepatology (Baltimore, Md.) |
| Fazirsiran for Adults with Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA). | Clark VC, Strange C, Strnad P, Sanchez AJ, Kwo P, Pereira VM, van Hoek B, Barjaktarevic I, Corsico AG, Pons M, Goldklang M, Gray M, Kuhn B, Vargas HE, Vierling JM, Vuppalanchi R, Brantly M, Kappe N, Chang T, Schluep T, Zhou R, Hamilton J, San Martin J, Loomba R | 2024-07-02 | AAT, Alpha-1 antitrypsin deficiency, Fazirsiran, Liver disease, Z-AAT | Gastroenterology |
| Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder. | Moga L, Paradis V, Ferreira-Silva J, Gudavalli K, Indulti F, Dajti E, Nicoara-Farcau O, Tosetti G, Antonenko A, Fodor A, Vidal-González J, Turco L, Capinha F, Elkrief L, Monllor-Nunell T, Goria O, Balcar L, Lannes A, Mallet V, Poujol-Robert A, Thabut D, Houssel-Debry P, Wong YJ, Ronot M, Vilgrain V, Rampally SP, Payancé A, Castera L, Reiberger T, Ferrusquía-Acosta J, Noronha Ferreira C, Vitale G, Simon-Talero M, Procopet B, Berzigotti A, Caccia R, Turon F, Schepis F, Ravaioli F, Colecchia A, Valsan A, Macedo G, Plessier A, Rautou PE | 2024-07-02 | | Hepatology (Baltimore, Md.) |
| The phenotypic landscape of primary biliary cholangitis and autoimmune hepatitis variants. | Bolis F, Cazzaniga G, Pagni F, Invernizzi P, Carbone M, Gerussi A | 2024-06-29 | autoimmunity, biliary, liver, overlap | Gastroenterologia y hepatologia |
| A robust clustering strategy for stratification unveils unique patient subgroups in acutely decompensated cirrhosis. | Palomino-Echeverria S, Huergo E, Ortega-Legarreta A, Uson Raposo EM, Aguilar F, Peña-Ramirez C, López-Vicario C, Alessandria C, Laleman W, Queiroz Farias A, Moreau R, Fernandez J, Arroyo V, Caraceni P, Lagani V, Sánchez-Garrido C, Clària J, Tegner J, Trebicka J, Kiani NA, Planell N, Rautou PE, Gomez-Cabrero D | 2024-06-27 | ACLF, Cirrhosis, Clustering, Complex diseases, Patient heterogeneity, Stratification, Unsupervised learning | Journal of translational medicine |
| Easy recognition and high autoimmune hepatitis specificity of smooth muscle antibodies giving an actin microfilament immunofluorescent pattern on embryonal vascular smooth muscle cells. | Granito A, Muratori P, Pappas G, Lenzi M, Czaja AJ, Muratori L | 2024-06-21 | anti-microfilament antibodies (anti-MF), autoantibodies, autoimmune hepatitis (AIH), indirect immunofluorescence (IFL), smooth muscle antibodies (SMA) | Clinical and experimental immunology |
| Genetic predisposition to porto-sinusoidal vascular disorder. | Ciriaci N, Bertin L, Rautou PE | 2024-06-20 | | Hepatology (Baltimore, Md.) |
| Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis. | | 2024-06-19 | Autoimmunity, Bile acids, Cholestasis, Liver | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver |
| Reply: Mycophenolate Mofetil in Autoimmune Hepatitis: Are We Ready for Primetime? | Slooter CD, Stoelinga AEC, Snijders RJALM | 2024-06-15 | | Journal of hepatology |
| Intergenic risk variant rs56258221 skews the fate of naive CD4+ T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis. | Poch T, Bahn J, Casar C, Krause J, Evangelakos I, Gilladi H, Kunzmann LK, Laschtowitz A, Iuso N, Schäfer AM, Liebig LA, Steinmann S, Sebode M, Folseraas T, Engesæter LK, Karlsen TH, Franke A, Hubner N, Schlein C, Galun E, Huber S, Lohse AW, Gagliani N, Schwinge D, Schramm C | 2024-06-13 | BACH2, CD4 T cells, TH17 cells, genetic polymorphism, immune-mediated liver disease, miR4464, naive T cells, primary sclerosing cholangitis, regulatory T cells | Cell reports. Medicine |
| Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement. | Montano-Loza AJ, Corpechot C, Burra P, Schramm C, Selzner N, Ronca V, Oo YH | 2024-06-11 | | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society |
| The evolution of the TIPS placement technique and its applications over four decades. | Wang G, Zhang F, Ojeda A, Shalaby S, Hernandez-Gea V, Garcia-Pagan JC | 2024-06-08 | Liver cirrhosis, Portal hypertension, Transjugular intrahepatic portosystemic shunt | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver |
| Predictive role of hepatic venous pressure gradient in bleeding events among patients with cirrhosis undergoing orthotopic liver transplantation. | Giabicani M, Joly P, Sigaut S, Timsit C, Devauchelle P, Dondero F, Durand F, Froissant PA, Lamamri M, Payancé A, Restoux A, Roux O, Thibault-Sogorb T, Valainathan SR, Lesurtel M, Rautou PE, Weiss E | 2024-06-01 | bleeding, cirrhosis, hepatic venous pressure gradient, liver transplantation, portal hypertension, pre-transplant assessment | JHEP reports : innovation in hepatology |
| Loss of fenestrae in liver sinusoidal endothelial cells contributes to MASLD. | Ciriaci N, Rautou PE, Poisson J | 2024-06-01 | | Nature cardiovascular research |
| Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry. | Riveiro-Barciela M, Barreira-Díaz A, Esteban P, Rota R, Álvarez-Navascúes C, Pérez-Medrano I, Mateos B, Gómez E, De-la-Cruz G, Ferre-Aracil C, Horta D, Díaz-González Á, Ampuero J, Díaz-Fontenla F, Salcedo M, Ruiz-Cobo JC, Londoño MC | 2024-05-29 | anti‐CD20 monoclonal antibodies, autoimmune hepatitis, corticosteroids, liver cirrhosis, rituximab | Liver international : official journal of the International Association for the Study of the Liver |
| Optimizing thiopurine therapy in autoimmune hepatitis: A multi-center study on monitoring metabolite profiles and co-therapy with allopurinol. | Weltzsch JP, Bartel CF, Waldmann M, Renné T, Schulze S, Terziroli Beretta-Piccoli B, Papp M, Ye O, Ronca V, Sebode M, Lohse AW, Schramm C, Hartl J | 2024-05-29 | | Hepatology (Baltimore, Md.) |
| Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis-Authors' reply. | Burghart L, Hofer BS, Halilbasic E, Simbrunner B, Staettermayer AF, Trauner M, Reiberger T | 2024-05-27 | | Alimentary pharmacology & therapeutics |
| Portal hypertension and its prognostic implications in patients with Wilson's disease. | Burghart L, Ferenci P, Petrenko O, Mandorfer M, Schwarz M, Gschwantler M, Trauner M, Reiberger T, Stättermayer AF | 2024-05-26 | | Alimentary pharmacology & therapeutics |
| Single Center Experience of Eus-Guided Cystogastrostomy and Lumen-Apposing Metal Stent (LAMS) Positioning in Children with Pancreatic Fluid Collections: A Case Series. | Pasqualetto AF, Boroni G, Moneghini D, Parolini F, Orizio P, Bulotta AL, Missale G, Alberti D | 2024-05-26 | LAMS, acute pancreatitis, endoscopic cyst-gastrostomy, pancreatic fluid collection, walled-off necrosis | Children (Basel, Switzerland) |
| French guidelines on TIPS: Indications and modalities. | Larrue H, Allaire M, Weil-Verhoeven D, Barge S, Thabut D, Payance A, Moga L, Jézéquel C, Artru F, Archambeaud I, Elkrief L, Oberti F, Roux C, Laleman W, Rudler M, Dharancy S, Laborde N, Minello A, Mouillot T, Desjonquères E, Wandji LCN, Bourlière M, Ganne-Carrié N, Bureau C | 2024-05-17 | TIPS, cirrhosis, guidelines, portal hypertension | Liver international : official journal of the International Association for the Study of the Liver |
| Impact of cholecystectomy on the gut-liver axis and metabolic disorders. | Raposo MA, Oliveira ES, Santos AD, Guadagnini D, Mourabit HE, Housset C, Lemoinne S, Saad MJA | 2024-05-08 | Bile Acids, Cholecystectomy, Gut microbiota, Metabolic Diseases | Clinics and research in hepatology and gastroenterology |
| Validation of NIAAAm-CRP criteria to predict alcohol-associated steatohepatitis on liver histology. | Stauber RE, Rautou PE, Stefanescu H, Horhat A, Thiele M, Lackner C | 2024-05-01 | Alcohol-associated liver disease, histology, noninvasive | JHEP reports : innovation in hepatology |
| Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply. | Hofer BS, Burghart L, Halilbasic E, Simbrunner B, Petrenko O, Mandorfer M, Stättermayer AF, Trauner M, Reiberger T | 2024-05-01 | | Alimentary pharmacology & therapeutics |
| Reply: Improving access to transient elastography data for real-world prognostic applications in primary biliary cholangitis. | Corpechot C, Lemoinne S, Soret PA, Chazouillères O, de Lédinghen V | 2024-05-01 | | Hepatology (Baltimore, Md.) |
| Abdominal surgery in patients with chronic noncirrhotic extra hepatic portal vein obstruction: A multicenter retrospective study. | Elkrief L, Denecheau-Girard C, Magaz M, Praktiknjo M, Colucci N, Ollivier-Hourmand I, Dumortier J, Simon Talero M, Tellez L, Artru F, Meszaros M, Verhelst X, Tabchouri N, Beires F, Andaluz I, Leo M, Diekhöner M, Dokmak S, Fundora Y, Vidal-Gonzalez J, Toso C, Plessier A, Carlos Garcia Pagan J, Rautou PE | 2024-04-29 | | Hepatology (Baltimore, Md.) |
| Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors. | Ollivier-Hourmand I, Lebedel L, Bartroli Alabau B, Goria O, Bureau C, Dumortier J, Heurgué A, Silvain C, De-Ledinghen V, Rautou PE, Payancé A, García Ballester T, Alvarado-Tapias E, Hernández-Gea V, Valla D, Zekrini K, Nguyen TTN, Dao T, Garcia Pagan JC, Morello R, Plessier A | 2024-04-26 | Acute portal thrombus, abdominal inflammation, recurrence, thrombophilia | Journal of hepatology |
| PPAR agonists in PBC: Where do we go from here? Or how to choose between the new and the old. | Tanaka A, Corpechot C | 2024-04-25 | | Clinics and research in hepatology and gastroenterology |
| Artificial intelligence supported ultrasonography: Can it be the solution for early and accurate diagnosis of steatotic liver disease? | Gabeta S, Rigopoulou EI, Dalekos GN | 2024-04-24 | Artificial intelligence, Metabolic dysfunction-associated steatotic liver disease, Steatotic liver disease, Ultrasonography | European journal of internal medicine |
| Blockade of neutrophil extracellular trap components ameliorates cholestatic liver disease in Mdr2 (Abcb4) knockout mice. | Hintermann E, Tondello C, Fuchs S, Bayer M, Pfeilschifter JM, Taubert R, Mollenhauer M, Elferink RPJO, Manns MP, Christen U | 2024-04-22 | Autoimmune liver disease, Hepatobiliary disease, Mdr2 (Abcb4) knockout mouse, Neutrophil elastase, Neutrophil extracellular trap | Journal of autoimmunity |
| Acute Hepatitis of Unknown Origin in Children: Analysis of 17 Cases Admitted to the Bambino Gesù Children's Hospital in Rome. | Di Maio VC, Gentile L, Scutari R, Colagrossi L, Coltella L, Ranno S, Linardos G, Liccardo D, Basso MS, Pietrobattista A, Landi S, Forqué L, Ciofi Degli Atti M, Ricotta L, Onetti Muda A, Maggiore G, Raponi M, Perno CF, Russo C | 2024-04-19 | acute hepatitis, adenovirus, pediatric | Microorganisms |
| Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score. | Gerussi A, Cappadona C, Bernasconi DP, Cristoferi L, Valsecchi MG, Carbone M, Invernizzi P, Asselta R | 2024-04-15 | autoimmunity, liver, precision medicine, risk stratification | Liver international : official journal of the International Association for the Study of the Liver |
| Metabolic-Associated Steatotic Liver Disease (MASLD): A New Term for a More Appropriate Therapy in Pediatrics? | Antonella M, Pietrobattista A, Maggiore G | 2024-04-10 | | Pediatric reports |
| Impact of MASLD and MetALD on clinical outcomes: A meta-analysis of preliminary evidence. | Ciardullo S, Mantovani A, Morieri ML, Muraca E, Invernizzi P, Perseghin G | 2024-04-10 | MASLD, MetALD, cardiovascular disease, mortality | Liver international : official journal of the International Association for the Study of the Liver |
| Prognosis algorithms for acute decompensation of cirrhosis and ACLF. | Valainathan SR, Xie Q, Arroyo V, Rautou PE | 2024-04-09 | acute decompensation of cirrhosis, acute‐on‐chronic liver failure, cirrhosis, prognosis | Liver international : official journal of the International Association for the Study of the Liver |
| Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma. | Roehrig A, Hirsch TZ, Pire A, Morcrette G, Gupta B, Marcaillou C, Imbeaud S, Chardot C, Gonzales E, Jacquemin E, Sekiguchi M, Takita J, Nagae G, Hiyama E, Guérin F, Fabre M, Aerts I, Taque S, Laithier V, Branchereau S, Guettier C, Brugières L, Fresneau B, Zucman-Rossi J, Letouzé E | 2024-04-08 | | Nature communications |
| Apoptotic cell identity induces distinct functional responses to IL-4 in efferocytic macrophages. | Liebold I, Al Jawazneh A, Casar C, Lanzloth C, Leyk S, Hamley M, Wong MN, Kylies D, Gräfe SK, Edenhofer I, Aranda-Pardos I, Kriwet M, Haas H, Krause J, Hadjilaou A, Schromm AB, Richardt U, Eggert P, Tappe D, Weidemann SA, Ghosh S, Krebs CF, A-Gonzalez N, Worthmann A, Lohse AW, Huber S, Rothlin CV, Puelles VG, Jacobs T, Gagliani N, Bosurgi L | 2024-04-05 | | Science (New York, N.Y.) |
| Hepatomegaly in a patient with a history of acute myeloid leukemia. | Moga L, Paradis V, Bruno O, Valla D, Rautou PE | 2024-04-01 | constrictive pericarditis, hepatic sinusoidal dilatation, mosaic enhancement, portal hypertension, right heart catheterization | Journal of hepatology |
| Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis-More evidence needed. Authors' reply. | Martini A, Pontisso P | 2024-04-01 | | Alimentary pharmacology & therapeutics |
| Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis. | Hofer BS, Burghart L, Halilbasic E, Simbrunner B, Petrenko O, Mandorfer M, Stättermayer AF, Trauner M, Reiberger T | 2024-04-01 | Baveno VII, advanced chronic liver disease, cholestatic liver disease, disease regression, hepatic recompensation | Alimentary pharmacology & therapeutics |
| New horizons in the diagnosis and management of patients with MASLD. | van Erpecum KJ, Dalekos GN | 2024-04-01 | Metabolic dysfunction-associated steatohepatitis, Metabolic dysfunction-associated steatotic liver disease, Nomenclature | European journal of internal medicine |
| Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU. | Riveiro-Barciela M, Carballal S, Díaz-González Á, Mañosa M, Gallego-Plazas J, Cubiella J, Jiménez-Fonseca P, Varela M, Menchén L, Sangro B, Fernández-Montes A, Mesonero F, Rodríguez-Gandía MÁ, Rivera F, Londoño MC | 2024-04-01 | Colitis, Diarrea, Diarrhea, Drug-induced liver injury, Efectos adversos inmunomediados, Hepatitis, Hepatotoxicidad, Immune checkpoint inhibitors, Immune-related adverse events, Immunotherapy, Inhibidores de checkpoint inmunológicos, Inmunoterapia, Toxicidad, Toxicity | Gastroenterologia y hepatologia |
| Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort. | Kondili LA, Zanetto A, Quaranta MG, Ferrigno L, Panetta V, Calvaruso V, Zignego AL, Brunetto MR, Raimondo G, Biliotti E, Ieluzzi D, Iannone A, Madonia S, Chemello L, Cavalletto L, Coppola C, Morisco F, Barbaro F, Licata A, Federico A, Cerini F, Persico M, Pompili M, Ciancio A, Piscaglia F, Chessa L, Giacometti A, Invernizzi P, Brancaccio G, Benedetti A, Baiocchi L, Gentile I, Coppola N, Nardone G, Craxì A, Russo FP | 2024-04-01 | coagulation, direct‐acting antiviral, long term outcomes, predictive factors, real‐life cohort | United European gastroenterology journal |
| Calprotectin serum levels on admission and during follow-up predict severity and outcome of patients with COVID-19: A prospective study. | Gatselis NK, Lyberopoulou A, Lygoura V, Giannoulis G, Samakidou A, Vaiou A, Antoniou K, Triantafyllou K, Stefos A, Georgiadou S, Sagris D, Sveroni D, Gabeta S, Ntaios G, Norman GL, Dalekos GN | 2024-04-01 | Biomarker, COVID-19, Calprotectin, Outcome, Prognosis | European journal of internal medicine |
| Prednisolone with azathioprine or mycophenolate mofetil as first-line therapy in autoimmune hepatitis: insights from a randomized controlled trial. | Snijders RJALM, Stoelinga AEC, van Hoek B, Drenth JPH | 2024-03-28 | | Journal of hepatology |
| Endoscopic features of low-phospholipid-associated cholelithiasis syndrome: A retrospective cohort study. | Salin G, Corpechot C, Ouazana S, Dong C, Becq A, Lemoinne S, Ben Belkacem K, Leenhardt R, Chaput U, Chazouillères O, Kirchgesner J, Camus M | 2024-03-23 | Ercp, Lpac, UDCA | Clinics and research in hepatology and gastroenterology |
| Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease. | Loomba R, Clark G, Teckman J, Ajmera V, Behling C, Brantly M, Brenner D, D'Armiento J, Fried MW, Iyer JS, Mandorfer M, Rockey DC, Tincopa M, Vuppalanchi R, Younossi Z, Krag A, Turner AM, Strnad P | 2024-03-22 | | Alimentary pharmacology & therapeutics |
| Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure. | Semmler G, Alonso López S, Pons M, Lens S, Dajti E, Griemsmann M, Zanetto A, Burghart L, Hametner-Schreil S, Hartl L, Manzano M, Rodriguez-Tajes S, Zanaga P, Schwarz M, Luisa Gutierrez M, Jachs M, Pocurull A, Polo B, Ecker D, Mateos B, Izquierdo S, Real Y, Ahumada A, Josef Maria Bauer D, Benjamin Mauz J, Casanova-Cabral M, Gschwantler M, Paolo Russo F, Azzaroli F, Maasoumy B, Reiberger T, Forns X, Genesca J, Bañares R, Mandorfer M | 2024-03-21 | Chronic hepatitis C, Compensated advanced chronic liver disease, Etiological cure, Liver stiffness measurement, SVR, Sustained virological response, Transient elastography | Journal of hepatology |
| Long-term outcome of combined radiologic and surgical strategy for the management of biliary complications after pediatric liver transplantation. | Calinescu AM, Monluc S, Franchi-Abella S, Habes D, Weber G, Almes MF, Waguet J, Jacquemin E, Fouquet V, Miatello J, Hery G, Baujard C, Gonzales E, Branchereau S, Guérin F | 2024-03-20 | Biliary complications, Pediatric liver transplantation, Repeated radiologic procedures | BMC research notes |
| ECFS standards of care on CFTR-related disorders: Identification and care of the disorders. | Simmonds NJ, Southern KW, De Wachter E, De Boeck K, Bodewes F, Mainz JG, Middleton PG, Schwarz C, Vloeberghs V, Wilschanski M, Bourrat E, Chalmers JD, Ooi CY, Debray D, Downey DG, Eschenhagen P, Girodon E, Hickman G, Koitschev A, Nazareth D, Nick JA, Peckham D, VanDevanter D, Raynal C, Scheers I, Waller MD, Sermet-Gaudelus I, Castellani C | 2024-03-19 | ABPA, Aquagenic palmoplantar keratoderma, Aquagenic wrinkling, Bronchiestasis, CFTR, CFTR-related disorder, Congenital absence of the vas deferens, Cystic fibrosis, Genetics, Intestinal current measurement, Nasal potential difference, Pancreatitis, Rhinosinusitis, Sclerosing cholangitis, Sweat test | Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society |
| Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study. | Dragoni G, Innocenti T, Amiot A, Castiglione F, Melotti L, Festa S, Savarino EV, Truyens M, Argyriou K, Noviello D, Molnar T, Bouillon V, Bezzio C, Eder P, Fernandes S, Kagramanova A, Armuzzi A, Oliveira R, Viola A, Ribaldone DG, Drygiannakis I, Viganò C, Calella F, Gravina AG, Pugliese D, Chaparro M, Ellul P, Vieujean S, Milla M, Caprioli F | 2024-03-19 | | The American journal of gastroenterology |
| Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial. | Kyriazopoulou E, Hasin-Brumshtein Y, Midic U, Poulakou G, Milionis H, Metallidis S, Astriti M, Fragkou A, Rapti A, Taddei E, Kalomenidis I, Chrysos G, Angheben A, Kainis I, Alexiou Z, Castelli F, Serino FS, Bakakos P, Nicastri E, Tzavara V, Ioannou S, Dagna L, Dimakou K, Tzatzagou G, Chini M, Bassetti M, Kotsis V, Tsoukalas DG, Selmi C, Konstantinou A, Samarkos M, Doumas M, Masgala A, Pagkratis K, Argyraki A, Akinosoglou K, Symbardi S, Netea MG, Panagopoulos P, Dalekos GN, Liesenfeld O, Sweeney TE, Khatri P, Giamarellos-Bourboulis EJ | 2024-03-12 | Anakinra, COVID-19, Endotypes, Viral sepsis | Critical care (London, England) |
| Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy. | Ampuero J, Lucena A, Berenguer M, Hernández-Guerra M, Molina E, Gómez-Camarero J, Valdivia C, Gómez E, Casado M, Álvarez-Navascuez C, Jorquera F, García-Buey L, Díaz-González Á, Morillas R, García-Retortillo M, Sousa JM, Pérez-Medrano I, Simón MÁ, Martínez J, Arenas J, Londoño MC, Olveira A, Fernández-Rodríguez C | 2024-03-06 | | Hepatology (Baltimore, Md.) |
| HEPARIN-BINDING PROTEIN LEVELS PREDICT UNFAVORABLE OUTCOME IN COVID-19 PNEUMONIA: A POST HOC ANALYSIS OF THE SAVE TRIAL. | Kyriazopoulou E, Dalekos GN, Metallidis S, Poulakou G, Papanikolaou IC, Tzavara V, Argyraki K, Alexiou Z, Panagopoulos P, Samarkos M, Chrysos G, Tseliou A, Milionis H, Sympardi S, Vasishta A, Giamarellos-Bourboulis EJ | 2024-03-01 | | Shock (Augusta, Ga.) |
| Corrigendum to "Expert management of congenital portosystemic shunts and their complications" [JHEP Reports 6 (2024)]. | McLin VA, Franchi-Abella S, Brütsch T, Bahadori A, Casotti V, de Ville de Goyet J, Dumery G, Gonzales E, Guérin F, Hascoet S, Heaton N, Kuhlmann B, Lador F, Lambert V, Marra P, Plessier DA, Quaglia A, Rougemont AL, Savale L, Sarma MS, Sitbon O, Superina RA, Uchida H, van Albada M, Johannes van der Doef HP, Vilgrain V, Wacker J, Zwaveling-Soonawala N, Debray D, Wildhaber BE | 2024-03-01 | | JHEP reports : innovation in hepatology |
| Failure of cholic acid therapy in a child with a bile acid synthesis defect and harboring plectin mutations. | Thébaut A, Aumar M, Gardin A, Almes M, Davit-Spraul A, Jacquemin E | 2024-03-01 | | Journal of pediatric gastroenterology and nutrition |
| Porto-sinusoidal vascular disorder in chronic HBV: A significant coexistence not to be overlooked. | Olivas P, Perez-Campuzano V, Orts L, Montironi C, Magaz M, Ruiz P, Shalaby S, Ojeda A, Rosich P, Baiges A, Turon F, Lens S, García Pagán JC, Hernández-Gea V | 2024-03-01 | Chronic Hepatitis B, Idiopathic portal hypertension, Incomplete septal cirrhosis, Non-cirrhotic Portal Hypertension, Obliterative portal venopathy, Porto-Sinusoidal Vascular Disease, Regenerative nodular hyperplasia, Vascular liver diseases | JHEP reports : innovation in hepatology |
| Expert opinion on bleeding risk from invasive procedures in cirrhosis. | Riescher-Tuczkiewicz A, Caldwell SH, Kamath PS, Villa E, Rautou PE | 2024-03-01 | INR, aPTT, anticoagulant, biopsy, coagulation, fibrinogen, haemorrhage, haemostasis, platelet, procedural related bleeding | JHEP reports : innovation in hepatology |
| The evolving phenotype of autoimmune hepatitis across the millennium: The 40-year experience of a referral centre in Italy. | Ferronato M, Lalanne C, Quarneti C, Panico ML, Guidi M, Lenzi M, Muratori L | 2024-03-01 | acute onset, autoimmune hepatitis, elderly, epidemiology, treatment response, update | Liver international : official journal of the International Association for the Study of the Liver |
| Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry. | Slooter CD, van den Brand FF, Lleo A, Colapietro F, Lenzi M, Muratori P, Kerkar N, Dalekos GN, Zachou K, Lucena MI, Robles-Díaz M, Di Zeo-Sánchez DE, Andrade RJ, Montano-Loza AJ, Lytvyak E, Lissenberg-Witte BI, Maisonneuve P, Bouma G, Macedo G, Liberal R, de Boer YS | 2024-03-01 | | Hepatology (Baltimore, Md.) |
| A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis. | Hirschfield GM, Bowlus CL, Mayo MJ, Kremer AE, Vierling JM, Kowdley KV, Levy C, Villamil A, Ladrón de Guevara Cetina AL, Janczewska E, Zigmond E, Jeong SH, Yilmaz Y, Kallis Y, Corpechot C, Buggisch P, Invernizzi P, Londoño Hurtado MC, Bergheanu S, Yang K, Choi YJ, Crittenden DB, McWherter CA | 2024-02-29 | | The New England journal of medicine |
| Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis. | Kowdley KV, Bowlus CL, Levy C, Akarca US, Alvares-da-Silva MR, Andreone P, Arrese M, Corpechot C, Francque SM, Heneghan MA, Invernizzi P, Jones D, Kruger FC, Lawitz E, Mayo MJ, Shiffman ML, Swain MG, Valera JM, Vargas V, Vierling JM, Villamil A, Addy C, Dietrich J, Germain JM, Mazain S, Rafailovic D, Taddé B, Miller B, Shu J, Zein CO, Schattenberg JM | 2024-02-29 | | The New England journal of medicine |
| NMR-based metabolomic signature: An important tool for the diagnosis and study of pathogenesis of autoimmune hepatitis. | Dimou A, Zachou K, Kostara C, Azariadis K, Giannoulis G, Lyberopoulou A, Bairaktari E, Dalekos GN | 2024-02-05 | | Hepatology (Baltimore, Md.) |
| Pediatric Autoimmune Hepatitis. | Nastasio S, Sciveres M, Francalanci P, Maggiore G | 2024-02-01 | | Pediatric reports |
| The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation. | Martini A, Turato C, Cannito S, Quarta S, Biasiolo A, Ruvoletto M, Novo E, Marafatto F, Guerra P, Tonon M, Clemente N, Bocca C, Piano SS, Guido M, Gregori D, Parola M, Angeli P, Pontisso P | 2024-02-01 | SB3-PD, SerpinB3, TGF-β1, fibrosis, portal hypertension, proinflammatory cytokines | Alimentary pharmacology & therapeutics |
| Autophagy and extracellular vesicles in the liver endothelium: friends or foes? | Biquard L, Rautou PE | 2024-02-01 | | Hepatology international |
| The ubiquitin-like modifier FAT10 is induced in MASLD and impairs the lipid-regulatory activity of PPARα. | Clavreul L, Bernard L, Cotte AK, Hennuyer N, Bourouh C, Devos C, Helleboid A, Haas JT, Verrijken A, Gheeraert C, Derudas B, Guille L, Chevalier J, Eeckhoute J, Vallez E, Dorchies E, Van Gaal L, Lassailly G, Francque S, Staels B, Paumelle R | 2024-02-01 | FAT10, Liver, MASH, MASLD, PPARα, UBD | Metabolism: clinical and experimental |
| Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ). | Fromme M, Hamesch K, Schneider CV, Mandorfer M, Pons M, Thorhauge KH, Pereira V, Sperl J, Frankova S, Reichert MC, Benini F, Burbaum B, Kleinjans M, Amzou S, Rademacher L, Bewersdorf L, Verbeek J, Nevens F, Genesca J, Miravitlles M, Nuñez A, Schaefer B, Zoller H, Janciauskiene S, Waern J, Oliveira A, Maia L, Simões C, Mahadeva R, Fraughen DD, Trauner M, Krag A, Lammert F, Bals R, Gaisa NT, Aigner E, Griffiths WJ, Denk H, Teumer A, McElvaney NG, Turner AM, Trautwein C, Strnad P | 2024-02-01 | Augmentation Therapy, Fibroscan, Liver Fibrosis, Pi∗Z, SERPINA1, α(1)-Antitrypsin Deficiency | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association |
| Expression of E-cadherin by CD8+ T cells promotes their invasion into biliary epithelial cells. | Davies SP, Ronca V, Wootton GE, Krajewska NM, Bozward AG, Fiancette R, Patten DA, Yankouskaya K, Reynolds GM, Pat S, Osei-Bordom DC, Richardson N, Grover LM, Weston CJ, Oo YH | 2024-01-29 | | Nature communications |
| Osteonecrosis risk after steroids-related treatment of COVID-19 is not negligible: A cross sectional study. | Koutalos AA, Koskiniotis A, Rountas C, Konstantinou E, Georgiadou S, Stefos A, Gatselis NK, Dalekos GN, Malizos KN | 2024-01-27 | COVID-19, Corticosteroids, Cross-Sectional studies, Femur head necrosis, Ferritin | European journal of internal medicine |
| Chronic Liver Diseases: What is Up? | Fagoonee S, Invernizzi P | 2024-01-22 | | Journal of clinical medicine |
| Long-term outcome for children undergoing open hepatico-jejunostomy for choledochal malformations: a 43-year single-center experience. | Stern MV, Boroni G, Parolini F, Torri F, Calza S, Alberti D | 2024-01-19 | Choledochal malformation, Long-term follow-up, Quality of life, Roux-en-Y hepaticojejunostomy | Pediatric surgery international |
| A novel way to evaluate autoantibody interference in samples with mixed antinuclear antibody patterns in the HEp-2 cell based indirect immunofluorescence assay and comparison of conventional microscopic and computer-aided pattern recognition. | Nagy G, Földesi R, Csípő I, Tarr T, Szűcs G, Szántó A, Bubán T, Szekanecz Z, Papp M, Kappelmayer J, Antal-Szalmás P | 2024-01-15 | ANA HEp-2 test, Automated pattern recognition, Indirect immunofluorescence, Mixed patterns, Multiple patterns | Clinica chimica acta; international journal of clinical chemistry |
| Beat the Clock: Assessment of Night Eating Syndrome and Circadian Rhythm in a Sample of Greek Adults. | Blouchou A, Chamou V, Eleftheriades C, Poulimeneas D, Kontouli KM, Gkiouras K, Bargiota A, Gkouskou KK, Rigopoulou E, Bogdanos DP, Goulis DG, Grammatikopoulou MG | 2024-01-05 | chronobiology, chrononutrition, chronotherapeutic interventions, circadian misalignment, eating disorder, insufficient sleep, metabolic disturbance, obesity, sleep disruption | Nutrients |
| SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma. | Martini A, Prasai K, Zemla TJ, Ahmed FY, Elnagar MB, Giama NH, Guzzardo V, Biasiolo A, Fassan M, Yin J, Pontisso P, Roberts LR | 2024-01-03 | SerpinB3/4, SerpinB3/4–IgM, cholangiocarcinoma, prognostic marker | Cancers |
| Advancements in pharmacological treatment of NAFLD/MASLD: a focus on metabolic and liver-targeted interventions. | Ciardullo S, Muraca E, Vergani M, Invernizzi P, Perseghin G | 2024-01-01 | GLP1-RA, MASH, MASLD, NASH, resmetirom | Gastroenterology report |
| Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease. | Kocheise L, Piseddu I, Vonderlin J, Tjwa ET, Buescher G, Meunier L, Goeggelmann P, Fianchi F, Dumortier J, Barciela MR, Gevers TJG, Beretta-Piccoli BT, Londoño MC, Frankova S, Roesner T, Joerg V, Schmidt C, Glaser F, Sutter JP, Fründt TW, Lohse AW, Huber S, von Felden J, Sebode M, Schulze K | 2024-01-01 | PD-1/PD-L1 immune checkpoint inhibitors, autoimmune disease (AID), autoimmune hepatitis (AIH), autoimmune liver diseases (AILD), immune checkpoint inhibitors (ICI), immune related adverse effects (irAEs), primary biliary cholangitis (PBC), primary sclerosing cholangites (PSC) | Frontiers in immunology |
| Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word setting. | Corpechot C, Verdoux M, Frank-Soltysiak M, Duclos-Vallée JC, Grimaldi L | 2024-01-01 | PBC, PSC, SARS-CoV-2, UDCA, chronic liver disease | Journal of medical virology |
| Expert management of congenital portosystemic shunts and their complications. | McLin VA, Franchi-Abella S, Brütsch T, Bahadori A, Casotti V, de Ville de Goyet J, Dumery G, Gonzales E, Guérin F, Hascoet S, Heaton N, Kuhlmann B, Lador F, Lambert V, Marra P, Plessier A, Quaglia A, Rougemont AL, Savale L, Sarma MS, Sitbon O, Superina RA, Uchida H, van Albada M, Johannes van der Doef HP, Vilgrain V, Wacker J, Zwaveling N, Debray D, Wildhaber BE | 2024-01-01 | adenoma, congenital portosystemic shunt, focal nodular hyperplasia, hepatocellular carcinoma, hyperandrogenism, hyperinsulinism, hypoglycemia, occlusion test, portal pressure, puberty, pulmonary hypertension, β-catenin | JHEP reports : innovation in hepatology |
| Developing a Tool for Differentiation Between Bacterial and Viral Respiratory Infections Using Myxovirus Resistance Protein A and C-Reactive Protein. | Iliopoulou K, Koufargyris P, Doulou S, Tasouli E, Katopodis S, Chachali SP, Schinas G, Karachalios C, Astriti M, Katsaounou P, Chrysos G, Seferlis T, Dimopoulou E, Kollia M, Poulakou G, Gerakari S, Papanikolaou IC, Milionis H, Dalekos GN, Tzavara V, Kontopoulou T, Giamarellos-Bourboulis EJ | 2024-01-01 | Bacterial infection, CRP, Diagnosis, MxA, Viral infection | Infectious diseases and therapy |
| Maternal liver-related symptoms during pregnancy in primary sclerosing cholangitis. | Nayagam JS, Weismüller TJ, Milkiewicz P, Wronka KM, Bik E, Schramm C, Fuessel K, Zhou T, Chang J, Färkkilä M, Carlsson Y, Lundman A, Cazzagon N, Corrà G, Rigopoulou E, Dalekos GN, Båve AL, Bergquist A, Ben Belkacem K, Marzioni M, Mancinelli M, Verhelst X, Marschall HU, Heneghan MA, Joshi D | 2024-01-01 | Bile acids, Cholangiopathy, Intrahepatic cholestasis of pregnancy, Primary sclerosing cholangitis, Pruritus, Ursodeoxycholic acid | JHEP reports : innovation in hepatology |
| Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica) study group. | Corti P, Ferrari GM, Faraguna MC, Capitoli G, Longo F, Corradini E, Casini T, Boscarol G, Pinto VM, Ghilardi R, Russo G, Colombatti R, Mariani R, Piperno A | 2024-01-01 | haemochromatosis, hyperferritinaemia, iron chelation, juvenile haemochromatosis, phlebotomy | British journal of haematology |
| [Splanchnic vein thrombosis]. | Riescher-Tuczkiewicz A, Elkrief L, Rautou PE | 2024-01-01 | Anticoagulants, Budd-Chiari syndrome, Cirrhose, Cirrhosis, Portal vein, Syndrome de Budd Chiari, Thrombose veineuse, Veine porte, Venous thrombosis | La Revue de medecine interne |
| Obeticholic acid as a second-line treatment for low phospholipid-associated cholelithiasis syndrome. | Soret PA, Lemoinne S, Mallet M, Belkacem KB, Chazouillères O, Corpechot C | 2024-01-01 | FXR, LPAC, OCA, UDCA | Alimentary pharmacology & therapeutics |
| HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy. | Sonneveld MJ, Chiu SM, Park JY, Brakenhoff SM, Kaewdech A, Seto WK, Tanaka Y, Carey I, Papatheodoridi M, Colombatto P, van Bömmel F, Janssen HL, Berg T, Zoulim F, Ahn SH, Dalekos GN, Erler NS, Brunetto M, Wedemeyer H, Cornberg M, Yuen MF, Agarwal K, Boonstra A, Buti M, Piratvisuth T, Papatheodoridis G, Chen CH, Maasoumy B | 2024-01-01 | Clinical Relapse, HBV DNA, HBsAg, HBsAg Loss | Gastroenterology |
| Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study. | Ribaldone DG, Parisio L, Variola A, Bossa F, Castiglione F, Marzo M, Piazza N, Aratari A, Savarino EV, Bodini G, Mastronardi M, Micheli F, Mazzuoli S, Ascolani M, Viganò C, Cappello M, Bezzio C, Ciccocioppo R, Scardino G, Sarli E, Pugliese D, Scaldaferri F, Napolitano D, Todeschini A, Geccherle A, Colaci N, Guerra M, Annese M, Testa A, Caiazzo A, Conforti FS, Festa S, Lorenzon G, Marra A, Magiotta A, Baccini F, Amato A, Poshnjari A, Vernero M, Caprioli F, Caviglia GP | 2024-01-01 | Biologics, IBD, Switch, Vedolizumab | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver |
| Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? | Corpechot C, Lemoinne S, Soret PA, Hansen B, Hirschfield G, Gulamhusein A, Montano-Loza AJ, Lytvyak E, Pares A, Olivas I, Eaton JE, Osman KT, Schramm C, Sebode M, Lohse AW, Dalekos G, Gatselis N, Nevens F, Cazzagon N, Zago A, Russo FP, Floreani A, Abbas N, Trivedi P, Thorburn D, Saffioti F, Barkai L, Roccarina D, Calvaruso V, Fichera A, Delamarre A, Sobenko N, Villamil AM, Medina-Morales E, Bonder A, Patwardhan V, Rigamonti C, Carbone M, Invernizzi P, Cristoferi L, van der Meer A, de Veer R, Zigmond E, Yehezkel E, Kremer AE, Deibel A, Bruns T, Große K, Wetten A, Dyson JK, Jones D, Dumortier J, Pageaux GP, de Lédinghen V, Chazouillères O, Carrat F | 2024-01-01 | | Hepatology (Baltimore, Md.) |
| The liver in Christian thought: Symbolism, morality, and spirituality. | Riva MA, Valnegri C, Invernizzi P | 2024-01-01 | | Clinical liver disease |
| Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? | Elvevi A, Laffusa A, Elisei F, Morzenti S, Guerra L, Rovere A, Invernizzi P, Massironi S | 2023-12-27 | Combined Therapies, Intrahepatic cholangiocarcinoma, Locoregional treatment, Neo-adjuvant therapy, Overall Survival, Prognostic factors, Response rates, Transarterial radioembolization | World journal of hepatology |
| Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA. | Hansen BE, Vandriel SM, Vig P, Garner W, Mogul DB, Loomes KM, Piccoli DA, Rand EB, Jankowska I, Czubkowski P, Gliwicz-Miedzińska D, Gonzales EM, Jacquemin E, Bouligand J, D'Antiga L, Nicastro E, Arnell H, Fischler B, Sokal É, Demaret T, Siew S, Stormon M, Karpen SJ, Romero R, Ebel NH, Feinstein JA, Roberts AJ, Evans HM, Sundaram SS, Chaidez A, Hardikar W, Shankar S, Fischer RT, Lacaille F, Debray D, Lin HC, Jensen MK, Jaramillo C, Karthikeyan P, Indolfi G, Verkade HJ, Larson-Nath C, Quiros-Tejeira RE, Valentino PL, Rogalidou M, Dezsőfi A, Squires JE, Schwarz K, Calvo PL, Bernabeu JQ, Zizzo AN, Nebbia G, Bulut P, Santos-Silva E, Fawaz R, Nastasio S, Karnsakul W, Tamara ML, Busoms CM, Kelly DA, Sandahl TD, Jimenez-Rivera C, Banales JM, Mujawar Q, Li LT, She H, Wang JS, Kim KM, Oh SH, Sanchez MC, Cavalieri ML, Lee WS, Hajinicolaou C, Lertudomphonwanit C, Waisbourd-Zinman O, Arikan C, Alam S, Carvalho E, Melere M, Eshun J, Önal Z, Desai DM, Wiecek S, Pinto RB, Wolters VM, Garcia J, Beretta M, Kerkar N, Brecelj J, Rock N, Lurz E, Blondet N, Shah U, Thompson RJ, Kamath BM | 2023-12-25 | | Hepatology (Baltimore, Md.) |
| Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis. | Ratziu V, Francque S, Behling CA, Cejvanovic V, Cortez-Pinto H, Iyer JS, Krarup N, Le Q, Sejling AS, Tiniakos D, Harrison SA | 2023-12-19 | | Hepatology (Baltimore, Md.) |
| Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma. | Calderaro J, Ghaffari Laleh N, Zeng Q, Maille P, Favre L, Pujals A, Klein C, Bazille C, Heij LR, Uguen A, Luedde T, Di Tommaso L, Beaufrère A, Chatain A, Gastineau D, Nguyen CT, Nguyen-Canh H, Thi KN, Gnemmi V, Graham RP, Charlotte F, Wendum D, Vij M, Allende DS, Aucejo F, Diaz A, Rivière B, Herrero A, Evert K, Calvisi DF, Augustin J, Leow WQ, Leung HHW, Boleslawski E, Rela M, François A, Cha AW, Forner A, Reig M, Allaire M, Scatton O, Chatelain D, Boulagnon-Rombi C, Sturm N, Menahem B, Frouin E, Tougeron D, Tournigand C, Kempf E, Kim H, Ningarhari M, Michalak-Provost S, Gopal P, Brustia R, Vibert E, Schulze K, Rüther DF, Weidemann SA, Rhaiem R, Pawlotsky JM, Zhang X, Luciani A, Mulé S, Laurent A, Amaddeo G, Regnault H, De Martin E, Sempoux C, Navale P, Westerhoff M, Lo RC, Bednarsch J, Gouw A, Guettier C, Lequoy M, Harada K, Sripongpun P, Wetwittayaklang P, Loménie N, Tantipisit J, Kaewdech A, Shen J, Paradis V, Caruso S, Kather JN | 2023-12-14 | | Nature communications |
| Prospective Comparison of Attenuation Imaging and Controlled Attenuation Parameter for Liver Steatosis Diagnosis in Patients With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes. | Dioguardi Burgio M, Castera L, Oufighou M, Rautou PE, Paradis V, Bedossa P, Sartoris R, Ronot M, Bodard S, Garteiser P, Van Beers B, Valla D, Vilgrain V, Correas JM | 2023-12-10 | Fatty Liver, Nonalcoholic, Steatohepatitis, Ultrasonography | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association |
| ∆4-3-oxo-5β-reductase deficiency: favorable outcome in 16 patients treated with cholic acid. | Gardin A, Ruiz M, Beime J, Cananzi M, Rathert M, Rohmer B, Grabhorn E, Almes M, Logarajah V, Peña-Quintana L, Casswall T, Darmellah-Remil A, Reyes-Domínguez A, Barkaoui E, Hierro L, Baquero-Montoya C, Baumann U, Fischler B, Gonzales E, Davit-Spraul A, Laplanche S, Jacquemin E | 2023-12-07 | AKR1D1, Bile acid, Genetic cholestasis | Orphanet journal of rare diseases |
| Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases. | Steinmann S, Hartl J, Weidemann S, Füssel K, Kroll C, Sebode M, Lohse AW, Schramm C | 2023-12-01 | Autoimmune hepatitis, Autoimmune liver disease, Controlled attenuation parameter, Inflammation, Non-invasive steatosis measurement, Primary biliary cholangitis, Primary sclerosing cholangitis, Steatosis hepatis | JHEP reports : innovation in hepatology |
| Predictors of 6-year event-free survival in Alagille syndrome patients treated with maralixibat, an ileal bile acid transporter inhibitor. | Sokol RJ, Gonzales EM, Kamath BM, Baker A, Vig P, Mogul DB, Garner W, Hansen BE, Jacquemin E, Thompson RJ | 2023-12-01 | | Hepatology (Baltimore, Md.) |
| Evaluation of Tofacitinib in Primary Sclerosing Cholangitis and Associated Colitis: A Multicenter, Retrospective Study. | Schregel I, Ramos GP, Ioannou S, Culver E, Färkkilä M, Schramm C | 2023-12-01 | | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association |
| Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors. | Sidali S, Borie R, Sicre de Fontbrune F, El Husseini K, Rautou PE, Lainey E, Goria O, Crestani B, Cadranel J, Cottin V, Bunel V, Dumortier J, Jacquemin E, Reboux N, Hirschi S, Bourdin A, Meszaros M, Dharancy S, Hilaire S, Mallet V, Reynaud-Gaubert M, Terriou L, Gottrand F, Abou Chahla W, Khan JE, Carrier P, Saliba F, Rubbia-Brandt L, Aubert JD, Elkrief L, de Lédinghen V, Abergel A, Olivier T, Houssel P, Jouneau S, Wemeau L, Bergeron A, Leblanc T, Ollivier-Hourmand I, Nguyen Khac E, Morisse-Pradier H, Ba I, Boileau C, Roudot-Thoraval F, Vilgrain V, Bureau C, Nunes H, Naccache JM, Durand F, Francoz C, Roulot D, Valla D, Paradis V, Kannengiesser C, Plessier A | 2023-11-06 | | Hepatology (Baltimore, Md.) |
| Current limitations of gene therapy for rare pediatric diseases: Lessons learned from clinical experience with AAV vectors. | Gardin A, Ronzitti G | 2023-11-01 | Adeno-associated virus, Gene therapy, Immune response, Neutralizing antibodies | Archives de pediatrie : organe officiel de la Societe francaise de pediatrie |
| FibroMeter scores are predictive noninvasive markers of advanced and significant liver fibrosis in patients with chronic viral hepatitis or metabolic dysfunction-associated steatotic liver disease. | Arvaniti P, Giannoulis G, Lygoura V, Gatselis NK, Gabeta S, Rigopoulou E, Koukoulis GK, Zachou K, Dalekos GN | 2023-11-01 | FibroMeter, FibroMeter vibration-controlled transient elastography, chronic viral hepatitis, liver fibrosis, metabolic dysfunction-associated steatotic liver disease | Annals of gastroenterology |
| Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant. | Mehta G, Riva A, Ballester MP, Uson E, Pujadas M, Carvalho-Gomes Â, Sahuco I, Bono A, D'Amico F, Viganò R, Diago E, Lanseros BT, Inglese E, Vazquez DM, Sharma R, Tsou HLP, Harris N, Broekhoven A, Kikkert M, Morales SPT, Myeni SK, Riveiro-Barciela M, Palom A, Zeni N, Brocca A, Cussigh A, Cmet S, Escudero-García D, Stocco M, Natola LA, Ieluzzi D, Paon V, Sangiovanni A, Farina E, di Benedetto C, Sánchez-Torrijos Y, Lucena-Varela A, Román E, Sánchez E, Sánchez-Aldehuelo R, López-Cardona J, Canas-Perez I, Eastgate C, Jeyanesan D, Morocho AE, Di Cola S, Lapenna L, Zaccherini G, Bongiovanni D, Zanaga P, Sayaf K, Hossain S, Crespo J, Robles-Díaz M, Madejón A, Degroote H, Fernández J, Korenjak M, Verhelst X, García-Samaniego J, Andrade RJ, Iruzubieta P, Wright G, Caraceni P, Merli M, Patel VC, Gander A, Albillos A, Soriano G, Donato MF, Sacerdoti D, Toniutto P, Buti M, Duvoux C, Grossi PA, Berg T, Polak WG, Puoti M, Bosch-Comas A, Belli L, Burra P, Russo FP, Coenraad M, Calleja JL, Perricone G, Berenguer M, Claria J, Moreau R, Arroyo V, Angeli P, Sánchez C, Ampuero J, Piano S, Chokshi S, Jalan R | 2023-11-01 | | Hepatology communications |
| Splanchnic vein thrombosis associated with SARS-CoV-2 infection: A VALDIG case-control study. | Deltenre P, Payancé A, Elkrief L, La Mura V, Artru F, Baiges A, Cervoni JP, China L, Colle I, Lemaitre E, Procopet B, Schiller D, Bureau C, Goria O, Ollivier I, Nuzzo A, Rautou PE, Plessier A | 2023-11-01 | Portal vein thrombosis, SARS-CoV-2 infection, Splanchnic vein thrombosis | JHEP reports : innovation in hepatology |
| Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity. | Tedbury PR, Manfredi C, Degenhardt F, Conway J, Horwath MC, McCracken C, Sorscher AJ, Moreau S, Wright C, Edwards C, Brewer J, Guarner J, de Wit E, Williamson BN, Suthar MS, Ong YT, Roback JD, Alter DN, Holter JC, Karlsen TH, Sacchi N, Romero-Gómez M, Invernizzi P, Fernández J, Buti M, Albillos A, Julià A, Valenti L, Asselta R, Banales JM, Bujanda L, de Cid R, Franke A, Sarafianos SG, Hong JS, Sorscher EJ, Ehrhardt A | 2023-11-01 | COVID-19, SARS-CoV-2, comorbidity, cystic fibrosis transmembrane conductance regulator, mucus membrane, virus replication | FASEB journal : official publication of the Federation of American Societies for Experimental Biology |
| The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study. | Dajti E, Ravaioli F, Paiola G, Volpi S, Colecchia L, Ferrarese A, Alemanni LV, Cusumano C, Di Biase AR, Marasco G, Vestito A, Festi D, Rautou PE, Cipolli M, Colecchia A | 2023-11-01 | CFLD, liver stiffness, liver transplantation, noncirrhotic portal hypertension, porto-sinusoidal vascular disease, spleen stiffness | Liver international : official journal of the International Association for the Study of the Liver |
| Artificial Intelligence and liver: Opportunities and barriers. | Balsano C, Burra P, Duvoux C, Alisi A, Piscaglia F, Gerussi A | 2023-11-01 | Artificial Intelligence, Big data, Imaging, Liver disease, Robotic, Transplantation | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver |
| Authors' reply to Zou et al. | Ciardullo S, Carbone M, Invernizzi P, Perseghin G | 2023-11-01 | | Liver international : official journal of the International Association for the Study of the Liver |
| Exploring the landscape of steatotic liver disease in the general US population. | Ciardullo S, Carbone M, Invernizzi P, Perseghin G | 2023-11-01 | Fibroscan, MAFLD, MASLD, steatotic liver disease | Liver international : official journal of the International Association for the Study of the Liver |
| Vaccination practices in pediatric transplantation: A survey among member centers of the European reference network TransplantChild. | Donà D, Bravo-Gallego LY, Remacha EF, Cananzi M, Gastaldi A, Canizalez JT, Stephenne X, Lacaille F, Lindemans C, Calore E, Galea N, Benetti E, Nachbaur E, Sandes AR, Teixeira A, Ferreira S, Klaudel-Dreszler M, Ackermann O, Boyer O, Espinosa L, Guereta LG, Sciveres M, Fischler B, Schwerk N, Neland M, Nicastro E, Dello Strologo L, Toporski J, Vainumae I, Rascon J, Urbonas V, Del Rosal T, López-Granados E, Perilongo G, Baker A, Vega PJ | 2023-11-01 | children, immunosuppression, transplant, vaccination, vaccine-preventable infections | Pediatric transplantation |
| Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms. | Massironi S, Mulinacci G, Gallo C, Elvevi A, Danese S, Invernizzi P, Vespa E | 2023-10-18 | Th2 response, cytokines, eosinophilic esophagitis, immune cells, pathogenesis, soluble inflammatory mediators, tissue remodeling | Cells |
| Therapeutic Challenges for Gastric Neuroendocrine Neoplasms: Take It or Leave It? | Cavalcoli F, Gallo C, Coltro LA, Rausa E, Cantù P, Invernizzi P, Massironi S | 2023-10-01 | chronic atrophic gastritis, endoscopic mucosal resection, endoscopic resection, endoscopic submucosal dissection, gastric neuroendocrine neoplasm, systemic therapies | Medicina (Kaunas, Lithuania) |
| Outcomes of 38 patients with PFIC3: Impact of genotype and of response to ursodeoxycholic acid therapy. | Gonzales E, Gardin A, Almes M, Darmellah-Remil A, Seguin H, Mussini C, Franchi-Abella S, Duché M, Ackermann O, Thébaut A, Habes D, Hermeziu B, Lapalus M, Falguières T, Combal JP, Benichou B, Valero S, Davit-Spraul A, Jacquemin E | 2023-10-01 | ABCB4, MDR3, biliary lithiasis, hepatocellular carcinoma, intrahepatic cholestasis of pregnancy, liver transplantation | JHEP reports : innovation in hepatology |
| Endothelial autophagy is not required for liver regeneration after partial hepatectomy in mice with fatty liver. | Hammoutene A, Tanguy M, Calmels M, Pravisani R, Albuquerque M, Casteleyn C, Slimani L, Sadoine J, Boulanger CM, Paradis V, Gilgenkrantz H, Rautou PE | 2023-10-01 | LSECs, NAFLD, autophagy, hepatectomy, liver regeneration | Liver international : official journal of the International Association for the Study of the Liver |
| Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group. | Gatselis NK, Zachou K, Loza AJM, Cançado ELR, Arinaga-Hino T, Muratori P, Efe C, Floreani A, Invernizzi P, Takahashi A, Takaki A, Beretta-Piccoli BT, van Hoek B, Lytvyak E, Guedes LV, Purnak T, Cazzagon N, Lygoura V, Arvaniti P, Rigopoulou EI, Muratori L, Dalekos GN | 2023-10-01 | Antimitochondrial antibodies, Autoantibodies, Autoimmune hepatitis, Autoimmune hepatitis/primary biliary cholangitis variant syndrome, Outcome, Primary biliary cholangitis | European journal of internal medicine |
| Hepatocyte-derived biomarkers predict liver-related events at 2 years in Child-Pugh class A alcohol-related cirrhosis. | Elkrief L, Ganne-Carrié N, Manceau H, Tanguy M, Valainathan SR, Riescher-Tuczkiewicz A, Biquard L, Barget N, Chaffaut C, Louvet A, Paradis V, Ziol M, Bæk R, Jørgensen MM, Van Niel G, Coly PM, Hammoutène A, Dujardin F, Peoc'h K, Poynard T, Chevret S, Rautou PE | 2023-10-01 | FibroTest, alcoholic liver disease, biomarkers, decompensation of cirrhosis, liver cirrhosis, prognosis | Journal of hepatology |
| Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis. | Lalloyer F, Mogilenko DA, Verrijken A, Haas JT, Lamazière A, Kouach M, Descat A, Caron S, Vallez E, Derudas B, Gheeraert C, Baugé E, Despres G, Dirinck E, Tailleux A, Dombrowicz D, Van Gaal L, Eeckhoute J, Lefebvre P, Goossens JF, Francque S, Staels B | 2023-10-01 | Roux-en-Y gastric bypass, bile acid, cholesterol, liver, transcriptome | Journal of hepatology |
| Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study. | Anstee QM, Lucas KJ, Francque S, Abdelmalek MF, Sanyal AJ, Ratziu V, Gadano AC, Rinella M, Charlton M, Loomba R, Mena E, Schattenberg JM, Noureddin M, Lazas D, Goh GBB, Sarin SK, Yilmaz Y, Martic M, Stringer R, Kochuparampil J, Chen L, Rodriguez-Araujo G, Chng E, Naoumov NV, Brass C, Pedrosa MC | 2023-10-01 | | Hepatology (Baltimore, Md.) |
| Diagnostic Approach to Elevated Liver Function Tests during Pregnancy: A Pragmatic Narrative Review. | Dajti E, Bruni A, Barbara G, Azzaroli F | 2023-09-16 | elastography, intrahepatic cholestasis of pregnancy, liver disease, liver enzymes, pre-eclampsia, pregnancy | Journal of personalized medicine |
| Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis. | Terziroli Beretta-Piccoli B, Buescher G, Dalekos G, Zachou K, Geerts A, Semmo N, Kolev M, De Martin E, Janik MK, Madaleno J, Lalosevic Stojkovic M, Dumortier J, Vanwolleghem T, Schregel I, Steinmann S, Lacaille F, Sebode M | 2023-09-14 | | Journal of autoimmunity |
| Total and individual PBC-40 scores are reliable for the assessment of health-related quality of life in Greek patients with primary biliary cholangitis. | I Rigopoulou E, Bakarozi M, Dimas I, Galanis K, Lygoura V, K Gatselis N, Koulentaki M, N Dalekos G | 2023-09-01 | PBC-40, Primary biliary cholangitis, quality of life | Journal of translational internal medicine |
| Autoimmune liver diseases and diabetes. | Jensen AH, Ytting H, Winther-Sørensen M, Burisch J, Bergquist A, Gluud LL, Wewer Albrechtsen NJ | 2023-09-01 | | European journal of gastroenterology & hepatology |
| Liver Histology Before Treatment Withdrawal in Autoimmune Hepatitis: Is It Time to Review the ESPGHAN Recommendations? | Maggiore G, Bernard O, Mosca A, Jacquemin E | 2023-09-01 | | Journal of pediatric gastroenterology and nutrition |
| Questionnaire PLD-complaint-specific assessment identifies need for therapy in polycystic liver disease: A multi-centric prospective study. | Billiet A, Temmerman F, Coudyzer W, Van den Ende N, Colle I, Francque S, De Maeght S, Janssens F, Orlent H, Sprengers D, Delwaide J, Decock S, De Vloo C, Moreno C, van Malenstein H, van der Merwe S, Verbeek J, Nevens F | 2023-09-01 | health-related quality of life, liver transplantation, liver volume, polycystic liver disease, somatostatin analogues | United European gastroenterology journal |
| Benefits of using exchangeable copper and the ratio of exchangeable copper in a real-world cohort of patients with Wilson disease. | Mariño Z, Molera-Busoms C, Badenas C, Quintero-Bernabeu J, Torra M, Forns X, Artuch R | 2023-09-01 | REC, Wilson disease, exchangeable copper, labile copper, non-ceruloplasmin bound copper, serum biomarkers | Journal of inherited metabolic disease |
| Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report. | Andrade RJ, Aithal GP, de Boer YS, Liberal R, Gerbes A, Regev A, Terziroli Beretta-Piccoli B, Schramm C, Kleiner DE, De Martin E, Kullak-Ublick GA, Stirnimann G, Devarbhavi H, Vierling JM, Manns MP, Sebode M, Londoño MC, Avigan M, Robles-Diaz M, García-Cortes M, Atallah E, Heneghan M, Chalasani N, Trivedi PJ, Hayashi PH, Taubert R, Fontana RJ, Weber S, Oo YH, Zen Y, Licata A, Lucena MI, Mieli-Vergani G, Vergani D, Björnsson ES | 2023-09-01 | AIH, DI-ALH, DILI, Drug-induced autoimmune-like hepatitis, Liver injury, autoimmune hepatitis, diagnosis, drug-induced liver injury, epidemiology, hepatotoxicity, management, outcome | Journal of hepatology |
| A proposal from the liver forum for the management of comorbidities in non-alcoholic steatohepatitis therapeutic trials. | Pais R, Cariou B, Noureddin M, Francque S, Schattenberg JM, Abdelmalek MF, Lalazar G, Varma S, Dietrich J, Miller V, Sanyal A, Ratziu V | 2023-09-01 | NAFLD, NASH, arterial hypertension, diabetes, dyslipidemia, fibrosis, metabolic syndrome, obesity, randomized placebo-controlled trials, run-in period | Journal of hepatology |
| Exploring the spectrum of incidental gastric polyps in autoimmune gastritis. | Massironi S, Elvevi A, Gallo C, Laffusa A, Tortorella A, Invernizzi P | 2023-09-01 | Atrophic gastritis, Autoimmune gastritis, Gastric polyp, Gastrin, Neuroendocrine tumors | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver |
| Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks. | Massironi S, Pirola L, Mulinacci G, Ciaccio A, Viganò C, Palermo A, Zilli A, Invernizzi P, Danese S | 2023-09-01 | Crohn’s disease, biologic therapy, inflammatory bowel diseases, liver toxicity, small molecules, ulcerative colitis | Inflammatory bowel diseases |
| Juvenile Autoimmune Hepatitis: Recent Advances in Diagnosis, Management and Long-Term Outcome. | Nastasio S, Mosca A, Alterio T, Sciveres M, Maggiore G | 2023-08-24 | active chronic hepatitis liver transplantation, acute liver failure, autoimmune hepatitis, autoimmune liver disease | Diagnostics (Basel, Switzerland) |
| Innate Immune Gene Polymorphisms and COVID-19 Prognosis. | Bakaros E, Voulgaridi I, Paliatsa V, Gatselis N, Germanidis G, Asvestopoulou E, Alexiou S, Botsfari E, Lygoura V, Tsachouridou O, Mimtsoudis I, Tseroni M, Sarrou S, Mouchtouri VA, Dadouli K, Kalala F, Metallidis S, Dalekos G, Hadjichristodoulou C, Speletas M | 2023-08-22 | CARD8, CD14, CD40, COVID-19, IL18, TLR2, TLR4, innate immunity, polymorphism, prognosis | Viruses |
| Circulating microRNAs improve bacterial infection diagnosis and overall survival prediction in acute decompensation of liver cirrhosis. | Chouik Y, Lebossé F, Plissonnier ML, Lega JC, Pradat P, Antonini T, Subic M, Hartig-Lavie K, Erard D, Villeret F, Guichon C, Payancé A, Radenne S, Rautou PE, Zoulim F, Levrero M | 2023-08-18 | Bacteriology, Cell biology | iScience |
| Focus on Liver Function Abnormalities in Patients With Turner Syndrome: Risk Factors and Evaluation of Fibrosis Risk. | Bourcigaux N, Dubost E, Buzzi JC, Donadille B, Corpechot C, Poujol-Robert A, Christin-Maitre S | 2023-08-18 | Turner syndrome, hormone replacement therapy, liver enzymes, liver fibrosis, primary ovarian insufficiency, steatosis | The Journal of clinical endocrinology and metabolism |
| JAG1 and THBS2 Mutations in a Child Presenting With Incomplete Alagille Syndrome. | Almes M, Gardin A, Davit-Spraul A, Bouligand J, Habes D, Jacquemin E | 2023-08-01 | cholestasis, modifier gene, next generation sequencing, thrombospondin 2 | JPGN reports |
| Reply to: "Ductular reaction is a prognostic factor in primary biliary cholangitis". | Carpino G, Cardinale V, Carbone M | 2023-08-01 | | JHEP reports : innovation in hepatology |
| Intensive care management of acute-on-chronic liver failure. | Perricone G, Artzner T, De Martin E, Jalan R, Wendon J, Carbone M | 2023-08-01 | Acute decompensation, Acute on chronic liver failure, Cirrhosis, Intensive care management, Liver transplantation, Organ failures | Intensive care medicine |
| Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study. | Sonneveld MJ, Chiu SM, Park JY, Brakenhoff SM, Kaewdech A, Seto WK, Tanaka Y, Carey I, Papatheodoridi M, Colombatto P, van Bömmel F, Berg T, Zoulim F, Ahn SH, Dalekos GN, Erler NS, Brunetto M, Wedemeyer H, Cornberg M, Yuen MF, Agarwal K, Boonstra A, Buti M, Piratvisuth T, Papatheodoridis G, Chen CH, Maasoumy B | 2023-08-01 | Entecavir, HBV DNA, HBcrAg, HBsAg, HBsAg loss, Tenofovir | JHEP reports : innovation in hepatology |
| Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis. | Thompson RJ, Artan R, Baumann U, Calvo PL, Czubkowski P, Dalgic B, D'Antiga L, Di Giorgio A, Durmaz Ö, Gonzalès E, Grammatikopoulos T, Gupte G, Hardikar W, Houwen RHJ, Kamath BM, Karpen SJ, Lacaille F, Lachaux A, Lainka E, Loomes KM, Mack CL, Mattsson JP, McKiernan P, Ni Q, Özen H, Rajwal SR, Roquelaure B, Shteyer E, Sokal E, Sokol RJ, Soufi N, Sturm E, Tessier ME, van der Woerd WL, Verkade HJ, Vittorio JM, Wallefors T, Warholic N, Yu Q, Horn P, Kjems L | 2023-08-01 | Bile acids and salts, Clinical trial, Enterohepatic circulation, Liver diseases | JHEP reports : innovation in hepatology |
| Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease. | Zachou K, Azariadis K, Lytvyak E, Snijders RJALM, Takahashi A, Gatselis NK, Robles M, Andrade RJ, Schramm C, Lohse AW, Tanaka A, Drenth JPH, Montano-Loza AJ, Dalekos GN | 2023-08-01 | Autoimmune hepatitis, Metabolic dysfunction-associated fatty liver disease, Non-alcoholic fatty liver disease, Non-alcoholic steatohepatitis | JHEP reports : innovation in hepatology |
| Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency. | Ruiz M, Lacaille F, Schrader C, Pons M, Socha P, Krag A, Sturm E, Bouchecareilh M, Strnad P | 2023-08-01 | | Seminars in liver disease |
| Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. | Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, Kremer AE, Zigmond E, Andreone P, Gordon SC, Bowlus CL, Lawitz EJ, Aspinall RJ, Pratt DS, Raikhelson K, Gonzalez-Huezo MS, Heneghan MA, Jeong SH, Ladrón de Guevara AL, Mayo MJ, Dalekos GN, Drenth JPH, Janczewska E, Leggett BA, Nevens F, Vargas V, Zuckerman E, Corpechot C, Fassio E, Hinrichsen H, Invernizzi P, Trivedi PJ, Forman L, Jones DEJ, Ryder SD, Swain MG, Steinberg A, Boudes PF, Choi YJ, McWherter CA | 2023-08-01 | | Hepatology (Baltimore, Md.) |
| Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression. | Jachs M, Panzer M, Hartl L, Schwarz M, Balcar L, Camp JV, Munda P, Mandorfer M, Trauner M, Aberle SW, Zoller H, Reiberger T, Ferenci P | 2023-08-01 | Antivirals, Cirrhosis, Hepatitis D, Treatment, Viral hepatitis | JHEP reports : innovation in hepatology |
| Nutritional optimization in medical and surgical treatment of IBD patients. | Viganò C, Sampietro GM | 2023-08-01 | | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver |
| Cholangiopathy in sickle cell disease. | Vo Quang E, Ithier G, Jager M, Plessier A | 2023-08-01 | Cholangiopathy, Sickle cell disease | Clinics and research in hepatology and gastroenterology |
| Patient-reported quality of care in primary sclerosing cholangitis. | Walmsley M, Tornai D, Cazzagon N, Leburgue A, Mrzljak A, Lenzen H, Carbone M, Madaleno J, Lleo A, Junge N, Schramm C, Bergquist A | 2023-08-01 | elastography, guidelines, inflammatory bowel disease, primary sclerosing cholangitis, symptoms | Liver international : official journal of the International Association for the Study of the Liver |
| Prevalence and dynamics of NAFLD-associated fibrosis in people living with HIV in Vienna from first presentation to last follow-up. | Schwarz C, Chromy D, Bauer D, Duong N, Schmidbauer VU, Schwarz M, Mandorfer M, Rieger A, Trauner M, Gschwantler M, Reiberger T | 2023-08-01 | Epidemiology, Human Immunodeficiency Virus, Metabolic dysfunction associated fatty liver disease, Non-alcoholic Fatty Liver Disease, Protease Inhibitors | Wiener klinische Wochenschrift |
| Health-Related Quality of Life in Patients Living with Wilson Disease in Spain: A Cross-Sectional Observational Study. | Mariño Z, Berenguer M, Peña-Quintana L, Olveira A, Miralpeix A, Sastre I, Reyes-Domínguez A, Castillo P, García-Solà C, Bono A, Romero M, Pérez-Sádaba FJ, Aceituno S, Anguera A | 2023-07-21 | Wilson disease, adherence, emotional status, health-related quality of life, real-world evidence | Journal of clinical medicine |
| Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later? | Brustia R, Bouattour M, Allaire M, Lequoy M, Hollande C, Regnault H, Blaise L, Ganne-Carrié N, Vilgrain V, Larrey E, Lim C, Scatton O, Mouhadi SE, Ozenne V, Paye F, Balladur P, Dohan A, Massault PP, Pol S, Dioguardi Burgio M, Sepulveda A, Cauchy F, Luciani A, Sommacale D, Leroy V, Calderaro J, Roudot-Thoraval F, Nault JC, Amaddeo G | 2023-07-17 | 2019-nCoV, COVID-19, Hepatocellular carcinoma, Management, cirrhosis | Annals of hepatology |
| SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves. | Bezzio C, Vernero M, Costa S, Armuzzi A, Fiorino G, Ardizzone S, Roselli J, Carparelli S, Orlando A, Caprioli FA, Castiglione F, Viganò C, Ribaldone DG, Zingone F, Monterubbianesi R, Imperatore N, Festa S, Daperno M, Scucchi L, Ferronato A, Pastorelli L, Alimenti E, Balestrieri P, Ricci C, Cappello M, Felice C, Coppini F, Alvisi P, Di Luna I, Gerardi V, Variola A, Mazzuoli S, Lenti MV, Saibeni S | 2023-07-05 | COVID-19, Inflammatory bowel disease, Outcome, Pandemic, SARS-CoV-2 | BMC gastroenterology |
| Radiologic Features of T10 Paravertebral Muscle Sarcopenia: Prognostic Factors in COVID-19. | Schinas G, Dimakopoulou V, Dionysopoulos K, Fezoulidi G, Vlychou M, Vassiou K, Gatselis NK, Samakidou A, Giannoulis G, Tzouvelekis A, Marangos M, Gogos C, Dalekos GN, Kalogeropoulou C, Akinosoglou K | 2023-07-01 | COVID-19, Chest computed tomography, Cross-sectional anatomy, Muscle mass, Prognostic factors, SAR-CoV-2 | Journal of clinical medicine research |
| NEN Gain or NEN Loss: Endoscopic Resection for Rectal Neuroendocrine Neoplasms < 15 mm. | Rossi RE, Massironi S | 2023-07-01 | | Digestive diseases and sciences |
| Setanaxib, a first-in-class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo-controlled, phase 2 trial. | Invernizzi P, Carbone M, Jones D, Levy C, Little N, Wiesel P, Nevens F | 2023-07-01 | NADPH oxidase 1/4 inhibitor, cholestasis, fibrosis, primary biliary cholangitis, setanaxib | Liver international : official journal of the International Association for the Study of the Liver |
| Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival. | Murillo Perez CF, Ioannou S, Hassanally I, Trivedi PJ, Corpechot C, van der Meer AJ, Lammers WJ, Battezzati PM, Lindor KD, Nevens F, Kowdley KV, Bruns T, Cazzagon N, Floreani A, Mason AL, Gulamhusein A, Ponsioen CY, Carbone M, Lleo A, Mayo MJ, Dalekos GN, Gatselis NK, Thorburn D, Verhelst X, Parés A, Londoño MC, Janssen HLA, Invernizzi P, Vuppalanchi R, Hirschfield GM, Hansen BE, Levy C | 2023-07-01 | early identification, monitoring, primary biliary cholangitis, prognosis, treatment | Liver international : official journal of the International Association for the Study of the Liver |
| Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value. | Sciascia S, Bizzaro N, Meroni PL, Dimitrios B, Borghi MO, Bossuyt X, Grossi C, Tornai D, Papp M, Shoenfeld Y, Ielo D, Fritzler MJ | 2023-07-01 | Antiphospholipid syndrome, Connective tissues disease, Interstitial lung disease, Primary biliary cirrhosis, Rheumatoid arthritis, Sclerosing cholangitis | Autoimmunity reviews |
| Bleeding and Thrombotic Complications in Patients With Cirrhosis: A State-of-the-Art Appraisal. | Rautou PE, Caldwell SH, Villa E | 2023-07-01 | Bleeding, Coagulation, Hemorrhage, Liver, Thrombus | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association |
| Reply to: "3P and 5P models of limited value for the detection of clinically significant portal hypertension in patients with hepatitis delta". | Jachs M, Mandorfer M, Reiberger T | 2023-07-01 | | Journal of hepatology |
| Etiology and Outcome of Adult and Pediatric Acute Liver Failure in Europe. | Lenz D, Hørby Jørgensen M, Kelly D, Cardinale V, Geerts A, Gonçalves Costa I, Fichtner A, Garbade SF, Hegen B, Hilberath J, de Kleine R, Kupčinskas L, McLin V, Niesert M, Prado Gonzalez V, Sturm E, Staufner C, Tjwa E, Willemse J, Zecher BF, Larsen FS, Sebode M, Ytting H | 2023-07-01 | | Journal of pediatric gastroenterology and nutrition |
| Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma. | Lapitz A, Azkargorta M, Milkiewicz P, Olaizola P, Zhuravleva E, Grimsrud MM, Schramm C, Arbelaiz A, O'Rourke CJ, La Casta A, Milkiewicz M, Pastor T, Vesterhus M, Jimenez-Agüero R, Dill MT, Lamarca A, Valle JW, Macias RIR, Izquierdo-Sanchez L, Pérez Castaño Y, Caballero-Camino FJ, Riaño I, Krawczyk M, Ibarra C, Bustamante J, Nova-Camacho LM, Falcon-Perez JM, Elortza F, Perugorria MJ, Andersen JB, Bujanda L, Karlsen TH, Folseraas T, Rodrigues PM, Banales JM | 2023-07-01 | Cholangiocarcinoma, Extracellular vesicles, Liquid biopsy, Mass spectrometry, Primary sclerosing cholangitis, Protein biomarkers, Single-cell RNA-sequencing | Journal of hepatology |
| Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis. | Guerrero A, Campo LD, Piscaglia F, Scheiner B, Han G, Violi F, Ferreira CN, Téllez L, Reiberger T, Basili S, Zamora J, Albillos A | 2023-07-01 | anticoagulation, cirrhosis, portal vein, thrombosis | Journal of hepatology |
| Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis. | de Veer RC, van Hooff MC, Corpechot C, Thorburn D, Invernizzi P, Lammers WJ, Janssen HLA, Battezzati PM, Nevens F, Lindor KD, Floreani A, Ponsioen CY, Mayo MJ, Parés A, Mason AL, Kowdley KV, Trivedi PJ, Hirschfield GM, Goet JC, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Hansen BE, Harms MH, van der Meer AJ | 2023-07-01 | | The American journal of gastroenterology |
| Evaluation of immunoserological detection of anti-liver kidney microsomal, anti-soluble liver antigen and anti-mitochondrial antibodies. | Campos-Murguia A, Henjes N, Loges S, Wedemeyer H, Jaeckel E, Taubert R, Engel B | 2023-06-20 | | Scientific reports |
| Inflammation and malnutrition in inflammatory bowel disease. | Massironi S, Viganò C, Palermo A, Pirola L, Mulinacci G, Allocca M, Peyrin-Biroulet L, Danese S | 2023-06-01 | | The lancet. Gastroenterology & hepatology |
| COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study. | Fazio N, Gervaso L, Halfdanarson TR, Sonbol M, Eiring RA, Pusceddu S, Prinzi N, Lombardi Stocchetti B, Grozinsky-Glasberg S, Gross DJ, Walter T, Robelin P, Lombard-Bohas C, Frassoni S, Bagnardi V, Antonuzzo L, Sparano C, Massironi S, Gelsomino F, Bongiovanni A, Ranallo N, Tafuto S, Rossi M, Cives M, Rasul Kakil I, Hamid H, Chirco A, Squadroni M, La Salvia A, Hernando J, Hofland J, Koumarianou A, Boselli S, Tamayo D, Mazzon C, Rubino M, Spada F | 2023-06-01 | COVID-19, SARS-CoV-2, coronavirus, neuroendocrine neoplasms, neuroendocrine tumors | Endocrine-related cancer |
| Late-onset enteric virus infection associated with hepatitis (EVAH) in transplanted SCID patients. | Riller Q, Fourgeaud J, Bruneau J, De Ravin SS, Smith G, Fusaro M, Meriem S, Magerus A, Luka M, Abdessalem G, Lhermitte L, Jamet A, Six E, Magnani A, Castelle M, Lévy R, Lecuit MM, Fournier B, Winter S, Semeraro M, Pinto G, Abid H, Mahlaoui N, Cheikh N, Florkin B, Frange P, Jeziorski E, Suarez F, Sarrot-Reynauld F, Nouar D, Debray D, Lacaille F, Picard C, Pérot P, Regnault B, Da Rocha N, de Cevins C, Delage L, Pérot BP, Vinit A, Carbone F, Brunaud C, Marchais M, Stolzenberg MC, Asnafi V, Molina T, Rieux-Laucat F, Notarangelo LD, Pittaluga S, Jais JP, Moshous D, Blanche S, Malech H, Eloit M, Cavazzana M, Fischer A, Ménager MM, Neven B | 2023-06-01 | B-cell function, CD8(+) T cells, SCID, enteric virus, gene therapy, interferon, transplantation | The Journal of allergy and clinical immunology |
| Cleaning up alpha-1 antitrypsin deficiency related liver disease. | Rademacher L, Fromme M, Strnad P | 2023-05-01 | | Current opinion in gastroenterology |
| Noninvasive identification of probable fibrotic nonalcoholic steatohepatitis across the spectrum of glucose tolerance in the United States. | Ciardullo S, Carbone M, Invernizzi P, Perseghin G | 2023-05-01 | FAST, Fibroscan, NAFLD, NASH, NFI | Diabetes research and clinical practice |
| Future Treatment Options and Regimens for Nonalcoholic Fatty Liver Disease. | Francque S, Ratziu V | 2023-05-01 | Endpoints, Fibrosis regression, NASH resolution, Pharmacological treatment | Clinics in liver disease |
| Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆" [J Hepatol (2020) 505-515]. | Anstee QM, Darlay R, Cockell S, Meroni M, Govaere O, Tiniakos D, Burt AD, Bedossa P, Palmer J, Liu YL, Aithal GP, Allison M, Yki-Järvinen H, Vacca M, Dufour JF, Invernizzi P, Prati D, Ekstedt M, Kechagias S, Francque S, Petta S, Bugianesi E, Clement K, Ratziu V, Schattenberg JM, Valenti L, Day CP, Cordell HJ, Daly AK | 2023-05-01 | | Journal of hepatology |
| Paediatric autoimmune hepatitis: Time to change the textbooks? | Lohse AW, Hørby Jørgensen M | 2023-05-01 | | Journal of hepatology |
| Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting in childhood. | Maggiore G, Bernard O, Mosca A, Ballot E, Johanet C, Jacquemin E | 2023-05-01 | autoimmune liver disease, liver transplantation, prothrombin ratio, treatment withdrawal | Journal of hepatology |
| Letter to the editor: discussing the place of TIPS in noncirrhotic patients with chronic extrahepatic portal vein occlusion (EHPVO). | Artru F, Rautou PE, Denys A | 2023-05-01 | | Hepatology (Baltimore, Md.) |
| Sporadic and MEN1-related gastrinoma and Zollinger-Ellison syndrome: differences in clinical characteristics and survival outcomes. | Massironi S, Rossi RE, Laffusa A, Eller-Vainicher C, Cavalcoli F, Zilli A, Ciafardini C, Sciola V, Invernizzi P, Peracchi M | 2023-05-01 | Gastrinoma, MEN-1, Multiple endocrine neoplasia type 1, Neuroendocrine neoplasms, Neuroendocrine tumors, Zollinger–Ellison syndrome | Journal of endocrinological investigation |
| Diet and non-alcoholic fatty liver disease, a short narrative review. | Kwanten WJ | 2023-04-01 | NAFLD, diet, lifestyle, mediterranean diet, recommendations, review | Acta gastro-enterologica Belgica |
| Salvage therapies of autoimmune hepatitis limit proinflammatory immune cells while sparing regulatory T cells. | Derben FC, Ytting H, Hartleben B, Bantel H, Wedemeyer H, Willemoe GL, Jaeckel E, Taubert R | 2023-04-01 | | Hepatology communications |
| Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study. | Dragoni G, Castiglione F, Bezzio C, Pugliese D, Spagnuolo R, Viola A, Cocomazzi F, Aratari A, Savarino EV, Balestrieri P, Onali S, Viganò C, Ribaldone DG, Innocenti T, Testa A, Saibeni S, Privitera G, Milla M, Armuzzi A, Fantini MC, Fiorino G | 2023-04-01 | Crohn's disease, Rutgeerts Score, endoscopic recurrence, ileo-colonic resection, immunoprophylaxis, inflammatory bowel disease, postoperative Crohn's disease, postoperative recurrence | United European gastroenterology journal |
| Management of splanchnic vein thrombosis. | Elkrief L, Payancé A, Plessier A, d'Alteroche L, Ronot M, Paradis V, Valla D, Rautou PE | 2023-04-01 | BCS, Budd-Chiari syndrome, CALR, calreticulin, Cavernoma, DOACs, direct-acting oral anticoagulants, Direct oral anticoagulants, EHPVO, extrahepatic portal vein obstruction, GFR, glomerular filtration rate, JAK2, Janus kinase 2, LMWH, low-molecular-weight heparin, MPN, myeloproliferative neoplasm, MTHFR, methylene-tetrahydrofolate reductase, PNH, paroxysmal nocturnal hemoglobinuria, PVT, portal vein thrombosis, Portal biliopathy, Portal vein recanalisation, SVT, splanchnic vein thrombosis, TIPS, transjugular intrahepatic portosystemic shunt, VKAs, vitamin K antagonists, Vascular liver diseases | JHEP reports : innovation in hepatology |
| Protective potential of the gallbladder in primary sclerosing cholangitis. | Cazzagon N, Gonzalez-Sanchez E, El-Mourabit H, Wendum D, Rainteau D, Humbert L, Corpechot C, Chazouillères O, Arrivé L, Housset C, Lemoinne S | 2023-04-01 | ABC, ATP-binding cassette transporter, Abcb4 knockout mice, BA, bile acid, Bile acids, C4, 7α-hydroxy-4-cholesten-3-one, CFTR, cystic fibrosis transmembrane conductance regulator, CK19, cytokeratin 19, Cholecystectomy, FGF19, fibroblast growth factor 19, Gallbladder volume, HPLC-MS/MS, high-performance liquid chromatography coupled to tandem mass spectrometry, IBD, inflammatory bowel disease, MRC, magnetic resonance cholangiography, Magnetic resonance imaging, PSC, primary sclerosing cholangitis, UDCA, ursodeoxycholic acid, ULN, upper limit of normal | JHEP reports : innovation in hepatology |
| The oft-overlooked cardiovascular complications of inflammatory bowel disease. | Massironi S, Mulinacci G, Gallo C, Viganò C, Fichera M, Villatore A, Peretto G, Danese S | 2023-04-01 | Atherosclerosis, JAK inhibitors, cardiovascular disease, inflammatory bowel disease/complications, myocarditis, prophylaxis, venous thromboembolism | Expert review of clinical immunology |
| Corrigendum to: "An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs" [J Hepatol 75 (2021) 572-581]. | Cordell HJ, Fryett JJ, Ueno K, Darlay R, Aiba Y, Hitomi Y, Kawashima M, Nishida N, Khor SS, Gervais O, Kawai Y, Nagasaki M, Tokunaga K, Tang R, Shi Y, Li Z, Juran BD, Atkinson EJ, Gerussi A, Carbone M, Asselta R, Cheung A, de Andrade M, Baras A, Horowitz J, Ferreira MAR, Sun D, Jones DE, Flack S, Spicer A, Mulcahy VL, Byan J, Han Y, Sandford RN, Lazaridis KN, Amos CI, Hirschfield GM, Seldin MF, Invernizzi P, Siminovitch KA, Ma X, Nakamura M, Mells GF | 2023-04-01 | | Journal of hepatology |
| Reply. | Valainathan SR, Ronot M, Vilgrain V, Rautou PE | 2023-04-01 | | Hepatology (Baltimore, Md.) |
| Bile detection of squamous cell carcinoma antigen (SCCA) in extrahepatic cholangiocarcinoma. | Gringeri E, Biasiolo A, Di Giunta M, Mescoli C, Guzzardo V, Sartori A, Cirillo G, Nieddu E, D'Amico FE, Pontisso P, Cillo U | 2023-04-01 | Biomarkers, Cholangiocarcinoma, Liver, Prognosis, SerpinB3/4 | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver |
| Role of autoantibodies in the clinical management of primary biliary cholangitis. | Rigopoulou EI, Bogdanos DP | 2023-03-28 | Anti-gp210, Anti-mitochondrial antibodies, Anti-sp100, Primary biliary cholangitis, Primary biliary cholangitis-specific antinuclear antibodies, Prognosis | World journal of gastroenterology |
| Molecular and Clinical Links between Drug-Induced Cholestasis and Familial Intrahepatic Cholestasis. | Vitale G, Mattiaccio A, Conti A, Berardi S, Vero V, Turco L, Seri M, Morelli MC | 2023-03-18 | ABCB1, ABCB11, ABCB4, ABCC2, BSEP protein, MDR1 protein, MDR3 protein, MRP2, drug-induced cholestasis, familial intrahepatic cholestasis, idiosyncratic drug-induced liver injury | International journal of molecular sciences |
| Interaction between Gut Microbiota and Celiac Disease: From Pathogenesis to Treatment. | Rossi RE, Dispinzieri G, Elvevi A, Massironi S | 2023-03-07 | celiac disease, gut microbiota, immune response, intestinal microbiota | Cells |
| Monkeypox: A real new warning or just a sign of times? | Georgiadou SP, Giamarellos-Bourboulis EJ, Dalekos GN | 2023-03-01 | | Journal of translational internal medicine |
| Health-related quality of life and symptoms in autoimmune liver diseases. | Janik MK, Wunsch E, Milkiewicz P | 2023-03-01 | | Minerva gastroenterology |
| Autoimmune liver diseases. | Scaravaglio M, Carbone M, Invernizzi P | 2023-03-01 | | Minerva gastroenterology |
| Editorial: The next-generation toolkit for exploring biliary diseases. | Housset C | 2023-03-01 | | Current opinion in gastroenterology |
| Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial. | Jones D, Carbone M, Invernizzi P, Little N, Nevens F, Swain MG, Wiesel P, Levy C | 2023-03-01 | | Hepatology communications |
| Reply to: "2022 international autoimmune hepatitis group non-response criteria in autoimmune hepatitis: Quick vs. slow responders". | Snijders RJALM, Gevers TJG, Drenth JPH | 2023-03-01 | | Journal of hepatology |
| A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis. | Cristoferi L, Porta M, Bernasconi DP, Leonardi F, Gerussi A, Mulinacci G, Palermo A, Gallo C, Scaravaglio M, Stucchi E, Maino C, Ippolito D, D'Amato D, Ferreira C, Nardi A, Banerjee R, Valsecchi MG, Antolini L, Corso R, Sironi S, Fagiuoli S, Invernizzi P, Carbone M | 2023-03-01 | Artificial intelligence, MRCP, Primary sclerosing cholangitis, Prognostic score | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver |
| 2022 International autoimmune hepatitis group non-response criteria in autoimmune hepatitis: Quick vs. slow responders. | Engel B, Jaeckel E, Taubert R | 2023-03-01 | | Journal of hepatology |
| Risk stratification in primary sclerosing cholangitis. | Mulinacci G, Cristoferi L, Palermo A, Luca M, Gerussi A, Invernizzi P, Carbone M | 2023-03-01 | | Minerva gastroenterology |
| Open challenges in the management of autoimmune hepatitis. | Gerussi A, Halliday N, Carbone M, Invernizzi P, Thorburn D | 2023-03-01 | | Minerva gastroenterology |
| Diagnosis and management of autoimmune hepatitis. | Muratori L, Lohse AW, Lenzi M | 2023-02-06 | | BMJ (Clinical research ed.) |
| Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency. | Felzen A, van Wessel DBE, Gonzales E, Thompson RJ, Jankowska I, Shneider BL, Sokal E, Grammatikopoulos T, Kadaristiana A, Jacquemin E, Spraul A, Lipiński P, Czubkowski P, Rock N, Shagrani M, Broering D, Nicastro E, Kelly D, Nebbia G, Arnell H, Fischler B, Hulscher JBF, Serranti D, Arikan C, Polat E, Debray D, Lacaille F, Goncalves C, Hierro L, Muñoz Bartolo G, Mozer-Glassberg Y, Azaz A, Brecelj J, Dezsőfi A, Calvo PL, Grabhorn E, Hartleif S, van der Woerd WJ, Kamath BM, Wang JS, Li L, Durmaz Ö, Kerkar N, Jørgensen MH, Fischer R, Jimenez-Rivera C, Alam S, Cananzi M, Laverdure N, Ferreira CT, Guerrero FO, Wang H, Sency V, Kim KM, Chen HL, de Carvalho E, Fabre A, Bernabeu JQ, Zellos A, Alonso EM, Sokol RJ, Suchy FJ, Loomes KM, McKiernan PJ, Rosenthal P, Turmelle Y, Horslen S, Schwarz K, Bezerra JA, Wang K, Hansen BE, Verkade HJ | 2023-02-01 | ABCB11, ATP-binding cassette, sub-family B member 11, ALT, alanine aminotransferase, AST, aspartate aminotransferase, BSEP, BSEP, bile salt export pump, ChiLDReN, Childhood Liver Disease Research Network, GGT, gamma-glutamyltransferase, HCC, hepatocellular carcinoma, LTx, liver transplantation, NAPPED, NAtural course and Prognosis of PFIC and Effect of biliary Diversion, NLS, native liver survival, PFIC2, PFIC2, progressive familial intrahepatic cholestasis type 2, PPTM, predicted protein truncating mutation, REDCap, Research Electronic Data Capture, TSB, total serum bilirubin, UDCA, ursodeoxycholic acid, compound heterozygosity, genotype, interruption of the enterohepatic circulation, phenotype, sBAs, serum bile acids, siEHC, surgical interruption of the enterohepatic circulation | JHEP reports : innovation in hepatology |
| Letter: chronic HDV infection-is ignorance bliss? Authors' reply. | Jachs M, Reiberger T, Ferenci P | 2023-02-01 | | Alimentary pharmacology & therapeutics |
| Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial. | Akinosoglou K, Kotsaki A, Gounaridi IM, Christaki E, Metallidis S, Adamis G, Fragkou A, Fantoni M, Rapti A, Kalomenidis I, Chrysos G, Boni G, Kainis I, Alexiou Z, Castelli F, Serino FS, Bakakos P, Nicastri E, Tzavara V, Safarika A, Ioannou S, Dagna L, Dimakou K, Tzatzagou G, Chini M, Bassetti M, Kotsis V, Angheben A, Tsoukalas G, Selmi C, Spiropoulou OM, Samarkos M, Doumas M, Damoraki G, Masgala A, Papanikolaou I, Argyraki A, Negri M, Leventogiannis K, Sympardi S, Gatselis NK, Petrakis V, Netea MG, Panagopoulos P, Sakka V, Milionis H, Dalekos GN, Giamarellos-Bourboulis EJ | 2023-02-01 | Anakinra, COVID-19, Clinical efficacy, Co-morbidities, Cost, Survival, suPAR | EClinicalMedicine |
| Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia. | Samaras C, Kyriazopoulou E, Poulakou G, Reiner E, Kosmidou M, Karanika I, Petrakis V, Adamis G, Gatselis NK, Fragkou A, Rapti A, Taddei E, Kalomenidis I, Chrysos G, Bertoli G, Kainis I, Alexiou Z, Castelli F, Saverio Serino F, Bakakos P, Nicastri E, Tzavara V, Kostis E, Dagna L, Koukidou S, Tzatzagou G, Chini M, Bassetti M, Trakatelli C, Tsoukalas G, Selmi C, Samarkos M, Pyrpasopoulou A, Masgala A, Antonakis E, Argyraki A, Akinosoglou K, Sympardi S, Panagopoulos P, Milionis H, Metallidis S, Syrigos KN, Angel A, Dalekos GN, Netea MG, Giamarellos-Bourboulis EJ | 2023-02-01 | Anakinra, COVID-19, IP-10, Prognosis, Respiratory failure | Cytokine |
| Autoimmune serology testing in clinical practice: An updated roadmap for the diagnosis of autoimmune hepatitis. | Dalekos GN, Gatselis NK | 2023-02-01 | Antinuclear antibodies, Autoimmune hepatitis, Liver kidney microsomal antibodies, Smooth muscle antibodies, Soluble liver antigen antibodies | European journal of internal medicine |
| Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases†. | Nevens F, Trauner M, Manns MP | 2023-02-01 | FXR, OCA, PBC, PPAR, PSC, cholestasis, second-line therapy | Journal of hepatology |
| Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder. | Lampichler K, Semmler G, Wöran K, Simbrunner B, Jachs M, Hartl L, Bauer DJM, Balcar L, Burghart L, Trauner M, Tamandl D, Ba-Ssalamah A, Mandorfer M, Reiberger T, Scheiner B, Scharitzer M | 2023-02-01 | Contrast agent, Liver cirrhosis, Multiparametric magnetic resonance imaging, Portal vein | European radiology |
| Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis. | Reiniš J, Petrenko O, Simbrunner B, Hofer BS, Schepis F, Scoppettuolo M, Saltini D, Indulti F, Guasconi T, Albillos A, Téllez L, Villanueva C, Brujats A, Garcia-Pagan JC, Perez-Campuzano V, Hernández-Gea V, Rautou PE, Moga L, Vanwolleghem T, Kwanten WJ, Francque S, Trebicka J, Gu W, Ferstl PG, Gluud LL, Bendtsen F, Møller S, Kubicek S, Mandorfer M, Reiberger T | 2023-02-01 | hepatic venous pressure gradient, machine learning, non-invasive testing | Journal of hepatology |
| Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study. | Vandriel SM, Li LT, She H, Wang JS, Gilbert MA, Jankowska I, Czubkowski P, Gliwicz-Miedzińska D, Gonzales EM, Jacquemin E, Bouligand J, Spinner NB, Loomes KM, Piccoli DA, D'Antiga L, Nicastro E, Sokal É, Demaret T, Ebel NH, Feinstein JA, Fawaz R, Nastasio S, Lacaille F, Debray D, Arnell H, Fischler B, Siew S, Stormon M, Karpen SJ, Romero R, Kim KM, Baek WY, Hardikar W, Shankar S, Roberts AJ, Evans HM, Jensen MK, Kavan M, Sundaram SS, Chaidez A, Karthikeyan P, Sanchez MC, Cavalieri ML, Verkade HJ, Lee WS, Squires JE, Hajinicolaou C, Lertudomphonwanit C, Fischer RT, Larson-Nath C, Mozer-Glassberg Y, Arikan C, Lin HC, Bernabeu JQ, Alam S, Kelly DA, Carvalho E, Ferreira CT, Indolfi G, Quiros-Tejeira RE, Bulut P, Calvo PL, Önal Z, Valentino PL, Desai DM, Eshun J, Rogalidou M, Dezsőfi A, Wiecek S, Nebbia G, Pinto RB, Wolters VM, Tamara ML, Zizzo AN, Garcia J, Schwarz K, Beretta M, Sandahl TD, Jimenez-Rivera C, Kerkar N, Brecelj J, Mujawar Q, Rock N, Busoms CM, Karnsakul W, Lurz E, Santos-Silva E, Blondet N, Bujanda L, Shah U, Thompson RJ, Hansen BE, Kamath BM | 2023-02-01 | | Hepatology (Baltimore, Md.) |
| Analysis of the humoral and cellular response after the third COVID-19 vaccination in patients with autoimmune hepatitis. | Hartl J, Rüther DF, Duengelhoef PM, Brehm TT, Steinmann S, Weltzsch JP, Glaser F, Sterneck M, Sebode M, Weiler-Normann C, Lütgehetmann M, Schaub GM, Haag F, Schramm C, Wiesch JSZ, Lohse AW | 2023-02-01 | COVID-19 vaccination, autoimmune hepatitis, immunosuppression | Liver international : official journal of the International Association for the Study of the Liver |
| Fibrosis-Related Gene Profiling in Liver Biopsies of PiZZ α1-Antitrypsin Children with Different Clinical Courses. | Kamp JC, Kappe NN, Moro CF, Fuge J, Kuehnel MP, Wrenger S, Welte T, Hoek BV, Jonigk DD, Khedoe PPSJ, Strnad P, Björnstedt M, Stolk J, Janciauskiene S, Nemeth A | 2023-01-27 | PiZZ deficiency, Z-AAT polymers, cholestasis, cirrhosis, lipid metabolism, liver, mRNA expression, nCounter Fibrosis Panel, transcriptome profiling | International journal of molecular sciences |
| SERPINB3, Adult-Onset Immunodeficiency, and Generalized Pustular Psoriasis. | Kantaputra P, Daroontum T, Chuamanochan M, Chaowattanapanit S, Kiratikanon S, Choonhakarn C, Intachai W, Olsen B, Tongsima S, Ngamphiw C, Pontisso P, Cox TC, Ounjai P | 2023-01-19 | SERPIN, SERPINB3 mutation, adult-onset immunodeficiency syndrome, anti-interferon-γ autoantibody, generalized pustular psoriasis, hyperactive elastase activity, pustular skin reaction | Genes |
| Incidence of Isolated Biliary Atresia during the COVID Lockdown in Europe: Results from a Collaborative Project by RARE-Liver. | Nomden M, Alizai NK, Betalli P, Bruggink JLM, Cananzi M, Christensen VB, D'Antiga L, Davenport M, Fischler B, Hindemith L, Hukkinen M, Johansen LS, de Kleine RH, Madadi-Sanjani O, Ong EGP, Pakarinen MP, Petersen C, Ruiz M, Schunn M, Sturm E, Verkade HJ, Wildhaber BE, Hulscher JBF, On Behalf Of Members Of The Biliary Atresia And Related Disorders Bard Community The Ern Ra-Re-Liver | 2023-01-18 | COVID lockdown, European reference network RARE-LIVER, biliary atresia, epidemiology, stringency index | Journal of clinical medicine |
| Making inroads to precision medicine for the treatment of autoimmune diseases: Harnessing genomic studies to better diagnose and treat complex disorders. | Baglaenko Y, Wagner C, Bhoj VG, Brodin P, Gershwin ME, Graham D, Invernizzi P, Kidd KK, Korsunsky I, Levy M, Mammen AL, Nizet V, Ramirez-Valle F, Stites EC, Williams MS, Wilson M, Rose NR, Ladd V, Sirota M | 2023-01-01 | Autoimmunity, bioinformatics, data integration, diagnosis, genomics | Cambridge prisms. Precision medicine |
| PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease. | Kocheise L, Piseddu I, Vonderlin J, Tjwa ET, Buescher G, Meunier L, Goeggelmann P, Fianchi F, Dumortier J, Riveiro Barciela M, Gevers TJG, Terziroli Beretta-Piccoli B, Londoño MC, Frankova S, Roesner T, Joerg V, Schmidt C, Glaser F, Sutter JP, Fründt TW, Lohse AW, Huber S, von Felden J, Sebode M, Schulze K | 2023-01-01 | PD-1/PD-L1 immune checkpoint inhibitors, autoimmune disease (AID), autoimmune hepatitis (AIH), autoimmune liver diseases (AILD), immune checkpoint inhibitors (ICI), immune related adverse effects (irAEs), primary biliary cholangitis (PBC), primary sclerosing cholangites (PSC) | Frontiers in immunology |
| Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)-A European Society of Organ Transplantation (ESOT) Consensus Statement. | Carbone M, Della Penna A, Mazzarelli C, De Martin E, Villard C, Bergquist A, Line PD, Neuberger JM, Al-Shakhshir S, Trivedi PJ, Baumann U, Cristoferi L, Hov J, Fischler B, Hadzic NH, Debray D, D'Antiga L, Selzner N, Belli LS, Nadalin S | 2023-01-01 | IBD, PSC, immunosuppression, liver transplantation, retransplantation | Transplant international : official journal of the European Society for Organ Transplantation |
| Premature birth associated with a favorable course in gestational alloimmune liver disease (GALD): A case report. | Mulzer LM, Reutter H, Jüngert J, Knisely AS, Schmid M, Hoerning A, Morhart P | 2023-01-01 | gestational alloimmune liver disease, liver disease, neonatal acute liver failure, neonatal hemochromatosis, prematurit, prematurity | Frontiers in pediatrics |
| Urea cycle disorders and indications for liver transplantation. | García Vega M, Andrade JD, Morais A, Frauca E, Muñoz Bartolo G, Lledín MD, Bergua A, Hierro L | 2023-01-01 | hepatology, hyperammonemia, inborn errors of metabolism, liver transplant, urea cycle disorders | Frontiers in pediatrics |
| Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation. | Cortesi PA, Viganò R, Conti S, Lenci I, Volpes R, Martini S, Angelico M, Fung J, Buti M, Coilly A, Durand F, Fondevila C, Lebray P, Nevens F, Polak WG, Rizzetto M, Zoulim F, Perricone G, Berenguer M, Mantovani LG, Duvoux C, Belli LS | 2023-01-01 | economics, hepatitis B, immunoglobulin (IgG), liver transplant, prophylaxis | Transplant international : official journal of the European Society for Organ Transplantation |
| Histological and serological features of acute liver injury after SARS-CoV-2 vaccination. | Codoni G, Kirchner T, Engel B, Villamil AM, Efe C, Stättermayer AF, Weltzsch JP, Sebode M, Bernsmeier C, Lleo A, Gevers TJ, Kupčinskas L, Castiella A, Pinazo J, De Martin E, Bobis I, Sandahl TD, Pedica F, Invernizzi F, Del Poggio P, Bruns T, Kolev M, Semmo N, Bessone F, Giguet B, Poggi G, Ueno M, Jang H, Elpek GÖ, Soylu NK, Cerny A, Wedemeyer H, Vergani D, Mieli-Vergani G, Lucena MI, Andrade RJ, Zen Y, Taubert R, Terziroli Beretta-Piccoli B | 2023-01-01 | AIH, autoimmune hepatitis, ALP, alkaline phosphatase, ALT, alanine aminotransferase, AMA, anti-mitochondrial antibody, ANA, anti-nuclear antibody, AST, aspartate aminotransferase, COVID-19, coronavirus disease 2019, DILI, drug-induced liver injury, IAIHG, International Autoimmune Hepatitis Group, IFT, indirect immunofluorescence, LKM, liver kidney microsomal, LT, liver transplantation, PCA, parietal cell antigen, SARS-CoV-2 vaccines, SARS-CoV-2, severe acute respiratory syndrome coronavirus type 2, SLA, soluble liver antigen, SMA, anti-smooth muscle antibody, ULN, upper limit of normal, acute liver injury, autoimmune liver serology, liver histology, pIgG, polyreactive IgG | JHEP reports : innovation in hepatology |
| Maralixibat Treatment Response in Alagille Syndrome is Associated with Improved Health-Related Quality of Life. | Kamath BM, Goldstein A, Howard R, Garner W, Vig P, Marden JR, Billmyer E, Anderson A, Kirson N, Jacquemin E, Gonzales E | 2023-01-01 | HRQoL, PedsQL, cholestasis, family impact, fatigue, ileal bile acid transporter, liver disease, pediatric, rare disease, serum bile acids | The Journal of pediatrics |
| Author Correction: JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm. | Al-Rifai R, Vandestienne M, Lavillegrand JR, Mirault T, Cornebise J, Poisson J, Laurans L, Esposito B, James C, Mansier O, Hirsch P, Favale F, Braik R, Knosp C, Vilar J, Rizzo G, Zernecke A, Saliba AE, Tedgui A, Lacroix M, Arrive L, Mallat Z, Taleb S, Diedisheim M, Cochain C, Rautou PE, Ait-Oufella H | 2022-12-23 | | Nature communications |
| The Emerging Role of Tumor Microenvironmental Stimuli in Regulating Metabolic Rewiring of Liver Cancer Stem Cells. | Correnti M, Binatti E, Gammella E, Invernizzi P, Recalcati S | 2022-12-20 | cancer stem cells, heterogeneity, liver cancer, metabolism, plasticity, tumor microenvironment | Cancers |
| No association of serum ferritin levels with advanced liver fibrosis in untreated German patients with autoimmune hepatitis. | Engel B, Jaeckel E, Taubert R | 2022-12-19 | AIH, Biochemical remission, Incomplete response, Iron, Treatment response | BMC gastroenterology |
| Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study. | Yanai H, Kagramanova A, Knyazev O, Sabino J, Haenen S, Mantzaris GJ, Mountaki K, Armuzzi A, Pugliese D, Furfaro F, Fiorino G, Drobne D, Kurent T, Yassin S, Maharshak N, Castiglione F, de Sire R, Nardone OM, Farkas K, Molnar T, Krznaric Z, Brinar M, Chashkova E, Livne Margolin M, Kopylov U, Bezzio C, Bar-Gil Shitrit A, Lukas M, Chaparro M, Truyens M, Nancey S, Lobaton T, Gisbert JP, Saibeni S, Bacsúr P, Bossuyt P, Schulberg J, Hoentjen F, Viganò C, Palermo A, Torres J, Revés J, Karmiris K, Velegraki M, Savarino E, Markopoulos P, Tsironi E, Ellul P, Calviño Suárez C, Weisshof R, Ben-Hur D, Naftali T, Eriksson C, Koutroubakis IE, Foteinogiannopoulou K, Limdi JK, Liu E, Surís G, Calabrese E, Zorzi F, Filip R, Ribaldone DG, Snir Y, Goren I, Banai-Eran H, Broytman Y, Amir Barak H, Avni-Biron I, Ollech JE, Dotan I, Aharoni Golan M | 2022-12-05 | Crohn’s disease, biologics, post-operative recurrence | Journal of Crohn's & colitis |
| Gamma-Glutamyl Transferase in Patients With Primary Biliary Cholangitis. | Gerussi A | 2022-12-01 | | Gastroenterology & hepatology |
| Rivaroxaban Prophylaxis in Noncirrhotic Portal Vein Thrombosis. | Plessier A, Goria O, Cervoni JP, Ollivier I, Bureau C, Poujol-Robert A, Minello A, Houssel-Debry P, Rautou PE, Payancé A, Scoazec G, Bruno O, Corbic M, Durand F, Vilgrain V, Paradis V, Boudaoud L, de Raucourt E, Roy C, Gault N, Valla D | 2022-12-01 | | NEJM evidence |
| Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis. | Dalekos GN, Arvaniti P, Gatselis NK, Gabeta S, Samakidou A, Giannoulis G, Rigopoulou E, Koukoulis GK, Zachou K | 2022-12-01 | AIH, autoimmune hepatitis, ALT, alanine aminotransferase, ANA, antinuclear antibodies, AZA, azathioprine, Autoimmune hepatitis, Azathioprine, CBR, complete biochemical response, HASL, Hellenic Association for the Study of the Liver, HR, hazard ratio, IAIHG, International AIH Group, LSM, liver stiffness measurement, MMF, mycophenolate mofetil, Mycophenolate mofetil, Outcome, SMA, smooth muscle antibodies, Survival, ULN, upper limit of normal, anti-LC1, anti-liver cytosol type 1 antibodies, anti-LKM1, anti-liver/kidney microsomal type 1 antibodies, anti-SLA/LP, antibodies against soluble liver antigen/liver pancreas, mHAI, modified hepatitis activity index | JHEP reports : innovation in hepatology |
| GWAS and autoimmunity: What have we learned and what next. | Gerussi A, Soskic B, Asselta R, Invernizzi P, Gershwin ME | 2022-12-01 | Autoimmunity, Fine mapping, GWAS, Genetic variants, Liver, eQTL | Journal of autoimmunity |
| Continuous clinical remission with biologics in ulcerative colitis: the 'AURORA' comparison study. | Cassinotti A, Mezzina N, De Silvestri A, Di Paolo D, Lenti MV, Bezzio C, Stradella D, Mauri M, Zadro V, Ricci C, Casini V, Radice E, Massari A, Maconi G, Saibeni S, Caprioli F, Tari R, Fichera M, Cortelezzi CC, Parravicini M, Tinelli C, Testoni PA, Pace F, Segato S, Invernizzi P, Occhipinti P, Manes G, Di Sabatino A, Pastorelli L, Vecchi M, Ardizzone S | 2022-12-01 | | European journal of gastroenterology & hepatology |
| Predicting bleeding after liver biopsy using comprehensive clinical and laboratory investigations: A prospective analysis of 302 procedures. | Bissonnette J, Riescher-Tuczkiewicz A, Gigante E, Bourdin C, Boudaoud L, Soliman H, Durand F, Ronot M, Valla D, Vilgrain V, de Raucourt E, Rautou PE | 2022-12-01 | blood coagulation, diagnostic techniques and procedures, hemorrhage, liver cirrhosis, liver diseases | Journal of thrombosis and haemostasis : JTH |
| Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma. | Calderaro J, Di Tommaso L, Maillé P, Beaufrère A, Nguyen CT, Heij L, Gnemmi V, Graham RP, Charlotte F, Chartier S, Wendum D, Vij M, Allende D, Diaz A, Fuster C, Rivière B, Herrero A, Augustin J, Evert K, Calvisi DF, Leow WQ, Leung HHW, Bednarsch J, Boleslawski E, Rela M, Chan AW, Forner A, Reig M, Pujals A, Favre L, Allaire M, Scatton O, Uguen A, Trépo E, Sanchez LO, Chatelain D, Remmelink M, Boulagnon-Rombi C, Bazille C, Sturm N, Menahem B, Frouin E, Tougeron D, Tournigand C, Kempf E, Kim H, Ningarhari M, Michalak-Provost S, Kather JN, Gouw ASH, Gopal P, Brustia R, Vibert E, Schulze K, Rüther DF, Weidemann SA, Rhaiem R, Nault JC, Laurent A, Amaddeo G, Regnault H, de Martin E, Sempoux C, Navale P, Shinde J, Bacchuwar K, Westerhoff M, Lo RC, Sebbagh M, Guettier C, Lequoy M, Komuta M, Ziol M, Paradis V, Shen J, Caruso S | 2022-12-01 | cancer, cholangiocarcinoma, combined hepatocellular-cholangiocarcinoma, hepatocellular carcinoma, liver, nestin | Journal of hepatology |
| Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis. | Corpechot C, Carrat F, Gaouar F, Chau F, Hirschfield G, Gulamhusein A, Montano-Loza AJ, Lytvyak E, Schramm C, Pares A, Olivas I, Eaton JE, Osman KT, Dalekos G, Gatselis N, Nevens F, Cazzagon N, Zago A, Russo FP, Abbas N, Trivedi P, Thorburn D, Saffioti F, Barkai L, Roccarina D, Calvaruso V, Fichera A, Delamarre A, Medina-Morales E, Bonder A, Patwardhan V, Rigamonti C, Carbone M, Invernizzi P, Cristoferi L, van der Meer A, de Veer R, Zigmond E, Yehezkel E, Kremer AE, Deibel A, Dumortier J, Bruns T, Große K, Pageaux GP, Wetten A, Dyson J, Jones D, Chazouillères O, Hansen B, de Lédinghen V | 2022-12-01 | FibroScan, Mortality, PBC, Prognosis, Transplantation | Journal of hepatology |
| Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome. | Efe C, Kulkarni AV, Terziroli Beretta-Piccoli B, Magro B, Stättermayer A, Cengiz M, Clayton-Chubb D, Lammert C, Bernsmeier C, Gül Ö, la Tijera FH, Anders M, Lytvyak E, Akın M, Purnak T, Liberal R, Peralta M, Ebik B, Duman S, Demir N, Balaban Y, Urzua Á, Contreras F, Venturelli MG, Bilgiç Y, Medina A, Girala M, Günşar F, Londoño MC, Androutsakos T, Kisch A, Yurci A, Güzelbulut F, Çağın YF, Avcı E, Akyıldız M, Dindar-Demiray EK, Harputluoğlu M, Kumar R, Satapathy SK, Mendizabal M, Silva M, Fagiuoli S, Roberts SK, Soylu NK, Idilman R, Yoshida EM, Montano-Loza AJ, Dalekos GN, Ridruejo E, Schiano TD, Wahlin S | 2022-12-01 | | Hepatology (Baltimore, Md.) |
| Detailed stratified GWAS analysis for severe COVID-19 in four European populations. | Degenhardt F, Ellinghaus D, Juzenas S, Lerga-Jaso J, Wendorff M, Maya-Miles D, Uellendahl-Werth F, ElAbd H, Rühlemann MC, Arora J, Özer O, Lenning OB, Myhre R, Vadla MS, Wacker EM, Wienbrandt L, Blandino Ortiz A, de Salazar A, Garrido Chercoles A, Palom A, Ruiz A, Garcia-Fernandez AE, Blanco-Grau A, Mantovani A, Zanella A, Holten AR, Mayer A, Bandera A, Cherubini A, Protti A, Aghemo A, Gerussi A, Ramirez A, Braun A, Nebel A, Barreira A, Lleo A, Teles A, Kildal AB, Biondi A, Caballero-Garralda A, Ganna A, Gori A, Glück A, Lind A, Tanck A, Hinney A, Carreras Nolla A, Fracanzani AL, Peschuck A, Cavallero A, Dyrhol-Riise AM, Ruello A, Julià A, Muscatello A, Pesenti A, Voza A, Rando-Segura A, Solier A, Schmidt A, Cortes B, Mateos B, Nafria-Jimenez B, Schaefer B, Jensen B, Bellinghausen C, Maj C, Ferrando C, de la Horra C, Quereda C, Skurk C, Thibeault C, Scollo C, Herr C, Spinner CD, Gassner C, Lange C, Hu C, Paccapelo C, Lehmann C, Angelini C, Cappadona C, Azuure C, Bianco C, Cea C, Sancho C, Hoff DAL, Galimberti D, Prati D, Haschka D, Jiménez D, Pestaña D, Toapanta D, Muñiz-Diaz E, Azzolini E, Sandoval E, Binatti E, Scarpini E, Helbig ET, Casalone E, Urrechaga E, Paraboschi EM, Pontali E, Reverter E, Calderón EJ, Navas E, Solligård E, Contro E, Arana-Arri E, Aziz F, Garcia F, García Sánchez F, Ceriotti F, Martinelli-Boneschi F, Peyvandi F, Kurth F, Blasi F, Malvestiti F, Medrano FJ, Mesonero F, Rodriguez-Frias F, Hanses F, Müller F, Hemmrich-Stanisak G, Bellani G, Grasselli G, Pezzoli G, Costantino G, Albano G, Cardamone G, Bellelli G, Citerio G, Foti G, Lamorte G, Matullo G, Baselli G, Kurihara H, Neb H, My I, Kurth I, Hernández I, Pink I, de Rojas I, Galván-Femenia I, Holter JC, Afset JE, Heyckendorf J, Kässens J, Damås JK, Rybniker J, Altmüller J, Ampuero J, Martín J, Erdmann J, Banales JM, Badia JR, Dopazo J, Schneider J, Bergan J, Barretina J, Walter J, Hernández Quero J, Goikoetxea J, Delgado J, Guerrero JM, Fazaal J, Kraft J, Schröder J, Risnes K, Banasik K, Müller KE, Gaede KI, Garcia-Etxebarria K, Tonby K, Heggelund L, Izquierdo-Sanchez L, Bettini LR, Sumoy L, Sander LE, Lippert LJ, Terranova L, Nkambule L, Knopp L, Gustad LT, Garbarino L, Santoro L, Téllez L, Roade L, Ostadreza M, Intxausti M, Kogevinas M, Riveiro-Barciela M, Berger MM, Schaefer M, Niemi MEK, Gutiérrez-Stampa MA, Carrabba M, Figuera Basso ME, Valsecchi MG, Hernandez-Tejero M, Vehreschild MJGT, Manunta M, Acosta-Herrera M, D'Angiò M, Baldini M, Cazzaniga M, Grimsrud MM, Cornberg M, Nöthen MM, Marquié M, Castoldi M, Cordioli M, Cecconi M, D'Amato M, Augustin M, Tomasi M, Boada M, Dreher M, Seilmaier MJ, Joannidis M, Wittig M, Mazzocco M, Ciccarelli M, Rodríguez-Gandía M, Bocciolone M, Miozzo M, Imaz Ayo N, Blay N, Chueca N, Montano N, Braun N, Ludwig N, Marx N, Martínez N, Cornely OA, Witzke O, Palmieri O, Faverio P, Preatoni P, Bonfanti P, Omodei P, Tentorio P, Castro P, Rodrigues PM, España PP, Hoffmann P, Rosenstiel P, Schommers P, Suwalski P, de Pablo R, Ferrer R, Bals R, Gualtierotti R, Gallego-Durán R, Nieto R, Carpani R, Morilla R, Badalamenti S, Haider S, Ciesek S, May S, Bombace S, Marsal S, Pigazzini S, Klein S, Pelusi S, Wilfling S, Bosari S, Volland S, Brunak S, Raychaudhuri S, Schreiber S, Heilmann-Heimbach S, Aliberti S, Ripke S, Dudman S, Wesse T, Zheng T, Bahmer T, Eggermann T, Illig T, Brenner T, Pumarola T, Feldt T, Folseraas T, Gonzalez Cejudo T, Landmesser U, Protzer U, Hehr U, Rimoldi V, Monzani V, Skogen V, Keitel V, Kopfnagel V, Friaza V, Andrade V, Moreno V, Albrecht W, Peter W, Poller W, Farre X, Yi X, Wang X, Khodamoradi Y, Karadeniz Z, Latiano A, Goerg S, Bacher P, Koehler P, Tran F, Zoller H, Schulte EC, Heidecker B, Ludwig KU, Fernández J, Romero-Gómez M, Albillos A, Invernizzi P, Buti M, Duga S, Bujanda L, Hov JR, Lenz TL, Asselta R, de Cid R, Valenti L, Karlsen TH, Cáceres M, Franke A | 2022-11-28 | | Human molecular genetics |
| Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial. | Leventogiannis K, Kyriazopoulou E, Antonakos N, Kotsaki A, Tsangaris I, Markopoulou D, Grondman I, Rovina N, Theodorou V, Antoniadou E, Koutsodimitropoulos I, Dalekos G, Vlachogianni G, Akinosoglou K, Koulouras V, Komnos A, Kontopoulou T, Prekates A, Koutsoukou A, van der Meer JWM, Dimopoulos G, Kyprianou M, Netea MG, Giamarellos-Bourboulis EJ | 2022-11-15 | ferritin, immunoparalysis, macrophage activation, monocytes, mortality, sepsis | Cell reports. Medicine |
| JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm. | Al-Rifai R, Vandestienne M, Lavillegrand JR, Mirault T, Cornebise J, Poisson J, Laurans L, Esposito B, James C, Mansier O, Hirsch P, Favale F, Braik R, Knosp C, Vilar J, Rizzo G, Zernecke A, Saliba AE, Tedgui A, Lacroix M, Arrive L, Mallat Z, Taleb S, Diedisheim M, Cochain C, Rautou PE, Ait-Oufella H | 2022-11-03 | | Nature communications |
| Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis. | Cazzagon N, El Mouhadi S, Vanderbecq Q, Ferreira C, Finnegan S, Lemoinne S, Corpechot C, Chazouillères O, Arrivé L | 2022-11-01 | 3D, 3-dimensional, Cholestasis, ERCP, endoscopic retrograde cholangiopancreatography, HR, hazard ratio, IBD, inflammatory bowel disease, IHBD, intrahepatic bile duct, LSM, liver stiffness measurement, LT, liver transplantation, Liver stiffness, MR, magnetic resonance, MRCP+, MRCP, magnetic resonance cholangiopancreatography, MRI, magnetic resonance imaging, Magnetic resonance imaging, PSC, primary sclerosing cholangitis, Prognosis, VCTE, vibration-controlled transient elastography | JHEP reports : innovation in hepatology |
| A BCB4 variant is associated with hepatobiliary MR abnormalities in people with low-phospholipid-associated cholelithiasis syndrome. | Biyoukar M, Corpechot C, El Mouhadi S, Chambenois E, Vanderbecq Q, Barbu V, Dong C, Lemoinne S, Tordjman M, Jomaah R, Chazouilleres O, Arrivé L | 2022-11-01 | 3D, 3-dimensional, ABCB4, ABCB4, ATP-binding-cassette subfamily B, member 4, Cholelithiasis, GGT, gamma-glutamyl transferase, LPAC, LPAC, low-phospholipid-associated cholelithiasis, MDR3, MDR3, multidrug resistance protein 3, MR, magnetic resonance, MRC, MR cholangiography, MRCP, MRI, magnetic resonance imaging, OR, odds ratio, PACS, picture archive and communication system, UDCA, ursodeoxycholic acid, US, ultrasound, Ursodesoxycholic acid | JHEP reports : innovation in hepatology |
| Editorial: differences in altered duodenal T-cell immunology in alcoholic liver damage versus NAFLD. | Francque SMA | 2022-11-01 | | Alimentary pharmacology & therapeutics |
| Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis. | Corpechot C | 2022-11-01 | Baveno criteria, Elastography, PBC, Prognosis, Serum fibrosis markers, VCTE | Clinics in liver disease |
| Genetics of Primary Biliary Cholangitis. | Gerussi A, Asselta R, Invernizzi P | 2022-11-01 | Autoimmunity, Complex trait, GWAS, HLA, Liver | Clinics in liver disease |
| Role of ductular reaction and ductular-canalicular junctions in identifying severe primary biliary cholangitis. | Overi D, Carpino G, Cristoferi L, Onori P, Kennedy L, Francis H, Zucchini N, Rigamonti C, Viganò M, Floreani A, D'Amato D, Gerussi A, Venere R, Alpini G, Glaser S, Alvaro D, Invernizzi P, Gaudio E, Cardinale V, Carbone M | 2022-11-01 | AE2, anion exchanger 2, ALP, alkaline phosphatase, ALPt0, ALP at diagnosis, ALPt12, ALP at 12 months after UDCA therapy, ALT, alanine aminotransferase, ALTt0, ALT at diagnosis, AMA, antimitochondrial antibody, ANA, antinuclear antibody, AST, aspartate aminotransferase, ASTt0, AST at diagnosis, BAC, bile acid control, BIL, bilirubin, BILt0, BIL at diagnosis, CA, cholangitis activity, CK19, cytokeratin 19, CK7, cytokeratin 7, Cholangiopathy, Cholestasis, DCJ, ductular–canalicular junction, DCJ/d, DCJ per ductule, DCJ/pt, DCJ per portal tract, DR, ductular reaction, EpCAM, epithelial cell adhesion molecule, GGT, gamma-glutamyl transferase, HA, hepatitis activity, HSC, hepatic stellate cell, Histology, IH, intermediate hepatocyte, Liver biopsy, MF, myofibroblast, Muc-1, mucin 1, PBC, primary biliary cholangitis, PCNA, proliferating cell nuclear antigen, RT-qPCR, real-time quantitative PCR, Regeneration, SCTR, secretin receptor, SQ, semiquantitative, UDCA, ursodeoxycholic acid, ULN, upper limit of normal, URS, UDCA response score, Ursodeoxycholic acid, WT, wild type, αSMA, α-smooth muscle actin | JHEP reports : innovation in hepatology |
| Survey uncovering variations in the management of primary sclerosing cholangitis across Europe. | Eliasson J, Lo B, Schramm C, Chazouilleres O, Folseraas T, Beuers U, Ytting H | 2022-11-01 | Primary sclerosing cholangitis, cholangiocarcinoma, gallbladder polyp, inflammatory bowel disease, surveillance | JHEP reports : innovation in hepatology |
| Hepatic venous pressure gradient in sinusoidal obstruction syndrome: diagnostic value and link with histological lesions. | Gressens SB, Cazals-Hatem D, Lloyd V, Plessier A, Payancé A, Lebrec D, Durand F, Socie G, Valla D, Paradis V, Michonneau D, Rautou PE | 2022-11-01 | HSCT, hematopoietic stem cell transplantation, HVPG, hepatic venous pressure gradient, NPV, negative predictive value, PPV, positive predictive value, SOS, sinusoidal obstruction syndrome, ascites, jaundice, liver biopsy, portal hypertension | JHEP reports : innovation in hepatology |
| Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid. | de Veer RC, Harms MH, Corpechot C, Thorburn D, Invernizzi P, Janssen HLA, Battezzati PM, Nevens F, Lindor KD, Floreani A, Ponsioen CY, Mayo MJ, Parés A, Mason AL, Kowdley KV, Trivedi PJ, Hirschfield GM, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Lammers WJ, Hansen BE, van Buuren HR, van der Meer AJ | 2022-11-01 | GLOBE score, primary biliary cholangitis, second-line treatment, treatment response | Alimentary pharmacology & therapeutics |
| Reply to: "Correspondence on 'Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group'": Defining endpoints that guide treatment in autoimmune hepatitis. | Snijders RJALM, Gevers TJG, Heneghan MA, Drenth JPH | 2022-11-01 | | Journal of hepatology |
| Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid. | De Vincentis A, D'Amato D, Cristoferi L, Gerussi A, Malinverno F, Lleo A, Colapietro F, Marra F, Galli A, Fiorini C, Coco B, Brunetto M, Niro GA, Cotugno R, Saitta C, Cozzolongo R, Losito F, Giannini EG, Labanca S, Marzioni M, Marconi G, Morgando A, Pellicano R, Vanni E, Cazzagon N, Floreani A, Chessa L, Morelli O, Muratori L, Pellicelli A, Pompili M, Ponziani F, Tortora A, Rosina F, Russello M, Cannavò M, Simone L, Storato S, Viganò M, Abenavoli L, D'Antò M, De Gasperi E, Distefano M, Scifo G, Zolfino T, Calvaruso V, Cuccorese G, Palitti VP, Sacco R, Bertino G, Frazzetto E, Alvaro D, Mulinacci G, Palermo A, Scaravaglio M, Terracciani F, Galati G, Ronca V, Zuin M, Claar E, Izzi A, Picardi A, Invernizzi P, Vespasiani-Gentilucci U, Carbone M | 2022-11-01 | decision curve analysis, efficacy, liver decompensation, safety, total bilirubin | Liver international : official journal of the International Association for the Study of the Liver |
| Portal fibroblasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis. | Lei L, Bruneau A, El Mourabit H, Guégan J, Folseraas T, Lemoinne S, Karlsen TH, Hoareau B, Morichon R, Gonzalez-Sanchez E, Goumard C, Ratziu V, Charbord P, Gautheron J, Tacke F, Jaffredo T, Cadoret A, Housset C | 2022-11-01 | | Hepatology (Baltimore, Md.) |
| Increased concentrations of conjugated bile acids are associated with osteoporosis in PSC patients. | Stürznickel J, Behler-Janbeck F, Baranowsky A, Schmidt T, Schwinge D, John C, Lohse AW, Schramm C, Heeren J, Schinke T, Amling M | 2022-10-03 | | Scientific reports |
| Prognosis of Children Undergoing Liver Transplantation: A 30-Year European Study. | Baumann U, Karam V, Adam R, Fondevila C, Dhawan A, Sokal E, Jacquemin E, Kelly DA, Grabhorn E, Pawlowska J, D'Antiga L, Jara Vega P, Debray D, Polak WG, de Ville de Goyet J, Verkade HJ | 2022-10-01 | | Pediatrics |
| SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis. | Efe C, Taşçılar K, Gerussi A, Bolis F, Lammert C, Ebik B, Stättermayer AF, Cengiz M, Gökçe DT, Cristoferi L, Peralta M, Massoumi H, Montes P, Cerda E, Rigamonti C, Yapalı S, Adali G, Çalışkan AR, Balaban Y, Eren F, Eşkazan T, Barutçu S, Lytvyak E, Zazueta GM, Kayhan MA, Heurgue-Berlot A, De Martin E, Yavuz A, Bıyık M, Narro GC, Duman S, Hernandez N, Gatselis NK, Aguirre J, Idilman R, Silva M, Mendizabal M, Atay K, Güzelbulut F, Dhanasekaran R, Montano-Loza AJ, Dalekos GN, Ridruejo E, Invernizzi P, Wahlin S | 2022-10-01 | Autoimmunity, Breakthrough infection, Immunosuppression, Liver failure, Vaccine | Journal of autoimmunity |
| Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease. | Kong Y, Lv T, Li M, Zhao L, Meng T, Wu S, Wei W, Zhang Q, Chen S, You H, Lens S, Yoshiji H, Francque S, Tsochatzis E, Sarin SK, Mandorfer M, Jia J | 2022-10-01 | Advanced chronic liver disease, Antiviral therapy, Meta-analysis, Systematic review | Hepatology international |
| Acute Hepatitis of Unknown Etiology Among Young Children: Research Agenda by the ESPGHAN Hepatology Committee. | Indolfi G, Czubkowski P, Fitzpatrick E, Gonzales E, Gupte G, Mancell S, Mozer-Glassberg Y, Nicastro E, Norman J, Stephenne X, Zellos A, Samyn M | 2022-10-01 | | Journal of pediatric gastroenterology and nutrition |
| Efficacy and Safety of Endoscopic Primary Prophylaxis of Bleeding in Children With High-Risk Gastroesophageal Varices. | Ackermann O, Darmellah-Remil A, Bernard O, Boytchev I, Staiti G, Gonzalès E, Jacquemin E, Duché M | 2022-10-01 | | Journal of pediatric gastroenterology and nutrition |
| LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis. | Gerussi A, Verda D, Cappadona C, Cristoferi L, Bernasconi DP, Bottaro S, Carbone M, Muselli M, Invernizzi P, Asselta R, On Behalf Of The Italian Pbc Genetics Study Group | 2022-09-26 | autoimmunity, explainable artificial intelligence, genome-wide association study, genomics, liver, machine learning, precision medicine, primary biliary cholangitis, risk stratification | Journal of personalized medicine |
| Recent advances in the diagnosis and management of autoimmune hepatitis. | Dalekos GN, Samakidou A, Lyberopoulou A, Banakou E, Gatselis NK | 2022-09-26 | | Polish archives of internal medicine |
| In Vitro Rescue of the Bile Acid Transport Function of ABCB11 Variants by CFTR Potentiators. | Mareux E, Lapalus M, Ben Saad A, Zelli R, Lakli M, Riahi Y, Almes M, Banet M, Callebaut I, Decout JL, Falguières T, Jacquemin E, Gonzales E | 2022-09-15 | ABC transporter, BSEP, VX-770, cholestasis, pediatrics, potentiator | International journal of molecular sciences |
| Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? | Lacetera R, Roggero L, Vercelloni P, Uzzo M, Carbone M, Invernizzi P, L'Imperio V, Pieruzzi F, Sinico RA | 2022-09-01 | AA amyloidosis, Nephrotic syndrome, Primary sclerosing cholangitis | Case reports in nephrology and dialysis |
| Acute non-A, non-B, non-C hepatitis differences and similarities between hepatitis E virus infection and autoimmune hepatitis, with phylogenetic analysis of hepatitis E virus in humans and wild boars. | Zachou K, Azariadis K, Sofia M, Lyberopoulou A, Arvaniti P, Gatselis N, Spyrou V, Billinis C, Dalekos GN | 2022-09-01 | Hepatitis E virus, acute autoimmune hepatitis, genotyping, wild boars | Annals of gastroenterology |
| Impact of thiopurines and tumour necrosis factor antagonists on primary sclerosing cholangitis outcomes in patients with inflammatory bowel disease. | Biron A, Beaugerie L, Chazouillères O, Kirchgesner J | 2022-09-01 | anti-TNF, biliary tract cancer, inflammatory bowel disease, primary sclerosing cholangitis, thiopurines | Alimentary pharmacology & therapeutics |
| Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial. | Thompson RJ, Arnell H, Artan R, Baumann U, Calvo PL, Czubkowski P, Dalgic B, D'Antiga L, Durmaz Ö, Fischler B, Gonzalès E, Grammatikopoulos T, Gupte G, Hardikar W, Houwen RHJ, Kamath BM, Karpen SJ, Kjems L, Lacaille F, Lachaux A, Lainka E, Mack CL, Mattsson JP, McKiernan P, Özen H, Rajwal SR, Roquelaure B, Shagrani M, Shteyer E, Soufi N, Sturm E, Tessier ME, Verkade HJ, Horn P | 2022-09-01 | | The lancet. Gastroenterology & hepatology |
| [Hepatic granuloma-A diagnostic challenge]. | Horst LJ, Weidemann S, Lohse AW, Sebode M | 2022-09-01 | Hepatic sarcoidosis, Liver biopsy, Liver parenchymal damage, Liver values, Primary biliary cholangitis | Zeitschrift fur Rheumatologie |
| Standardizing the histological assessment of late posttransplantation biopsies from pediatric liver allograft recipients. | Hübscher SG, Feng S, Gouw ASH, Haga H, Kang HJ, Kelly DA, Komuta M, Lesniak A, Popp BA, Verkade HJ, Yu E, Demetris AJ | 2022-09-01 | | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society |
| Reply. | Valainathan SR, Rautou PE | 2022-09-01 | | Hepatology (Baltimore, Md.) |
| Primary biliary cholangitis: perception and expectation of illness. | Floreani A, Scaffidi M, Coco B, Giannini EG, Labanca S, Bonaiuto E, De Martin S, Invernizzi P, Carbone M, Alvaro D, Bragazzi MC, Calvaruso V, Cossiga V, Cazzagon N | 2022-09-01 | Illness perception, PBC, Quality of life, Questionnaire | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver |
| Complement C3 inhibition in severe COVID-19 using compstatin AMY-101. | Skendros P, Germanidis G, Mastellos DC, Antoniadou C, Gavriilidis E, Kalopitas G, Samakidou A, Liontos A, Chrysanthopoulou A, Ntinopoulou M, Kogias D, Karanika I, Smyrlis A, Cepaityte D, Fotiadou I, Zioga N, Mitroulis I, Gatselis NK, Papagoras C, Metallidis S, Milionis H, Dalekos GN, Willems L, Persson B, Manivel VA, Nilsson B, Connolly ES, Iacobelli S, Papadopoulos V, Calado RT, Huber-Lang M, Risitano AM, Yancopoulou D, Ritis K, Lambris JD | 2022-08-19 | | Science advances |
| Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency. | Strnad P, Mandorfer M, Choudhury G, Griffiths W, Trautwein C, Loomba R, Schluep T, Chang T, Yi M, Given BD, Hamilton JC, San Martin J, Teckman JH | 2022-08-11 | | The New England journal of medicine |
| Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction. | Artru F, Vietti-Violi N, Sempoux C, Vieira Barbosa J, Becce F, Sah N, Marot A, Deltenre P, Moschouri E, Fraga M, Hocquelet A, Duran R, Moradpour D, Rautou PE, Denys A | 2022-08-01 | CNC-EHPVO, chronic noncirrhotic extrahepatic portal vein obstruction, Chronic non-cirrhotic extrahepatic portal vein obstruction (CNC-EHPVO), DICOM, digital imaging and communications in medicine, EHPVO, extrahepatic portal vein obstruction, Gastrointestinal bleeding, HE, hepatic encephalopathy, L3, lumbar 3, L3SMI, skeletal muscle index at L3, L4, lumbar 4, NFH, non-fractioned heparin, PVR, portal vein recanalisation, Portal cholangiopathy, Portal hypertension, Portal vein recanalisation, SMI, skeletal muscle index, SMV, superior mesenteric vein, SV, splenic vein, Sarcopenia, TIPS, transjugular intrahepatic portosystemic shunt, TPMA, total psoas muscle area, US, ultrasound | JHEP reports : innovation in hepatology |
| HERACLIS-TAF: a multi-centre prospective cohort study on 2-year safety and efficacy of tenofovir alafenamide in patients with chronic hepatitis B with renal and/or bone disorders or risks. | Papatheodoridis GV, Mimidis K, Manolakopoulos S, Gatselis N, Goulis J, Kapatais A, Manesis E, Vasiliadis T, Triantos C, Samonakis D, Sevastianos V, Karatapanis S, Elefsiniotis I, Deutsch M, Mylopoulou T, Papatheodoridi M, Kranidioti H, Agorastou P, Karaoulani T, Kyriazidou A, Zisimopoulos K, Dalekos GN | 2022-08-01 | | Alimentary pharmacology & therapeutics |
| Children with autoimmune liver disease have limited access to age-appropriate drug formulations, results from a European survey. | Jørgensen MH, Cananzi M, Buescher G, Samyn M, De Bruyne R | 2022-08-01 | Liver, autoimmune liver disease, children, drug formulations, hepatitis, medications, paediatric, pharmacology | Journal of hepatology |
| Impact of the new definition of metabolic dysfunction-associated fatty liver disease on detection of significant liver fibrosis in US adolescents. | Ciardullo S, Carbone M, Invernizzi P, Perseghin G | 2022-08-01 | | Hepatology communications |
| Contrast-enhanced CT and liver surface nodularity for the diagnosis of porto-sinusoidal vascular disorder: A case-control study. | Valainathan SR, Sartoris R, Elkrief L, Magaz M, Betancourt F, Pellegrino S, Nivolli A, Dioguardi Burgio M, Flattet Y, Terraz S, Drilhon N, Lazareth M, Herrou J, Bruno O, Payance A, Plessier A, Durand F, Ronot M, Valla DC, Paradis V, Garcia-Pagan JC, Vilgrain V, Rautou PE | 2022-08-01 | | Hepatology (Baltimore, Md.) |
| International registry of congenital porto-systemic shunts: a multi-centre, retrospective and prospective registry of neonates, children and adults with congenital porto-systemic shunts. | Korff S, Mostaguir K, Beghetti M, D'Antiga L, Debray D, Franchi-Abella S, Gonzales E, Guerin F, Hachulla AL, Lambert V, Makrythanasis P, Roduit N, Savale L, Senat MV, Spaltenstein J, van Steenbeek F, Wildhaber BE, Zwahlen M, McLin VA | 2022-07-19 | Congenital, Liver, Portosystemic, Rare disease, Registry, Shunt | Orphanet journal of rare diseases |
| Tolerance and autoimmunity in the liver. | Schramm C, Oo YH, Lohse AW | 2022-07-01 | | Seminars in immunopathology |
| Imaging-guided interventions modulating portal venous flow: Evidence and controversies. | Cannella R, Tselikas L, Douane F, Cauchy F, Rautou PE, Duran R, Ronot M | 2022-07-01 | ALPPS, associating liver partition and portal vein ligation for staged hepatectomy, BSG, British Society of Gastroenterology, EASL, European Association for the Study of the Liver, FLR, future liver remnant, HE, hepatic encephalopathy, NCBA, N-butyl cyanoacrylate, PH, portal hypertension, PVE, portal vein embolisation, PVR, portal vein recanalisation, Portal vein interventions, RCT, randomised controlled trial, TACE, trans-arterial chemoembolization, TIPS, transjugular intrahepatic portosystemic shunt, image guided, portal hypertension, portal vein embolization, portal vein recanalization, transjugular intrahepatic portosystemic shunt | JHEP reports : innovation in hepatology |
| Review article: vascular effects of PPARs in the context of NASH. | Guixé-Muntet S, Biquard L, Szabo G, Dufour JF, Tacke F, Francque S, Rautou PE, Gracia-Sancho J | 2022-07-01 | | Alimentary pharmacology & therapeutics |
| Histological spectrum of autoimmune hepatitis-reply to Fujiwara K. et al. | Sebode M, Lohse AW, Hübscher SG, Tiniakos D | 2022-07-01 | | Liver international : official journal of the International Association for the Study of the Liver |
| Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" study. | Jachs M, Schwarz C, Panzer M, Binter T, Aberle SW, Hartl L, Dax K, Aigner E, Stättermayer AF, Munda P, Graziadei I, Holzmann H, Trauner M, Zoller H, Gschwantler M, Mandorfer M, Reiberger T, Ferenci P | 2022-07-01 | | Alimentary pharmacology & therapeutics |
| Autoimmune hepatitis and COVID-19: No increased risk for AIH after vaccination but reduced care. | Rüther DF, Weltzsch JP, Schramm C, Sebode M, Lohse AW | 2022-07-01 | Autoimmune hepatitis, COVID-19 vaccination, Orphanet | Journal of hepatology |
| Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation. | Montano-Loza AJ, Ronca V, Ebadi M, Hansen BE, Hirschfield G, Elwir S, Alsaed M, Milkiewicz P, Janik MK, Marschall HU, Burza MA, Efe C, Calışkan AR, Harputluoglu M, Kabaçam G, Terrabuio D, de Quadros Onofrio F, Selzner N, Bonder A, Parés A, Llovet L, Akyıldız M, Arikan C, Manns MP, Taubert R, Weber AL, Schiano TD, Haydel B, Czubkowski P, Socha P, Ołdak N, Akamatsu N, Tanaka A, Levy C, Martin EF, Goel A, Sedki M, Jankowska I, Ikegami T, Rodriguez M, Sterneck M, Weiler-Normann C, Schramm C, Donato MF, Lohse A, Andrade RJ, Patwardhan VR, van Hoek B, Biewenga M, Kremer AE, Ueda Y, Deneau M, Pedersen M, Mayo MJ, Floreani A, Burra P, Secchi MF, Beretta-Piccoli BT, Sciveres M, Maggiore G, Jafri SM, Debray D, Girard M, Lacaille F, Lytvyak E, Mason AL, Heneghan M, Oo YH | 2022-07-01 | autoimmune liver disease, graft survival, liver transplantation, recurrent disease, survival | Journal of hepatology |
| Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases. | Baiges A, Cerda E, Amicone C, Téllez L, Alvarado-Tapias E, Puente A, Fortea JI, Llop E, Rocha F, Orts L, Ros-Fargas O, Vizcarra P, Zekrini K, Lounes OA, Touati G, Jiménez-Esquivel N, Serrano MJ, Falgà A, Magaz M, Olivas P, Betancourt F, Perez-Campuzano V, Turon F, Payancé A, Goria O, Rautou PE, Hernández-Gea V, Villanueva C, Albillos A, Plessier A, García-Pagán JC | 2022-07-01 | Budd Chiari Syndrome, COVID-19, Portosinusoidal Vascular Disease, SARS-CoV-2, Splanchnic Vein Thrombosis, Vascular Liver Diseases | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association |
| The Increasing Incidence of Neuroendocrine Neoplasms Worldwide: Current Knowledge and Open Issues. | Rossi RE, Massironi S | 2022-06-30 | | Journal of clinical medicine |
| The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities. | Binatti E, Gerussi A, Barisani D, Invernizzi P | 2022-06-14 | Kupffer cells, drug delivery, fibrosis, inflammation, liver fibrosis, macrophages, targeted therapies | International journal of molecular sciences |
| Hepcidin as a Sensitive and Treatment-Responsive Acute-Phase Marker in Patients with Bacteremia: A Pilot Study. | Koukoulas K, Lygoura V, Kartalidis P, Gatselis NK, Petinaki E, Dalekos GN, Simos G | 2022-06-06 | CRP, acute phase marker, bacteremia, ferritin, hepcidin | Diagnostics (Basel, Switzerland) |
| Modern therapeutic approaches to liver-related disorders. | Gardin A, Remih K, Gonzales E, Andersson ER, Strnad P | 2022-06-01 | gene addition, gene editing, gene silencing, gene therapy, liver disease, monogenic defects | Journal of hepatology |
| Breakthroughs in therapies for NASH and remaining challenges. | Ratziu V, Francque S, Sanyal A | 2022-06-01 | artificial intelligence, cirrhosis, diabetes, digital pathology, fibrosis, hepatocellular carcinoma, non-invasive diagnosis, obesity, randomized controlled trials, steatohepatitis, trial end-points | Journal of hepatology |
| Systematic review-pancreatic involvement in inflammatory bowel disease. | Massironi S, Fanetti I, Viganò C, Pirola L, Fichera M, Cristoferi L, Capurso G, Invernizzi P, Danese S | 2022-06-01 | | Alimentary pharmacology & therapeutics |
| Altered DNA methylation pattern characterizes the peripheral immune cells of patients with autoimmune hepatitis. | Zachou K, Arvaniti P, Lyberopoulou A, Sevdali E, Speletas M, Ioannou M, Koukoulis GK, Renaudineau Y, Dalekos GN | 2022-06-01 | DNA methylation, DNA-methyltransferases, autoimmune hepatitis, epigenetics, epigenome-wide association studies | Liver international : official journal of the International Association for the Study of the Liver |
| Targeted-Capture Next-Generation Sequencing in Diagnosis Approach of Pediatric Cholestasis. | Almes M, Spraul A, Ruiz M, Girard M, Roquelaure B, Laborde N, Gottrand F, Turquet A, Lamireau T, Dabadie A, Bonneton M, Thebaut A, Rohmer B, Lacaille F, Broué P, Fabre A, Mention-Mulliez K, Bouligand J, Jacquemin E, Gonzales E | 2022-05-07 | Alagille syndrome, NGS, PFIC, children, genetic cholestasis, neonatal sclerosing cholangitis, transient neonatal cholestasis | Diagnostics (Basel, Switzerland) |
| Severe acute hepatitis and acute liver failure of unknown origin in children: a questionnaire-based study within 34 paediatric liver centres in 22 European countries and Israel, April 2022. | de Kleine RH, Lexmond WS, Buescher G, Sturm E, Kelly D, Lohse AW, Lenz D, Hørby Jørgensen M | 2022-05-01 | acute liver failure, hepatitis, liver transplantation, paediatric, virus | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin |
| Hepatitis C virus infection and diabetes: A complex bidirectional relationship. | Ciardullo S, Mantovani A, Ciaccio A, Carbone M, Invernizzi P, Perseghin G | 2022-05-01 | Cirrhosis, DAA, Diabetes, HCV | Diabetes research and clinical practice |
| X marks the spot in autoimmunity. | Gerussi A, Caime C, Binatti E, Cappadona C, Cristoferi L, Asselta R, Gershwin ME, Invernizzi P | 2022-05-01 | Autoimmune diseases, X-chromosome inactivation, autoimmunity, escape from X-chromosome inactivation, mammalian evolution, sex bias, sex chromosomes | Expert review of clinical immunology |
| Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology. | Lohse AW, Sebode M, Bhathal PS, Clouston AD, Dienes HP, Jain D, Gouw ASH, Guindi M, Kakar S, Kleiner DE, Krech T, Lackner C, Longerich T, Saxena R, Terracciano L, Washington K, Weidemann S, Hübscher SG, Tiniakos D | 2022-05-01 | autoimmune hepatitis, histology, lobular hepatitis, portal hepatitis | Liver international : official journal of the International Association for the Study of the Liver |
| Spontaneous evolution patterns of focal congenital hepatic hemangiomas: a case series of 25 patients. | Rutten C, Ladarre D, Ackermann O, Gonzales E, Guettier C, Franchi-Abella S | 2022-05-01 | Children, Congenital hepatic hemangioma, Hemangioma, Infants, Liver, Ultrasonography | Pediatric radiology |
| A Model for Early Endoscopic Detection of High-Risk Gastroesophageal Varices in Children With Biliary Atresia. | Ackermann O, de Boissieu P, Bernard O, Gonzales E, Jacquemin E, Duché M | 2022-05-01 | | Journal of pediatric gastroenterology and nutrition |
| The Role of Epigenetics in Primary Biliary Cholangitis. | Gerussi A, Paraboschi EM, Cappadona C, Caime C, Binatti E, Cristoferi L, Asselta R, Invernizzi P | 2022-04-28 | autoimmunity, chromosome X, non-coding RNA, sex bias, somatic mosaicism | International journal of molecular sciences |
| Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma. | Hobeika C, Guyard C, Sartoris R, Maino C, Rautou PE, Dokmak S, Bouattour M, Durand F, Weiss E, Vilgrain V, Beaufrère A, Sepulveda A, Farges O, Paradis V, Luciani A, Lim C, Sommacale D, Scatton O, Laurent A, Nault JC, Soubrane O, Ronot M, Cauchy F | 2022-04-19 | | The British journal of surgery |
| Soluble IL-2R Levels at Baseline Predict the Development of Severe Respiratory Failure and Mortality in COVID-19 Patients. | Gatselis NK, Lygoura V, Lyberopoulou A, Giannoulis G, Samakidou A, Vaiou A, Vatidis G, Antoniou K, Stefos A, Georgiadou S, Sagris D, Sveroni D, Stergioula D, Gabeta S, Ntaios G, Dalekos GN | 2022-04-10 | biomarker, coronavirus disease-19, soluble interleukin-2 receptor | Viruses |
| SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease. | Duengelhoef P, Hartl J, Rüther D, Steinmann S, Brehm TT, Weltzsch JP, Glaser F, Schaub GM, Sterneck M, Sebode M, Weiler-Normann C, Addo MM, Lütgehetmann M, Haag F, Schramm C, Schulze Zur Wiesch J, Lohse AW | 2022-04-01 | SARS-CoV-2 vaccination, autoimmune hepatitis, chronic liver disease, immunosuppression, primary biliary cholangitis, primary sclerosing cholangitis | United European gastroenterology journal |
| Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group. | Pape S, Snijders RJALM, Gevers TJG, Chazouilleres O, Dalekos GN, Hirschfield GM, Lenzi M, Trauner M, Manns MP, Vierling JM, Montano-Loza AJ, Lohse AW, Schramm C, Drenth JPH, Heneghan MA | 2022-04-01 | autoimmune hepatitis, complete biochemical response, endpoints, insufficient response, intolerance, non-response, remission | Journal of hepatology |
| Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complications. | Plessier A, Esposito-Farèse M, Baiges A, Shukla A, Garcia Pagan JC, De Raucourt E, Ollivier-Hourmand I, Cervoni JP, De Ledinghen V, Tazi Z, Nousbaum JB, Bun R, Bureau C, Silvain C, Tournilhac O, Gerfaud-Valentin M, Durand F, Goria O, Tellez L, Albillos A, Gioia S, Riggio O, De Gottardi A, Payance A, Rautou PE, Terriou L, Charbonnier A, Elkrief L, de la Tour RP, Valla DC, Gault N, de Fontbrune FS | 2022-04-01 | | American journal of hematology |
| Alpha-1 antitrypsin deficiency: A re-surfacing adult liver disorder. | Fromme M, Schneider CV, Trautwein C, Brunetti-Pierri N, Strnad P | 2022-04-01 | Fibroscan, Pi∗S, Pi∗Z, SERPINA1, liver cirrhosis, liver fibrosis | Journal of hepatology |
| Characterization and Pharmacological Validation of a Preclinical Model of NASH in Göttingen Minipigs. | Duvivier V, Creusot S, Broux O, Helbert A, Lesage L, Moreau K, Lesueur N, Gerard L, Lemaitre K, Provost N, Hubert EL, Baltauss T, Brzustowski A, De Preville N, Geronimi J, Adoux L, Letourneur F, Hammoutene A, Valla D, Paradis V, Delerive P | 2022-03-01 | CDAHFD, choline-deficient amino acid-defined high fat diet, FDR, false discovery rate, FFC, fatfructose cholesterol diet, NAFLD, nonalcoholic fatty liver disease, NAS, NAFLD activity score, NASH, NASH, nonalcoholic steatohepatitis, PNPLA3, patatin-like phospholipase domain-containing 3, minipig, translational value | Journal of clinical and experimental hepatology |
| Proceedings of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition Monothematic Conference, 2020: "Acute Liver Failure in Children": Treatment and Directions for Future Research. | Zellos A, Debray D, Indolfi G, Czubkowski P, Samyn M, Hadzic N, Gupte G, Fischler B, Smets F, Clément de Cléty S, Grenda R, Mozer Y, Mancell S, Jahnel J, Auzinger G, Worth A, Lisman T, Staufner C, Baumann U, Dhawan A, Alonso E, Squires RH, Verkade HJ | 2022-03-01 | | Journal of pediatric gastroenterology and nutrition |
| Proceedings of ESPGHAN Monothematic Conference 2020: "Acute Liver Failure in Children": Diagnosis and Initial Management. | Zellos A, Debray D, Indolfi G, Czubkowski P, Samyn M, Hadzic N, Gupte G, Fischler B, Smets F, de Cléty SC, Grenda R, Mozer Y, Mancell S, Jahnel J, Auzinger G, Worth A, Lisman T, Staufner C, Baumann U, Dhawan A, Alonso E, Squires RH, Verkade HJ | 2022-03-01 | | Journal of pediatric gastroenterology and nutrition |
| Corrigendum to "ATP7B variant spectrum in a French pediatric Wilson disease cohort" [Eur. J. Med. Genet. 64 (10) (October 2021) 104305]. | Couchonnal E, Bouchard S, Sandahl TD, Pagan C, Lion-François L, Guillaud O, Habes D, Debray D, Lamireau T, Broué P, Fabre A, Vanlemmens C, Sobesky R, Gottrand F, Bridoux-Henno L, Belmalih A, Poujois A, Collet C, Francou B, Brunet AS, Lachaux A, Misrahi M, Bost M | 2022-03-01 | | European journal of medical genetics |
| Machine learning in primary biliary cholangitis: A novel approach for risk stratification. | Gerussi A, Verda D, Bernasconi DP, Carbone M, Komori A, Abe M, Inao M, Namisaki T, Mochida S, Yoshiji H, Hirschfield G, Lindor K, Pares A, Corpechot C, Cazzagon N, Floreani A, Marzioni M, Alvaro D, Vespasiani-Gentilucci U, Cristoferi L, Valsecchi MG, Muselli M, Hansen BE, Tanaka A, Invernizzi P | 2022-03-01 | artificial intelligence, autoimmune liver disease, cluster analysis, prognosis | Liver international : official journal of the International Association for the Study of the Liver |
| Comparison of Transient Elastography, ShearWave Elastography, Magnetic Resonance Elastography and FibroTest as routine diagnostic markers for assessing liver fibrosis in children with Cystic Fibrosis. | Dana J, Girard M, Franchi-Abella S, Berteloot L, Benoit-Cherifi M, Imbert-Bismut F, Sermet-Gaudelus I, Debray D | 2022-03-01 | Children, Cystic fibrosis liver disease, Elastography, Liver stiffness | Clinics and research in hepatology and gastroenterology |
| Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature. | Gemelli M, Carbone M, Abbate MI, Mancin M, Zucchini N, Colonese F, Invernizzi P, Bidoli P, Cortinovis D | 2022-03-01 | immune-related adverse events, immune-related hepatitis, immunotherapy, lung cancer, pembrolizumab, vanishing bile duct syndrome | Immunotherapy |
| Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis. | Efe C, Lammert C, Taşçılar K, Dhanasekaran R, Ebik B, Higuera-de la Tijera F, Calışkan AR, Peralta M, Gerussi A, Massoumi H, Catana AM, Purnak T, Rigamonti C, Aldana AJG, Khakoo N, Nazal L, Frager S, Demir N, Irak K, Melekoğlu-Ellik Z, Kacmaz H, Balaban Y, Atay K, Eren F, Alvares-da-Silva MR, Cristoferi L, Urzua Á, Eşkazan T, Magro B, Snijders R, Barutçu S, Lytvyak E, Zazueta GM, Demirezer-Bolat A, Aydın M, Heurgue-Berlot A, De Martin E, Ekin N, Yıldırım S, Yavuz A, Bıyık M, Narro GC, Kıyıcı M, Akyıldız M, Kahramanoğlu-Aksoy E, Vincent M, Carr RM, Günşar F, Reyes EC, Harputluoğlu M, Aloman C, Gatselis NK, Üstündağ Y, Brahm J, Vargas NCE, Güzelbulut F, Garcia SR, Aguirre J, Anders M, Ratusnu N, Hatemi I, Mendizabal M, Floreani A, Fagiuoli S, Silva M, Idilman R, Satapathy SK, Silveira M, Drenth JPH, Dalekos GN, N Assis D, Björnsson E, Boyer JL, Yoshida EM, Invernizzi P, Levy C, Montano-Loza AJ, Schiano TD, Ridruejo E, Wahlin S | 2022-03-01 | SARS-CoV-2, autoimmunity, azathioprine, budesonide, liver transplantation, mercaptopurine | Liver international : official journal of the International Association for the Study of the Liver |
| Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: A case control study from the prospective COVID-ICU database. | Giabicani M, Le Menestrel A, Roux O, Rautou PE, Weiss E | 2022-03-01 | | Journal of hepatology |
| Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules. | Stravalaci M, Pagani I, Paraboschi EM, Pedotti M, Doni A, Scavello F, Mapelli SN, Sironi M, Perucchini C, Varani L, Matkovic M, Cavalli A, Cesana D, Gallina P, Pedemonte N, Capurro V, Clementi N, Mancini N, Invernizzi P, Bayarri-Olmos R, Garred P, Rappuoli R, Duga S, Bottazzi B, Uguccioni M, Asselta R, Vicenzi E, Mantovani A, Garlanda C | 2022-02-01 | | Nature immunology |
| Vasoconstrictor antagonism improves functional and structural vascular alterations and liver damage in rats with early NAFLD. | van der Graaff D, Chotkoe S, De Winter B, De Man J, Casteleyn C, Timmermans JP, Pintelon I, Vonghia L, Kwanten WJ, Francque S | 2022-02-01 | ALT, alanine aminotransferase, ARB, angiotensin receptor blocker, AST, aspartate aminotransferase, ATII, angiotensin II, COX, cyclooxygenase, ET, endothelin, HFHFD, high-fat high-fructose diet, IHVR, intrahepatic vascular resistance, Jak2, Janus-kinase-2, MCD, methionine-choline deficient diet, Mx, methoxamine, NAFLD, non-alcoholic fatty liver disease, NASH, non-alcoholic steatohepatitis, NO, nitric oxide, PP, portal pressure, PR, pulse rate, SEM, scanning electron microscopy, TBW, total body weight, TEM, transmission electron microscopy, TXAS, thromboxane synthase, TxA2, thromboxane A2, ZFR, Zucker fatty rats, angiotensin II, endothelin-1, non-alcoholic fatty liver disease, portal hypertension, thromboxane A2, transhepatic pressure gradient | JHEP reports : innovation in hepatology |
| Advances in genetic, epigenetic and environmental aspects of rare liver diseases. | Andersson ER, Lohse AW | 2022-02-01 | | European journal of medical genetics |
| Corrigendum to 'An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs' [J Hepatol 2021;75(3):572-581]. | Cordell HJ, Fryett JJ, Ueno K, Darlay R, Aiba Y, Hitomi Y, Kawashima M, Nishida N, Khor SS, Gervais O, Kawai Y, Nagasaki M, Tokunaga K, Tang R, Shi Y, Li Z, Juran BD, Atkinson EJ, Gerussi A, Carbone M, Asselta R, Cheung A, de Andrade M, Baras A, Horowitz J, Ferreira MAR, Sun D, Jones DE, Flack S, Spicer A, Mulcahy VL, Byun J, Han Y, Sandford RN, Lazaridis KN, Amos CI, Hirschfield GM, Seldin MF, Invernizzi P, Siminovitch KA, Ma X, Nakamura M, Mells GF | 2022-02-01 | | Journal of hepatology |
| Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis. | Burghart L, Halilbasic E, Schwabl P, Simbrunner B, Stättermayer AF, Petrenko O, Scheiner B, Bauer D, Pinter M, Boztug K, Mandorfer M, Trauner M, Reiberger T | 2022-02-01 | CSPH, Decompensation, Elastography, PBC, Portal hypertension | Journal of gastroenterology |
| Galaxy Is a Suitable Bioinformatics Platform for the Molecular Diagnosis of Human Genetic Disorders Using High-Throughput Sequencing Data Analysis: Five Years of Experience in a Clinical Laboratory. | Chappell K, Francou B, Habib C, Huby T, Leoni M, Cottin A, Nadal F, Adnet E, Paoli E, Oliveira C, Verstuyft C, Davit-Spraul A, Gaignard P, Lebigot E, Duclos-Vallee JC, Young J, Kamenicky P, Adams D, Echaniz-Laguna A, Gonzales E, Bouvattier C, Linglart A, Picard V, Bergoin E, Jacquemin E, Guiochon-Mantel A, Proust A, Bouligand J | 2022-02-01 | bioinformatics, clinical genomics and molecular biology, next-generation sequencing data analysis | Clinical chemistry |
| The mode of dexamethasone decoration influences avidin-nucleic-acid-nano-assembly organ biodistribution and in vivo drug persistence. | Ongaro A, Violatto MB, Casarin E, Pellerani I, Marchini G, Ribaudo G, Salmona M, Carbone M, Passoni A, Gnodi E, Schiavon E, Mattarei A, Barisani D, Invernizzi P, Bigini P, Morpurgo M | 2022-02-01 | ANANAS, Autoimmune liver disease, Dexamethasone, Liver disease, Liver targeting, Nanomedicine | Nanomedicine : nanotechnology, biology, and medicine |
| SARS-CoV-2 in Pediatric Liver Transplant Recipients: The European Experience. | Buescher G, Sebode M, Marjot T, Webb GJ, Moon AM, Barnes E, Barritt AS, Cananzi M, Lohse AW, Jørgensen MH, McLin V | 2022-02-01 | | Journal of pediatric gastroenterology and nutrition |
| Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency. | Fromme M, Schneider CV, Pereira V, Hamesch K, Pons M, Reichert MC, Benini F, Ellis P, H Thorhauge K, Mandorfer M, Burbaum B, Woditsch V, Chorostowska-Wynimko J, Verbeek J, Nevens F, Genesca J, Miravitlles M, Nuñez A, Schaefer B, Zoller H, Janciauskiene S, Abreu N, Jasmins L, Gaspar R, Liberal R, Macedo G, Mahadeva R, Gomes C, Schneider KM, Trauner M, Krag A, Gooptu B, Thorburn D, Marshall A, Hurst JR, Lomas DA, Lammert F, Gaisa NT, Clark V, Griffiths W, Trautwein C, Turner AM, McElvaney NG, Strnad P | 2022-02-01 | cancer, fibrosis, liver, liver cirrhosis | Gut |
| Impact of muscle mass on the prognosis of liver transplantation for infants with biliary atresia. | Lledín MD, Parrón-Pajares M, Morais A, Hernández-Oliveros F, Botella-Carretero JI, Hierro L | 2022-01-01 | biliary atresia, infants, liver transplant, muscle mass, pediatrics, sarcopenia | Frontiers in pediatrics |
| Artificial intelligence for precision medicine in autoimmune liver disease. | Gerussi A, Scaravaglio M, Cristoferi L, Verda D, Milani C, De Bernardi E, Ippolito D, Asselta R, Invernizzi P, Kather JN, Carbone M | 2022-01-01 | autoimmunity, deep learning, digital pathology, genomics, machine learning, population genetics, radiomics, whole-slide digital image analysis | Frontiers in immunology |
| Case report: Huppke-Brendel syndrome in an adult, mistaken for and treated as Wilson disease for 25 years. | Kirk FT, Munk DE, Ek J, Birk Møller L, Bendixen Thorup M, Hvid Danielsen E, Vilstrup H, Ott P, Damgaard Sandahl T | 2022-01-01 | Huppke-Brendel syndrome, SLC33A1, Wilson disease, case report, copper, neurology, rare disease | Frontiers in neurology |
| New insights on the role of human leukocyte antigen complex in primary biliary cholangitis. | Mulinacci G, Palermo A, Gerussi A, Asselta R, Gershwin ME, Invernizzi P | 2022-01-01 | HLA haplotypes, genetics, human leukocyte antigens complex, immunotolerance, primary biliary cholangitis | Frontiers in immunology |
| Clinical and Endoscopic Outcomes in Coronavirus Disease-2019 Patients With Gastrointestinal Bleeding. | Ashktorab H, Russo T, Oskrochi G, Latella G, Massironi S, Luca M, Chirumamilla LG, Laiyemo AO, Brim H | 2022-01-01 | ACE2, angiotensin-converting enzyme 2, COVID-19, coronavirus disease–2019, Coronavirus Disease-19, EGD, esophagogastroduodenoscopy, Endoscopy, GI, gastrointestinal, GIB, gastrointestinal bleeding, Gastrointestinal Bleeding, Hematemesis, ICU, intensive care unit, Melena, UGIB, upper GIB | Gastro hep advances |
| An update on novel pharmacological agents for primary sclerosing cholangitis. | Gallo C, Howardson BO, Cristoferi L, Carbone M, Gershwin ME, Invernizzi P | 2022-01-01 | Primary sclerosing cholangitis, anti-inflammatory agents, antibiotics, bile acids, fecal microbiota transplantation, gut–liver axis | Expert opinion on therapeutic targets |
| The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. | Karlsen TH, Sheron N, Zelber-Sagi S, Carrieri P, Dusheiko G, Bugianesi E, Pryke R, Hutchinson SJ, Sangro B, Martin NK, Cecchini M, Dirac MA, Belloni A, Serra-Burriel M, Ponsioen CY, Sheena B, Lerouge A, Devaux M, Scott N, Hellard M, Verkade HJ, Sturm E, Marchesini G, Yki-Järvinen H, Byrne CD, Targher G, Tur-Sinai A, Barrett D, Ninburg M, Reic T, Taylor A, Rhodes T, Treloar C, Petersen C, Schramm C, Flisiak R, Simonova MY, Pares A, Johnson P, Cucchetti A, Graupera I, Lionis C, Pose E, Fabrellas N, Ma AT, Mendive JM, Mazzaferro V, Rutter H, Cortez-Pinto H, Kelly D, Burton R, Lazarus JV, Ginès P, Buti M, Newsome PN, Burra P, Manns MP | 2022-01-01 | | Lancet (London, England) |
| Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease. | De Broucker C, Plessier A, Ollivier-Hourmand I, Dharancy S, Bureau C, Cervoni JP, Sogni P, Goria O, Corcos O, Sartoris R, Ronot M, Vilgrain V, de Raucourt E, Zekrini K, Davy H, Durand F, Payancé A, Fidouh-Houhou N, Yazdanpanah Y, Valla D, Rautou PE | 2022-01-01 | CMV, cavernoma, cytomegalovirus, factor II gene mutation, immunocompetent, infection, prothrombin, recanalization, thrombophilia, thrombosis, vascular liver disease | Journal of hepatology |
| Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study. | Mazza S, Piazza O Sed N, Conforti FS, Fascì A, Rimondi A, Marinoni B, Casini V, Ricci C, Munari F, Pirola L, Invernizzi P, Girelli C, Lupinacci G, Pastorelli L, Cavallaro F, Ferraris L, Colucci A, Amato A, Eugenio Tontini G, Vecchi M, Fiorino G, Caprioli F | 2022-01-01 | | Clinical and translational science |
| The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma. | Correnti M, Cappon A, Pastore M, Piombanti B, Lori G, Oliveira DVPN, Munoz-Garrido P, Lewinska M, Andersen JB, Coulouarn C, Sulpice L, Peraldo Neia C, Cavalloni G, Quarta S, Biasiolo A, Fassan M, Ramazzotti M, Parri M, Recalcati S, di Tommaso L, Campani C, Invernizzi P, Torzilli G, Marra F, Pontisso P, Raggi C | 2022-01-01 | SerpinB3, cancer stem cells, cholangiocarcinoma, invasion | Liver international : official journal of the International Association for the Study of the Liver |
| Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis. | Taubert R, Engel B, Diestelhorst J, Hupa-Breier KL, Behrendt P, Baerlecken NT, Sühs KW, Janik MK, Zachou K, Sebode M, Schramm C, Londoño MC, Habes S, Oo YH, Lalanne C, Pape S, Schubert M, Hust M, Dübel S, Thevis M, Jonigk D, Beimdiek J, Buettner FFR, Drenth JPH, Muratori L, Adams DH, Dyson JK, Renand A, Graupera I, Lohse AW, Dalekos GN, Milkiewicz P, Stangel M, Maasoumy B, Witte T, Wedemeyer H, Manns MP, Jaeckel E | 2022-01-01 | | Hepatology (Baltimore, Md.) |
| Non-invasive diagnosis and follow-up of primary biliary cholangitis. | Corpechot C, Heurgue A, Tanne F, Potier P, Hanslik B, Decraecker M, de Lédinghen V, Ganne-Carrié N, Bureau C, Bourlière M | 2022-01-01 | PBC | Clinics and research in hepatology and gastroenterology |
| Non-invasive diagnosis and follow-up of vascular liver diseases. | Rautou PE, Elkrief L, Decraecker M, Ollivier-Hourmand I, Plessier A, Ronot M, Vilgrain V, Bourlière M, Ganne-Carrié N, de Lédinghen V, Bureau C | 2022-01-01 | | Clinics and research in hepatology and gastroenterology |
| Non-invasive diagnosis and follow-up of autoimmune hepatitis. | Lemoinne S, Heurgue A, Bouzbib C, Hanslik B, Gournay J, Nguyen-Khac E, Bureau C, de Lédinghen V, Ganne-Carrié N, Bourlière M | 2022-01-01 | | Clinics and research in hepatology and gastroenterology |
| Impact of vascular liver disease on the menstrual cycle and metabolic status in premenopausal women. | Stempak-Droissart T, Rousset-Jablonski C, Spritzer PM, Lalhou N, Larger E, Pichard C, Plessier A, Gompel A | 2022-01-01 | Budd-Chiari syndrome, Contraception, Hyperandrogenism, IgF-1, Portal hypertension, Portal vein thrombosis | Clinics and research in hepatology and gastroenterology |
| MARC1 p.A165T variant is associated with decreased markers of liver injury and enhanced antioxidant capacity in autoimmune hepatitis. | Janik MK, Smyk W, Kruk B, Szczepankiewicz B, Górnicka B, Lebiedzińska-Arciszewska M, Potes Y, Simões ICM, Weber SN, Lammert F, Więckowski MR, Milkiewicz P, Krawczyk M | 2021-12-23 | | Scientific reports |
| Development of extracellular vesicle-based medicinal products: A position paper of the group "Extracellular Vesicle translatiOn to clinicaL perspectiVEs - EVOLVE France". | Silva AKA, Morille M, Piffoux M, Arumugam S, Mauduit P, Larghero J, Bianchi A, Aubertin K, Blanc-Brude O, Noël D, Velot E, Ravel C, Elie-Caille C, Sebbagh A, Boulanger C, Wilhelm C, Rahmi G, Raymond-Letron I, Cherukula K, Montier T, Martinaud C, Bach JM, Favre-Bulle O, Spadavecchia J, Jorgensen C, Menasché P, Aussel C, Chopineau J, Mosser M, Ullah M, Sailliet N, Luciani N, Mathieu N, Rautou PE, Brouard S, Boireau W, Jauliac S, Dedier M, Trouvin JH, Gazeau F, Trouillas M, Peltzer J, Monsel A, Banzet S | 2021-12-01 | Biological medicinal products, Cell-free therapy, Clinical-grade EV, Exosomes, Medicinal products, Microvesicles, Regulatory requirements, Secretome | Advanced drug delivery reviews |
| [Severe secondary sclerosing cholangitis as manifestation of a very rare underlying disease]. | Zecher BF, Zenouzi R, Lang M, Karagiannis P, Clauditz T, Fischer L, Sterneck M, Schramm C, Lohse AW, Sebode M | 2021-12-01 | Cholangiography, endoscopic retrograde, Cholangitis, sclerosing, secondary, Histiocytosis, Langerhans cell, Liver transplantation, Unclear cholestasis | Der Internist |
| Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process. | Ponsioen CY, Assis DN, Boberg KM, Bowlus CL, Deneau M, Thorburn D, Aabakken L, Färkkilä M, Petersen B, Rupp C, Hübscher SG | 2021-12-01 | | Gastroenterology |
| Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor-Stroma Paracrine Signaling. | Lobe C, Vallette M, Arbelaiz A, Gonzalez-Sanchez E, Izquierdo L, Pellat A, Guedj N, Louis C, Paradis V, Banales JM, Coulouarn C, Housset C, Vaquero J, Fouassier L | 2021-12-01 | | Hepatology (Baltimore, Md.) |
| Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool. | Murillo Perez CF, Gulamhusein A, Carbone M, Trivedi PJ, van der Meer AJ, Corpechot C, Battezzati PM, Lammers WJ, Cazzagon N, Floreani A, Parés A, Nevens F, Lleo A, Mayo MJ, Kowdley KV, Ponsioen CY, Dalekos GN, Gatselis NK, Thorburn D, Mason AL, Janssen H, Verhelst X, Bruns T, Lindor KD, Chazouillères O, Invernizzi P, Hansen BE, Hirschfield GM | 2021-12-01 | | European journal of gastroenterology & hepatology |
| Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis: a prospective longitudinal study. | Nery F, Carneiro P, Correia S, Macedo C, Gandara J, Lopes V, Valadares D, Ferreira S, Oliveira J, Teixeira Gomes M, Miranda HP, Rautou PE, Valla D | 2021-12-01 | | European journal of gastroenterology & hepatology |
| In vitro functional rescue by ivacaftor of an ABCB11 variant involved in PFIC2 and intrahepatic cholestasis of pregnancy. | Mareux E, Lapalus M, Ben-Saad A, Callebaut I, Falguières T, Gonzales E, Jacquemin E | 2021-11-18 | ABC transporters superfamily, BSEP, Cholestasis, Paediatrics, Potentiator, VX-770 | Orphanet journal of rare diseases |
| MEDTEC Students against Coronavirus: Investigating the Role of Hemostatic Genes in the Predisposition to COVID-19 Severity. | Cappadona C, Paraboschi EM, Ziliotto N, Bottaro S, Rimoldi V, Gerussi A, Azimonti A, Brenna D, Brunati A, Cameroni C, Campanaro G, Carloni F, Cavadini G, Ciravegna M, Composto A, Converso G, Corbella P, D'Eugenio D, Dal Rì G, Di Giorgio SM, Grondelli MC, Guerrera L, Laffoucriere G, Lando B, Lopedote L, Maizza B, Marconi E, Mariola C, Matronola GM, Menga LM, Montorsi G, Papatolo A, Patti R, Profeta L, Rebasti V, Smidili A, Tarchi SM, Tartaglia FC, Tettamanzi G, Tinelli E, Stuani R, Bolchini C, Pattini L, Invernizzi P, Degenhardt F, Franke A, Duga S, Asselta R | 2021-11-09 | COVID-19, MTHFR, SARS-CoV-2, association analysis, hemostatic genes, meta-analysis, polygenic risk score | Journal of personalized medicine |
| One liver, two samples and two diagnoses-An example of how multiple samples by laparoscopically guided liver biopsy can be decisive. | Beisel C, Weidemann SA, Sebode M | 2021-11-01 | autoimmune hepatitis, laparoscopically guided liver biopsy, non-alcoholic fatty liver disease | Liver international : official journal of the International Association for the Study of the Liver |
| Corrigendum to "ATP7B variant spectrum in a French pediatric Wilson disease cohort" [Eur. J. Med. Genet. 64(10) (2021) 104305]. | Couchonnal E, Bouchard S, Sandahl TD, Pagan C, Lion-François L, Guillaud O, Habes D, Debray D, Lamireau T, Broué P, Fabre A, Vanlemmens C, Sobesky R, Gottrand F, Bridoux-Henno L, Belmalih A, Poujois A, Brunet AS, Lachaux A, Bost M | 2021-11-01 | | European journal of medical genetics |
| Mobile app requirements for patients with rare liver diseases: A single center survey for the ERN RARE-LIVER. | Rüther DF, Sebode M, Lohse AW, Wernicke S, Böttinger E, Casar C, Braun F, Schramm C | 2021-11-01 | Autoimmune hepatitis, European reference networks, Mobile applications, Patient reported outcome measures, Primary biliary cholangitis, Primary sclerosing cholangitis | Clinics and research in hepatology and gastroenterology |
| Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients. | Schmidbauer C, Chromy D, Schmidbauer VU, Schwarz M, Jachs M, Bauer DJM, Binter T, Apata M, Nguyen DT, Mandorfer M, Simbrunner B, Rieger A, Mayer F, Breuer M, Strassl R, Schmidt R, Holzmann H, Trauner M, Gschwantler M, Reiberger T | 2021-11-01 | HBV, HDV, HIV, epidemiology | Liver international : official journal of the International Association for the Study of the Liver |
| Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study. | Arab JP, Díaz LA, Baeza N, Idalsoaga F, Fuentes-López E, Arnold J, Ramírez CA, Morales-Arraez D, Ventura-Cots M, Alvarado-Tapias E, Zhang W, Clark V, Simonetto D, Ahn JC, Buryska S, Mehta TI, Stefanescu H, Horhat A, Bumbu A, Dunn W, Attar B, Agrawal R, Haque ZS, Majeed M, Cabezas J, García-Carrera I, Parker R, Cuyàs B, Poca M, Soriano G, Sarin SK, Maiwall R, Jalal PK, Abdulsada S, Higuera-de la Tijera MF, Kulkarni AV, Rao PN, Guerra Salazar P, Skladaný L, Bystrianska N, Prado V, Clemente-Sanchez A, Rincón D, Haider T, Chacko KR, Cairo F, de Sousa Coelho M, Romero GA, Pollarsky FD, Restrepo JC, Castro-Sanchez S, Toro LG, Yaquich P, Mendizabal M, Garrido ML, Narvaez A, Bessone F, Marcelo JS, Piombino D, Dirchwolf M, Arancibia JP, Altamirano J, Kim W, Araujo RC, Duarte-Rojo A, Vargas V, Rautou PE, Issoufaly T, Zamarripa F, Torre A, Lucey MR, Mathurin P, Louvet A, García-Tsao G, González JA, Verna E, Brown RS, Roblero JP, Abraldes JG, Arrese M, Shah VH, Kamath PS, Singal AK, Bataller R | 2021-11-01 | MELD, Maddrey discriminant function, alcohol, alcohol-associated liver disease, alcoholic hepatitis, alcoholic liver disease, cirrhosis, corticosteroids, steroids | Journal of hepatology |
| Transient elastography in chronic liver disease: Beware of the cut-offs! | Cristoferi L, Nardi A, Carbone M | 2021-11-01 | dual cut-off, liver fibrosis, non-invasive liver fibrosis markers, transient elastography | Journal of hepatology |
| REPLY. | Elkrief L, Lazareth M, Rautou PE | 2021-11-01 | | Hepatology (Baltimore, Md.) |
| Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study. | Gonzales E, Hardikar W, Stormon M, Baker A, Hierro L, Gliwicz D, Lacaille F, Lachaux A, Sturm E, Setchell KDR, Kennedy C, Dorenbaum A, Steinmetz J, Desai NK, Wardle AJ, Garner W, Vig P, Jaecklin T, Sokal EM, Jacquemin E | 2021-10-30 | | Lancet (London, England) |
| Liver-first strategy for a combined lung and liver transplant in patients with cystic fibrosis. | Aburahma K, Salman J, Engel B, Vondran FWR, Greer M, Boethig D, Siemeni T, Avsar M, Schwerk N, Müller C, Taubert R, Hoeper MM, Welte T, Wedemeyer HH, Richter N, Warnecke G, Tudorache I, Haverich A, Kuehn C, Grannas G, Ius F | 2021-10-22 | Chronic lung allograft dysfunction, Graft survival, Liver transplantation, Lung transplantation | European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery |
| Current pharmacological treatment of hepatocellular carcinoma. | Muñoz-Martínez S, Iserte G, Sanduzzi-Zamparelli M, Llarch N, Reig M | 2021-10-01 | | Current opinion in pharmacology |
| ATP7B variant spectrum in a French pediatric Wilson disease cohort. | Couchonnal E, Bouchard S, Sandahl TD, Pagan C, Lion-François L, Guillaud O, Habes D, Debray D, Lamireau T, Broué P, Fabre A, Vanlemmens C, Sobesky R, Gottrand F, Bridoux-Henno L, Belmalih A, Poujois A, Brunet AS, Lachaux A, Bost M | 2021-10-01 | ATP7B, Phenotype-genotype correlation, Wilson's disease, p.His1069Gln | European journal of medical genetics |
| Reply to: "Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered". | Mallet V | 2021-10-01 | COVID-19, Chemical and Drug Induced Liver Injury, Cholangiopathy, Cholangitis, Cholestasis, Intrahepatic, Ketamine | Journal of hepatology |
| Drug-induced liver injury at a tertiary care centre in Germany: Model for end-stage liver disease is the best predictor of outcome. | Reike-Kunze M, Zenouzi R, Hartel J, Krech T, Weidemann S, Sterneck M, Weiler-Normann C, Lohse AW, Schramm C, Sebode M | 2021-10-01 | MELD, acute liver failure, drug-induced liver injury, liver transplantation, outcome | Liver international : official journal of the International Association for the Study of the Liver |
| Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease. | Lackner C, Stauber RE, Davies S, Denk H, Dienes HP, Gnemmi V, Guido M, Miquel R, Paradis V, Schirmacher P, Terracciano L, Berghold A, Pregartner G, Binder L, Douschan P, Rainer F, Sygulla S, Jager M, Rautou PE, Bumbu A, Horhat A, Rusu I, Stefanescu H, Detlefsen S, Krag A, Thiele M, Cortez-Pinto H, Moreno C, Gouw ASH, Tiniakos DG | 2021-10-01 | Alcohol-related liver disease, cholestasis, grading, prognosis, staging | Journal of hepatology |
| Pediatric Wilson's Disease: Phenotypic, Genetic Characterization and Outcome of 182 Children in France. | Couchonnal E, Lion-François L, Guillaud O, Habes D, Debray D, Lamireau T, Broué P, Fabre A, Vanlemmens C, Sobesky R, Gottrand F, Bridoux-Henno L, Dumortier J, Belmalih A, Poujois A, Jacquemin E, Brunet AS, Bost M, Lachaux A | 2021-10-01 | | Journal of pediatric gastroenterology and nutrition |
| REPLY. | Elkrief L, Lazareth M, Rautou PE | 2021-10-01 | | Hepatology (Baltimore, Md.) |
| Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer. | Hirsch TZ, Pilet J, Morcrette G, Roehrig A, Monteiro BJE, Molina L, Bayard Q, Trépo E, Meunier L, Caruso S, Renault V, Deleuze JF, Fresneau B, Chardot C, Gonzales E, Jacquemin E, Guerin F, Fabre M, Aerts I, Taque S, Laithier V, Branchereau S, Guettier C, Brugières L, Rebouissou S, Letouzé E, Zucman-Rossi J | 2021-10-01 | | Cancer discovery |
| The genetic architecture of primary biliary cholangitis. | Gerussi A, Carbone M, Corpechot C, Schramm C, Asselta R, Invernizzi P | 2021-09-01 | Autoimmunity, Complex traits, GWAS, HLA, Missing heritability | European journal of medical genetics |
| Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study. | Baumann U, Sturm E, Lacaille F, Gonzalès E, Arnell H, Fischler B, Jørgensen MH, Thompson RJ, Mattsson JP, Ekelund M, Lindström E, Gillberg PG, Torfgård K, Soni PN | 2021-09-01 | Alagille syndrome, Apical sodium-dependent bile acid transporter, Biliary atresia, Cholestasis, intrahepatic, Ileal bile acid transporter, Pediatrics | Clinics and research in hepatology and gastroenterology |
| Prevalence of COVID-19 in patients with autoimmune liver disease in Europe: A patient-oriented online survey. | Zecher BF, Buescher G, Willemse J, Walmsley M, Taylor A, Leburgue A, Schramm C, Lohse AW, Sebode M | 2021-09-01 | (AILD), COVID-19, Europe, SARS-CoV-2, advanced liver disease, autoimmuneliver disease, chronic liver disease, incidence, online survey, prevalence | United European gastroenterology journal |
| An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs. | Cordell HJ, Fryett JJ, Ueno K, Darlay R, Aiba Y, Hitomi Y, Kawashima M, Nishida N, Khor SS, Gervais O, Kawai Y, Nagasaki M, Tokunaga K, Tang R, Shi Y, Li Z, Juran BD, Atkinson EJ, Gerussi A, Carbone M, Asselta R, Cheung A, de Andrade M, Baras A, Horowitz J, Ferreira MAR, Sun D, Jones DE, Flack S, Spicer A, Mulcahy VL, Byan J, Han Y, Sandford RN, Lazaridis KN, Amos CI, Hirschfield GM, Seldin MF, Invernizzi P, Siminovitch KA, Ma X, Nakamura M, Mells GF | 2021-09-01 | ALSPAC, ERN RARE-LIVER, Genomic co-localization, Network-based in silico drug efficacy screening, UK-PBC | Journal of hepatology |
| Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach. | Cristoferi L, Calvaruso V, Overi D, Viganò M, Rigamonti C, Degasperi E, Cardinale V, Labanca S, Zucchini N, Fichera A, Di Marco V, Leutner M, Venere R, Picciotto A, Lucà M, Mulinacci G, Palermo A, Gerussi A, D'Amato D, Elisabeth O'Donnell S, Cerini F, De Benedittis C, Malinverno F, Ronca V, Mancuso C, Cazzagon N, Ciaccio A, Barisani D, Marzioni M, Floreani A, Alvaro D, Gaudio E, Invernizzi P, Carpino G, Nardi A, Carbone M | 2021-09-01 | | Hepatology (Baltimore, Md.) |
| Cost of illness of Primary Biliary Cholangitis - a population-based study. | Gerussi A, Restelli U, Croce D, Bonfanti M, Invernizzi P, Carbone M | 2021-09-01 | Cholangiopathies, Cost-of-illness, Liver, Population-based studies, Rare diseases | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver |
| Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis. | Laschtowitz A, Zachou K, Lygoura V, Pape S, Derben F, Jaeckel E, Oller-Moreno S, Weidemann S, Krech T, Piecha F, Schön G, Liebhoff AM, Al Tarrah M, Heneghan M, Drenth JPH, Dalekos G, Taubert R, Lohse AW, Schramm C | 2021-08-01 | AIH, autoimmune hepatitis, ALD, alcoholic liver disease, ALP, alkaline phosphatase, ALT, alanine aminotransferase, AST, aspartate aminotransferase, Autoimmune hepatitis, Biochemical remission, Cirrhosis, EASL, European Association for the Study of the Liver, Histological activity, ICC, intraclass correlation coefficient, INR, international normalised ratio, LLN, lower limit of normal, Liver biopsy, MELD, model for end-stage liver disease, NAFLD, non-alcoholic fatty liver disease, TE, transient elastography, TIPS, transjugular intrahepatic portosystemic shunt, ULN, upper limit of normal, gamma-GT, gamma glutamyl transferase, mHAI, mHAI, modified Hepatitis Activity Index | JHEP reports : innovation in hepatology |
| Alpha1-antitrypsin deficiency: New therapies on the horizon. | Remih K, Amzou S, Strnad P | 2021-08-01 | | Current opinion in pharmacology |
| Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency. | Karatas E, Raymond AA, Leon C, Dupuy JW, Di-Tommaso S, Senant N, Collardeau-Frachon S, Ruiz M, Lachaux A, Saltel F, Bouchecareilh M | 2021-08-01 | AAT, alpha 1-antitrypsin, AATD, alpha 1-antitrypsin deficiency, Alpha 1-antitrypsin deficiency, CF, cystic fibrosis, CFTR, cystic fibrosis transmembrane conductance regulator, Cysteamine, ER, endoplasmic reticulum, FFPE, formalin-fixed paraffin-embedded, FKBP10, FK506-binding protein (FKBP) isoform 10, HCC, hepatocellular carcinoma, IHC, immunohistochemistry, IP, immunoprecipitation, Liver damage, NHK, null Hong Kong variant of AAT, P4HB, prolyl 4-hydroxylase subunit beta/PDIA1, PDI, protein disulfide isomerase, PDIA3, protein disulfide isomerase family A member 3/ERP57, PDIA4, PDIA4, protein disulfide isomerase family A member 4/ERP70/ERP72, PDIi, PDI inhibitors, Protein disulfide isomerase, ROS, reactive oxygen species, SURF4, proteins Surfeit 4, Scr, scramble, TRX, thioredoxin, TXNDC5, thioredoxin domain containing 5/PDIA15, Treatment, WT, wild-type, Z-AAT, alpha 1-antitrypsin Z variant, ZZ, homozygosis for the Z mutant allele, siRNA, small RNA interference, ΔF508-CFTR, most common mutation of CFTR, which deletes phenylalanine508 | JHEP reports : innovation in hepatology |
| Role of extracellular vesicles in liver diseases and their therapeutic potential. | Kostallari E, Valainathan S, Biquard L, Shah VH, Rautou PE | 2021-08-01 | Cirrhosis, Exosomes, Fibrosis, Microvesicles, Portal hypertension, Steatosis | Advanced drug delivery reviews |
| SARS-CoV-2 infection in alpha1-antitrypsin deficiency. | Schneider CV, Strnad P | 2021-08-01 | AAT, AATD, SARS-CoV2 | Respiratory medicine |
| Towards personalised medicine in autoimmune hepatitis: Measurement of thiopurine metabolites results in higher biochemical response rates. | Candels LS, Rahim MN, Shah S, Heneghan MA | 2021-08-01 | autoimmune hepatitis, azathioprine, outcomes, thioguanine, thiopurine metabolites | Journal of hepatology |
| Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis. | Gerussi A, Bernasconi DP, O'Donnell SE, Lammers WJ, Van Buuren H, Hirschfield G, Janssen H, Corpechot C, Reig A, Pares A, Battezzati PM, Zuin MG, Cazzagon N, Floreani A, Nevens F, Gatselis N, Dalekos G, Mayo MJ, Thorburn D, Bruns T, Mason AL, Verhelst X, Kowdley K, van der Meer A, Niro GA, Beretta-Piccoli BT, Marzioni M, Belli LS, Marra F, Valsecchi MG, Lindor KD, Invernizzi P, Hansen BE, Carbone M | 2021-08-01 | Autoimmune Liver Disease, Biomarkers, Prediction, UDCA | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association |
| Diagnostic and prognostic scoring systems for autoimmune hepatitis: a review. | Ducazu O, Degroote H, Geerts A, Hoorens A, Schouten J, Van Vlierberghe H, Verhelst X | 2021-07-01 | autoimmune hepatitis, diagnosis, prognosis, scoring system | Acta gastro-enterologica Belgica |
| Thrombotic risk in gastroenteropancreatic neuroendocrine tumor patients: a single-center experience. | Massironi S, Cavalcoli F, Artoni A, Sciola V, Zilli A, Ciafardini C, Rossi RE | 2021-07-01 | Gastroenteropancreatic neuroendocrine neoplasms, gastrointestinal tumors, paraneoplastic syndromes, thromboembolic complication, thromboembolism | Annals of gastroenterology |
| Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension. | Elkrief L, Lazareth M, Chevret S, Paradis V, Magaz M, Blaise L, Rubbia-Brandt L, Moga L, Durand F, Payancé A, Plessier A, Chaffaut C, Valla D, Malphettes M, Diaz A, Nault JC, Nahon P, Audureau E, Ratziu V, Castera L, Garcia Pagan JC, Ganne-Carrie N, Rautou PE | 2021-07-01 | | Hepatology (Baltimore, Md.) |
| RAB10 Interacts with ABCB4 and Regulates Its Intracellular Traffic. | Ben Saad A, Vauthier V, Lapalus M, Mareux E, Bennana E, Durand-Schneider AM, Bruneau A, Delaunay JL, Gonzales E, Housset C, Aït-Slimane T, Guillonneau F, Jacquemin E, Falguières T | 2021-06-30 | MDR3, RAB GTPase, bile secretion, intracellular traffic, phosphatidylcholine | International journal of molecular sciences |
| Genetic aspects of adult and pediatric autoimmune hepatitis: A concise review. | Engel B, Laschtowitz A, Janik MK, Junge N, Baumann U, Milkiewicz P, Taubert R, Sebode M | 2021-06-01 | Autoimmune hepatitis, Human leukocyte antigen, Regulatory T-cells | European journal of medical genetics |
| Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study. | Efe C, Dhanasekaran R, Lammert C, Ebik B, Higuera-de la Tijera F, Aloman C, Rıza Calışkan A, Peralta M, Gerussi A, Massoumi H, Catana AM, Torgutalp M, Purnak T, Rigamonti C, Gomez Aldana AJ, Khakoo N, Kacmaz H, Nazal L, Frager S, Demir N, Irak K, Ellik ZM, Balaban Y, Atay K, Eren F, Cristoferi L, Batıbay E, Urzua Á, Snijders R, Kıyıcı M, Akyıldız M, Ekin N, Carr RM, Harputluoğlu M, Hatemi I, Mendizabal M, Silva M, Idilman R, Silveira M, Drenth JPH, Assis DN, Björnsson E, Boyer JL, Invernizzi P, Levy C, Schiano TD, Ridruejo E, Wahlin S | 2021-06-01 | | Hepatology (Baltimore, Md.) |
| Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants. | Ben Saad A, Vauthier V, Tóth Á, Janaszkiewicz A, Durand-Schneider AM, Bruneau A, Delaunay JL, Lapalus M, Mareux E, Garcin I, Gonzales E, Housset C, Aït-Slimane T, Jacquemin E, Di Meo F, Falguières T | 2021-06-01 | ABC transporters, bile secretion, cell models, cholestatic liver diseases, molecular docking, targeted pharmacotherapy | Liver international : official journal of the International Association for the Study of the Liver |
| SARS-CoV-2 infection in patients with autoimmune hepatitis. | Marjot T, Buescher G, Sebode M, Barnes E, Barritt AS, Armstrong MJ, Baldelli L, Kennedy J, Mercer C, Ozga AK, Casar C, Schramm C, Moon AM, Webb GJ, Lohse AW | 2021-06-01 | COVID-19, SARS-CoV-2, autoimmune hepatitis, coronavirus, immunosuppression, liver disease | Journal of hepatology |
| Safety and efficacy of in vitro fertilisation in patients with chronic liver disease and liver transplantation recipients. | Rahim MN, Theocharidou E, Yen Lau KG, Ahmed R, Marattukalam F, Long L, Cannon MD, Heneghan MA | 2021-06-01 | Cirrhosis, Foetal outcomes, In vitro fertilisation, Liver transplantation, Maternal outcomes, Pregnancy | Journal of hepatology |
| Role of miR-506 in ulcerative colitis associated with primary sclerosing cholangitis. | Kempinska-Podhorodecka A, Adamowicz M, Ostrycharz E, Chmielarz M, Wójcicki M, Milkiewicz P, Milkiewicz M | 2021-05-12 | | Scientific reports |
| Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH. | Reig M, Forner A, Ávila MA, Ayuso C, Mínguez B, Varela M, Bilbao I, Bilbao JI, Burrel M, Bustamante J, Ferrer J, Gómez MÁ, Llovet JM, De la Mata M, Matilla A, Pardo F, Pastrana MA, Rodríguez-Perálvarez M, Tabernero J, Urbano J, Vera R, Sangro B, Bruix J | 2021-05-07 | Carcinoma hepatocelular, Cirrhosis, Cirrosis, Diagnosis, Diagnóstico, Hepatocellular carcinoma, Prevención, Prevention, Prognosis, Pronóstico, Tratamiento, Treatment | Medicina clinica |
| Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"☆ (J Hepatol [2020] 505-515). | Anstee QM, Darlay R, Cockell S, Meroni M, Govaere O, Tiniakos D, Burt AD, Bedossa P, Palmer J, Liu YL, Aithal GP, Allison M, Yki-Järvinen H, Vacca M, Dufour JF, Invernizzi P, Prati D, Ekstedt M, Kechagias S, Francque S, Petta S, Bugianesi E, Clement K, Ratziu V, Schattenberg JM, Valenti L, Day CP, Cordell HJ, Daly AK | 2021-05-01 | | Journal of hepatology |
| Intravenous ketamine and progressive cholangiopathy in COVID-19 patients. | | 2021-05-01 | COVID-19, Chemical and Drug Induced Liver Injury, Cholangiopathy, Cholangitis, Cholestasis, Intrahepatic, Ketamine | Journal of hepatology |
| Patients with NAFLD do not have severe portal hypertension in the absence of cirrhosis. | Moga L, Laroyenne A, Larrue H, Bureau C, Rautou PE | 2021-05-01 | Portal hypertension, cirrhosis, hepatic venous pressure gradient, liver fibrosis, non-alcoholic fatty liver disease, steatosis | Journal of hepatology |
| Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet). | Panzuto F, Maccauro M, Campana D, Faggiano A, Massironi S, Pusceddu S, Spada F, Ferone D, Modica R, Grana CM, Ferolla P, Rinzivillo M, Badalamenti G, Zatelli MC, Gelsomino F, De Carlo E, Bartolomei M, Brizzi MP, Cingarlini S, Versari A, Fanciulli G, Arvat E, Merola E, Cives M, Tafuto S, Baldari S, Falconi M | 2021-05-01 | COVID-19, Management, Multidisciplinary team, Neuroendocrine tumors, Pandemic, Peptide receptors radionuclide therapy, SARS-CoV2 | Journal of endocrinological investigation |
| Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All. | Palermo A, Gerussi A, Mulinacci G, Invernizzi P, Carbone M | 2021-05-01 | | Digestive diseases and sciences |
| Ursodeoxycholic acid therapy throughout pregnancy in women affected with chronic cholestasis of childhood: No evidence for teratogenicity. | Lykavieris P, Bernard O, Jacquemin E | 2021-05-01 | Alagille syndrome, Biliary atresia, Gestation, Liver transplantation, Teratogenicity, UDCA | Clinics and research in hepatology and gastroenterology |
| Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models. | Gerussi A, Natalini A, Antonangeli F, Mancuso C, Agostinetto E, Barisani D, Di Rosa F, Andrade R, Invernizzi P | 2021-04-27 | autoimmune hepatitis, autoimmunity, drug-induced liver injury, genetics, inflammation | International journal of molecular sciences |
| [Microvesicles derived from JAK2V617F erythrocytes induce arterial spasms in myeloproliferative neoplasm]. | Poisson J, Tanguy M, Rautou PE | 2021-04-01 | | Medecine sciences : M/S |
| [European Reference Network for Rare Hepatological Diseases (ERN RARE-LIVER)]. | Schulz L, Sebode M, Schramm C, Lohse AW | 2021-04-01 | Clinical patient management system, Patient organizations, Rare diseases, Remote consultation, Standardization of care | Der Internist |
| Real-world experience with obeticholic acid in patients with primary biliary cholangitis. | D'Amato D, De Vincentis A, Malinverno F, Viganò M, Alvaro D, Pompili M, Picciotto A, Palitti VP, Russello M, Storato S, Pigozzi MG, Calvaruso V, De Gasperi E, Lleo A, Castellaneta A, Pellicelli A, Cazzagon N, Floreani A, Muratori L, Fagiuoli S, Niro GA, Feletti V, Cozzolongo R, Terreni N, Marzioni M, Pellicano R, Pozzoni P, Baiocchi L, Chessa L, Rosina F, Bertino G, Vinci M, Morgando A, Vanni E, Scifo G, Sacco R, D'Antò M, Bellia V, Boldizzoni R, Casella S, Omazzi B, Poggi G, Cristoferi L, Gerussi A, Ronca V, Venere R, Ponziani F, Cannavò M, Mussetto A, Fontana R, Losito F, Frazzetto E, Distefano M, Colapietro F, Labanca S, Marconi G, Grassi G, Galati G, O'Donnell SE, Mancuso C, Mulinacci G, Palermo A, Claar E, Izzi A, Picardi A, Invernizzi P, Carbone M, Vespasiani-Gentilucci U | 2021-04-01 | AIH, autoimmune hepatitis, ALP, alkaline phosphatase, ALT, alanine transferase, AMA, antimitochondrial antibodies, ANA, antinuclear antibodies, AST, aspartate transferase, Autoimmunity, CRFs, case record forms, Cholestasis, Cirrhosis, EDC, electronic data capture, GGT, gamma-glutamyl transferase, OC, Overall cohort, OCA, obeticholic acid, Overlap PBC-AIH, PBC, primary biliary cholangitis, QC, quality control, RCT, randomised controlled trial, RR, risk ratio, TCC, Treatment Completer Cohort, TIPS, transjugular intrahepatic portosystemic shunt, UDCA, ursodeoxycholic acid, ULN, upper limit of normal, aRR, adjusted risk ratio | JHEP reports : innovation in hepatology |
| Low-phospholipid-associated cholelithiasis syndrome: Prevalence, clinical features, and comorbidities. | Dong C, Condat B, Picon-Coste M, Chrétien Y, Potier P, Noblinski B, Arrivé L, Hauuy MP, Barbu V, Maftouh A, Gaouar F, Ben Belkacem K, Housset C, Poupon R, Zanditenas D, Chazouillères O, Corpechot C | 2021-04-01 | ABCB4, ABCB4, ATP-binding cassette subfamily B member 4, CBD, common bile duct, Cancer, Cholestasis, ERCP, endoscopic retrograde cholangiopancreatography, FDR, false discovery rate, GGT, gamma-glutamyltransferase, ICP, intrahepatic cholestasis of pregnancy, LPAC, LPAC, low-phospholipid-associated cholelithiasis, MRCP, magnetic resonance cholangiopancreatography, Metabolic syndrome, Pregnancy, UDCA, ursodeoxycholic acid | JHEP reports : innovation in hepatology |
| Reply. | Schneider CV, Hamesch K, Strnad P | 2021-04-01 | | Gastroenterology |
| Shear Wave Elastography and Shear Wave Dispersion Imaging in the Assessment of Liver Disease in Alpha1-Antitrypsin Deficiency. | Schulz M, Kleinjans M, Strnad P, Demir M, Holtmann TM, Tacke F, Wree A | 2021-03-31 | alpha1-antitrypsin deficiency (AATD), shear wave dispersion (SWD), shear wave elastography (SWE) | Diagnostics (Basel, Switzerland) |
| Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know. | Cristoferi L, Gerussi A, Invernizzi P | 2021-03-01 | | Liver international : official journal of the International Association for the Study of the Liver |
| Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis. | Bossen L, Vesterhus M, Hov JR, Färkkilä M, Rosenberg WM, Møller HJ, Boberg KM, Karlsen TH, Grønbæk H | 2021-03-01 | | Clinical and translational gastroenterology |
| ABCB4-alteration screening in adult-onset cholestasis. | Carbone M, Cardinale V | 2021-03-01 | | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver |
| Reply to: "Both tacrolimus and mycophenylate mophetil should be considered second-line therapy for autoimmune hepatitis". | Lohse AW, Sebode M, Vesterhus M | 2021-03-01 | | Journal of hepatology |
| Direct oral anticoagulants and advanced liver disease: A systematic review and meta-analysis. | Menichelli D, Ronca V, Di Rocco A, Pignatelli P, Marco Podda G | 2021-03-01 | DOACs, bleeding, child pugh, cirrhosis, oesophageal varices | European journal of clinical investigation |
| Molecular Regulation of Canalicular ABC Transporters. | Ben Saad A, Bruneau A, Mareux E, Lapalus M, Delaunay JL, Gonzales E, Jacquemin E, Aït-Slimane T, Falguières T | 2021-02-20 | ABCB1, ABCB11, ABCB4, ABCC2, ABCG5/G8, bile secretion, molecular partners | International journal of molecular sciences |
| Measurement of liver and spleen stiffness as complementary methods for assessment of liver fibrosis in autoimmune hepatitis. | Janik MK, Kruk B, Szczepankiewicz B, Kostrzewa K, Raszeja-Wyszomirska J, Górnicka B, Lammert F, Milkiewicz P, Krawczyk M | 2021-02-01 | autoimmune hepatitis, liver fibrosis, liver stiffness, shear wave elastography, spleen stifness, transient elastography | Liver international : official journal of the International Association for the Study of the Liver |
| Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing. | Galaski J, Weiler-Normann C, Schakat M, Zachou K, Muratori P, Lampalzer S, Haag F, Schramm C, Lenzi M, Dalekos GN, Lohse AW | 2021-02-01 | Antinuclear antibodies, Autoantibodies, ELISA, F-actin, Immunofluorescence, Smooth muscle antibodies | Journal of hepatology |
| Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease? | Mulinacci G, Palermo A, Cristoferi L, Invernizzi P, Carbone M | 2021-01-01 | Inflammatory bowel disease, Primary sclerosing cholangitis, Takayasu arteritis, Vasculitis | Journal of translational autoimmunity |
| Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib. | Pomej K, Balcar L, Scheiner B, Semmler G, Meischl T, Mandorfer M, Reiberger T, Müller C, Trauner M, Pinter M | 2021-01-01 | antibiotics, hepatocellular carcinoma, sorafenib, targeted therapy | Journal of hepatocellular carcinoma |
| Regulatory T-Cell Therapy in Liver Transplantation and Chronic Liver Disease. | Hann A, Oo YH, Perera MTPR | 2021-01-01 | Treg, cell therapy, cirrhosis, immunity, liver, rejection, transplant | Frontiers in immunology |
| COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital. | Pomej K, Scheiner B, Hartl L, Balcar L, Meischl T, Mandorfer M, Reiberger T, Müller C, Trauner M, Pinter M | 2021-01-01 | | PloS one |
| Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension. | Ørntoft NW, Blé M, Baiges A, Ferrusquia J, Hernández-Gea V, Turon F, Magaz M, Møller S, Møller HJ, Garcia-Pagan JC, Gronbaek H | 2021-01-01 | biomarker, cirrhosis, macrophages, non-cirrhotic portal hypertension, portal hypertension | Frontiers in physiology |
| Case Report: Hypomorphic Function and Somatic Reversion in DOCK8 Deficiency in One Patient With Two Novel Variants and Sclerosing Cholangitis. | Saettini F, Fazio G, Moratto D, Galbiati M, Zucchini N, Ippolito D, Dinelli ME, Imberti L, Mauri M, Melzi ML, Bonanomi S, Gerussi A, Pinelli M, Barisani C, Bugarin C, Chiarini M, Giacomelli M, Piazza R, Cazzaniga G, Invernizzi P, Giliani SC, Badolato R, Biondi A | 2021-01-01 | DOCK 8, EBV - Epstein-Barr Virus, lymphopenia, primary immumunodeficiencies, sclerosing cholangitis, somatic reversion, thrombocytopenia | Frontiers in immunology |
| Ex situ Normothermic Split Liver Machine Perfusion: Protocol for Robust Comparative Controls in Liver Function Assessment Suitable for Evaluation of Novel Therapeutic Interventions in the Pre-clinical Setting. | Attard JA, Osei-Bordom DC, Boteon Y, Wallace L, Ronca V, Reynolds G, Perera MTPR, Oo YH, Mergental H, Mirza DF, Afford SC | 2021-01-01 | liver function, machine perfusion, normothermic, organ preservation, split liver technique | Frontiers in surgery |
| Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison. | Montali L, Gragnano A, Miglioretti M, Frigerio A, Vecchio L, Gerussi A, Cristoferi L, Ronca V, D'Amato D, O'Donnell SE, Mancuso C, Lucà M, Yagi M, Reig A, Jopson L, Pilar S, Jones D, Pares A, Mells G, Tanaka A, Carbone M, Invernizzi P | 2021-01-01 | Autoimmunity, Cholestasis, Fatigue, Liver | Journal of translational autoimmunity |
| Gastrointestinal Manifestations, Clinical Characteristics and Outcomes of COVID-19 in Adult and Pediatric Patients. | Russo T, Pizuorno A, Oskrochi G, Latella G, Massironi S, Schettino M, Aghemo A, Pugliese N, Brim H, Ashktorab H | 2021-01-01 | Adults, Coronavirus Disease-19, Gastrointestinal Manifestation, Italy, Pandemic, Pediatrics | SOJ microbiology & infectious diseases |
| Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. | Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC | 2021-01-01 | | Hepatology (Baltimore, Md.) |
| Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis. | Wang L, Guo X, Xu X, De Stefano V, Plessier A, Noronha Ferreira C, Qi X | 2021-01-01 | Anticoagulants, Liver cirrhosis, Meta-analysis, Survival, Venous thrombosis | Advances in therapy |
| Reply to: "A spotlight on natural killer cells in primary biliary cholangitis". | Carbone M, Ronca V, Invernizzi P | 2021-01-01 | Autoimmunity, Biliary cirrhosis, Biliary fibrosis, Cholestasis, PBC | Journal of hepatology |
| CK-18 cell death markers improve the prediction of histological remission in autoimmune hepatitis during biochemical remission. | Derben FC, Engel B, Zachou K, Hartl J, Hartleben B, Bantel H, Schramm C, Dalekos GN, Manns MP, Jaeckel E, Taubert R | 2021-01-01 | M30, M65, cytokeratin-18, therapy | Liver international : official journal of the International Association for the Study of the Liver |
| Benefits of molecular profiling with next-generation sequencing for the diagnosis and prognosis of myeloproliferative neoplasms in splanchnic vein thrombosis. | Kiladjian JJ, Debureaux PE, Plessier A, Soret-Dulphy J, Valla D, Cassinat B, Rautou PE | 2021-01-01 | | Journal of hepatology |
| DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma. | Nevi L, Di Matteo S, Carpino G, Zizzari IG, Samira S, Ambrosino V, Costantini D, Overi D, Giancotti A, Monti M, Bosco D, De Peppo V, Oddi A, De Rose AM, Melandro F, Bragazzi MC, Faccioli J, Massironi S, Grazi GL, Panici PB, Berloco PB, Giuliante F, Cardinale V, Invernizzi P, Caretti G, Gaudio E, Alvaro D | 2021-01-01 | | Hepatology (Baltimore, Md.) |
| Health status of patients with autoimmune hepatitis is not affected by the SARS-CoV-2 outbreak in Flanders, Belgium. | Verhelst X, Somers N, Geerts A, Degroote H, Van Vlierberghe H | 2021-01-01 | | Journal of hepatology |
| Management of cholangiocarcinoma in the third millennium: time to be guided! | Carbone M, Baiocchi L | 2020-12-01 | Cholangiocarcinoma, PSC, cancer, diagnosis, staging, treatment | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver |
| Up to 50% of portal vein thrombosis remains undiagnosed until liver transplantation. | Bert J, Geerts A, Vanlander A, Abreu de Carvalho L, Degroote H, Berrevoet F, Rogiers X, van Vlierberghe H, Verhelst X | 2020-12-01 | anticoagulants, portal vein, risk factors, survival analysis, thrombosis | Clinical transplantation |
| Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group. | Lohse AW, Sebode M, Jørgensen MH, Ytting H, Karlsen TH, Kelly D, Manns MP, Vesterhus M | 2020-12-01 | 6-Mercaptopurine, Autoimmune hepatitis, Azathioprine, Mycophenolate mofetil | Journal of hepatology |
| Extracellular vesicles as biomarkers in liver diseases: A clinician's point of view. | Thietart S, Rautou PE | 2020-12-01 | Alcohol, Cancer, Cirrhosis, Exosome, Liver, Microparticle, Microvesicle, Vesicle | Journal of hepatology |
| Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation. | Goubran M, Aderibigbe A, Jacquemin E, Guettier C, Girgis S, Bain V, Mason AL | 2020-11-30 | ABCB4, Case report, MDR3, Progressive familial intrahepatic cholestasis | BMC medical genetics |
| Long-term outcome in PSC patients receiving azathioprine: Does immunosuppression have a positive effect on survival? | Creutzfeldt AM, Piecha F, Schattenberg JM, Schramm C, Lohse AW | 2020-11-01 | | Journal of hepatology |
| Primary biliary cholangitis management: controversies, perspectives and daily practice implications from an expert panel. | Alvaro D, Carpino G, Craxi A, Floreani A, Moschetta A, Invernizzi P | 2020-11-01 | fibrates, liver biopsy, management, obeticholic acid, primary biliary cholangitis, risk stratification | Liver international : official journal of the International Association for the Study of the Liver |
| High rates of 30-day mortality in patients with cirrhosis and COVID-19. | Iavarone M, D'Ambrosio R, Soria A, Triolo M, Pugliese N, Del Poggio P, Perricone G, Massironi S, Spinetti A, Buscarini E, Viganò M, Carriero C, Fagiuoli S, Aghemo A, Belli LS, Lucà M, Pedaci M, Rimondi A, Rumi MG, Invernizzi P, Bonfanti P, Lampertico P | 2020-11-01 | HBV, HCV, Hepatitis, Hepatocellular carcinoma, Liver transplantation, SARS-CoV-2 | Journal of hepatology |
| COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy. | Viganò C, Massironi S, Pirola L, Cristoferi L, Fichera M, Bravo M, Mauri M, Redaelli AE, Dinelli ME, Invernizzi P | 2020-10-23 | COVID-19, Crohn’s disease, SARS-CoV-2, inflammatory bowel disease, ulcerative colitis | Inflammatory bowel diseases |
| Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib. | Pomej K, Scheiner B, Park D, Bauer D, Balcar L, Meischl T, Mandorfer M, Reiberger T, Müller C, Trauner M, Pinter M | 2020-10-13 | bleeding complications, cardiovascular risk, hepatocellular carcinoma, metabolic risk factors, sorafenib, thromboembolic events, vascular complications | Cancers |
| [Not Available]. | Zecher B, Sebode M, Lohse AW | 2020-10-01 | | Zeitschrift fur Gastroenterologie |
| Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma. | Souhami A, Sartoris R, Rautou PE, Cauchy F, Bouattour M, Durand F, Giannelli V, Gigante E, Castera L, Valla D, Soubrane O, Vilgrain V, Ronot M | 2020-10-01 | AUROC, area under the receiver operating characteristic, CSPH, clinically significant portal hypertension, HCC, hepatocellular carcinoma, HPV, hepatic venous pressure, HVPG, hepatic venous pressure gradient, LSM, liver stiffness measurements, LSN, liver surface nodularity, LSPS, LSM-spleen-size-to-platelet ratio score, NRI, Net Classification Index Improvement, PHT, portal hypertension, TE, transient elastography | JHEP reports : innovation in hepatology |
| Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets. | Carbone M, Milani C, Gerussi A, Ronca V, Cristoferi L, Invernizzi P | 2020-10-01 | Autoimmunity, Biliary cirrhosis, Biliary fibrosis, Cholestasis, PBC | Journal of hepatology |
| Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction. | Elkrief L, Houssel-Debry P, Ackermann O, Franchi-Abella S, Branchereau S, Valla D, Hillaire S, Dutheil D, Plessier A, Hernandez-Gea V, Bureau C | 2020-09-01 | Cavernoma cholangiopathy, Portal cavernoma, Variceal | Clinics and research in hepatology and gastroenterology |
| Autoantibodies to intracellular "rods and rings" structures in two patients with autoimmune hepatitis treated with azathioprine. | Galaski J, Koop AC, Lütgehetmann M, Lohse AW, Weiler-Normann C | 2020-09-01 | Autoimmune hepatitis, autoantibodies, azathioprine, immunofluorescence, rods and rings | Autoimmunity |
| Risk factors for vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. | Soret J, Debray D, Fontbrune FS, Kiladjian JJ, Saadoun D, Latour RP, Valla D, Hernandez-Gea V, Hillaire S, Dutheil D, Plessier A, Bureau C, De Raucourt E | 2020-09-01 | Behçet's disease, Thrombosis, Vascular liver disease | Clinics and research in hepatology and gastroenterology |
| Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy. | Massironi S, Viganò C, Dioscoridi L, Filippi E, Pagliarulo M, Manfredi G, Conti CB, Signorelli C, Redaelli AE, Bonato G, Iiritano E, Frego R, Zucchini N, Ungari M, Pedaci M, Bono F, Di Bella C, Buscarini E, Mutignani M, Penagini R, Dinelli ME, Invernizzi P | 2020-09-01 | | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association |
| Ischemic cholangiopathy: An update. | Goria O, Archambeaud I, Lemaitre C, Dutheil D, Plessier A, Rautou PE, Hernandez-Gea V, Valla D | 2020-09-01 | Hepatic artery thrombosis, Intensive care, Ischemic cholangiopathy, Liver transplantation | Clinics and research in hepatology and gastroenterology |
| Recent (non-cirrhotic) extrahepatic portal vein obstruction. | Heurgué A, Habes D, Brugel M, Franchi-Abella S, Condat B, Valla D, Hillaire S, Debray D, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C, Payancé A | 2020-09-01 | Cavernoma, Extra hepatic portal vein obstruction, Hypertension, Thrombosis | Clinics and research in hepatology and gastroenterology |
| Drug induced liver injury and vascular liver disease. | Larrey D, Meunier L, Valla D, Hillaire S, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C | 2020-09-01 | | Clinics and research in hepatology and gastroenterology |
| No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease. | Biquard L, Valla D, Rautou PE | 2020-09-01 | | Journal of hepatology |
| "Vascular liver diseases: Position paper(s) from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and the European Reference Network on Hepatological Diseases (ERN RARE-LIVER)". | Plessier A, Bureau C | 2020-09-01 | | Clinics and research in hepatology and gastroenterology |
| Social and medical support initiatives in vascular liver diseases in France, from child to adult. | Aurélie P, Gasperment M, Debray D, Le Beux E, Brault C, Ollivier-Hourmand I, Dutheil D, Leclercq A, Devictor J, Hernández-Gea V, Pierre Emmanuel R, Goria O | 2020-09-01 | Advanced practice nurse, Coordinating nurse, Patient association, Psychological support, Social support, Therapeutic patient education, Transition, Vascular liver disease | Clinics and research in hepatology and gastroenterology |
| Porto-sinusoidal vascular disease. Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. | Giudicelli H, Rautou PE, Paradis V, Bedossa P, Goria O, Lambert V, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C, Valla D | 2020-09-01 | Hepatoportal sclerosis, Incomplete septal fibrosis, Nodular regenerative hyperplasia, Non-cirrhotic portal fibrosis, Obliterative portal venopathy, Portal hypertension, Porto-sinusoidal vascular disease | Clinics and research in hepatology and gastroenterology |
| Extrahepatic portal vein obstruction (EHPVO) in cirrhosis. | Abergel A, Gasperment M, Nery FG, Buchard B, Lebreton A, Hordonneau C, Duron C, Valla D, Sophie H, Ledain-Rautou E, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C, Francoz C | 2020-09-01 | Cirrhosis, Extra hepatic portal vein obstruction | Clinics and research in hepatology and gastroenterology |
| Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆. | Anstee QM, Darlay R, Cockell S, Meroni M, Govaere O, Tiniakos D, Burt AD, Bedossa P, Palmer J, Liu YL, Aithal GP, Allison M, Yki-Järvinen H, Vacca M, Dufour JF, Invernizzi P, Prati D, Ekstedt M, Kechagias S, Francque S, Petta S, Bugianesi E, Clement K, Ratziu V, Schattenberg JM, Valenti L, Day CP, Cordell HJ, Daly AK | 2020-09-01 | Fibrosis, GCKR, GWAS, HSD17B13, NAFLD, NASH, PNPLA3, SNP, TM6SF2 | Journal of hepatology |
| Congenital portosystemic shunts: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. | Guérin F, Franchi Abella S, McLin V, Ackermann O, Girard M, Cervoni JP, Savale L, Hernandez-Gea V, Valla D, Hillaire S, Dutheil D, Bureau C, Gonzales E, Plessier A | 2020-09-01 | Congenital, Portocaval, Postosystemic | Clinics and research in hepatology and gastroenterology |
| Management of anticoagulation in adult patients with chronic parenchymal or vascular liver disease: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. | Ollivier-Hourmand I, Nguyen N, De Gottardi A, Valla D, Hillaire S, Dutheil D, Bureau C, Hernandez-Gea V, De Raucourt E, Plessier A | 2020-09-01 | Anticoagulation, Chronic parenchymal, Vascular liver disease | Clinics and research in hepatology and gastroenterology |
| Pregnancy and vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. | Payancé A, Ceccaldi PF, De Raucourt E, Valla D, Hillaire S, Dutheil D, Hernandez-Gea V, Bureau C, Plessier A | 2020-09-01 | Pregnancy, Vascular liver disease | Clinics and research in hepatology and gastroenterology |
| Hereditary hemorrhagic telangiectasia and liver involvement: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. | Silvain C, Thévenot T, Colle I, Vilgrain V, Dupuis-Girod S, Buscarini E, Valla D, Hillaire S, Dutheil D, Sitbon O, Bureau C, Plessier A | 2020-09-01 | Hereditary hemorrhagic telangiectasia, Liver, Portal hypertension, Rendu-Osler-Weber disease | Clinics and research in hepatology and gastroenterology |
| Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis. | Corpechot C, Chazouillères O, Belnou P, Montano-Loza AJ, Mason A, Ebadi M, Eurich D, Chopra S, Jacob D, Schramm C, Sterneck M, Bruns T, Reuken P, Rauchfuss F, Roccarina D, Thorburn D, Gerussi A, Trivedi P, Hirschfield G, McDowell P, Nevens F, Boillot O, Bosch A, Giostra E, Conti F, Poupon R, Parés A, Reig A, Donato MF, Malinverno F, Floreani A, Russo FP, Cazzagon N, Verhelst X, Goet J, Harms M, van Buuren H, Hansen B, Carrat F, Dumortier J | 2020-09-01 | Cyclosporine, PBC, Recurrence, Survival, Tacrolimus, Transplantation, UDCA | Journal of hepatology |
| Sinusoidal obstruction syndrome. | de Lédinghen V, Villate A, Robin M, Decraecker M, Valla D, Hillaire S, Hernandez-Gea V, Dutheil D, Bureau C, Plessier A | 2020-09-01 | Hematopoietic stem cells transplant, Hepatic Veno-occlusive disease, Sinusoidal obstruction syndrome | Clinics and research in hepatology and gastroenterology |
| Budd-Chiari syndrome. | Coilly A, Potier P, Broué P, Kounis I, Valla D, Hillaire S, Lambert V, Dutheil D, Hernández-Gea V, Plessier A, Vilgrain V, Bureau C | 2020-09-01 | Anticoagulation, Ascite, Budd-Chiari syndrome, Hepatomegaly, Obstruction, Thrombosis | Clinics and research in hepatology and gastroenterology |
| Why and when to diagnose Behcet's disease in patients with Budd Chiari Syndrome? | Desbois AC, Plessier A | 2020-09-01 | | Clinics and research in hepatology and gastroenterology |
| Non-invasive screening for subclinical liver graft injury in adults via donor-specific anti-HLA antibodies. | Höfer A, Jonigk D, Hartleben B, Verboom M, Hallensleben M, Manns MP, Jaeckel E, Taubert R | 2020-08-28 | | Scientific reports |
| Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses. | Debureaux PE, Cassinat B, Soret-Dulphy J, Mora B, Verger E, Maslah N, Plessier A, Rautou PE, Ollivier-Hourman I, De Ledinghen V, Goria O, Bureau C, Siracusa C, Valla D, Giraudier S, Passamonti F, Kiladjian JJ | 2020-08-11 | | Blood advances |
| [Role of autophagy in liver sinusoidal endothelial cells in nonalcoholic steatohepatitis]. | Hammoutene A, Rautou PE | 2020-08-01 | | Medecine sciences : M/S |
| Therapeutic plasma exchange in acute on chronic liver failure. | Stahl K, Busch M, Fuge J, Schneider A, Manns MP, Seeliger B, Schmidt JJ, Wiesner O, Schmidt BMW, Taubert R, Vondran FWR, Hoeper MM, David S | 2020-08-01 | decompensation of liver cirrhosis, liver transplantation, plasmapheresis | Journal of clinical apheresis |
| Functional rescue of an ABCB11 mutant by ivacaftor: A new targeted pharmacotherapy approach in bile salt export pump deficiency. | Mareux E, Lapalus M, Amzal R, Almes M, Aït-Slimane T, Delaunay JL, Adnot P, Collado-Hilly M, Davit-Spraul A, Falguières T, Callebaut I, Gonzales E, Jacquemin E | 2020-08-01 | ABC transporters superfamily, PFIC2, VX-770, cholestatic liver diseases, paediatrics, potentiator | Liver international : official journal of the International Association for the Study of the Liver |
| Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers. | Schneider CV, Hamesch K, Gross A, Mandorfer M, Moeller LS, Pereira V, Pons M, Kuca P, Reichert MC, Benini F, Burbaum B, Voss J, Gutberlet M, Woditsch V, Lindhauer C, Fromme M, Kümpers J, Bewersdorf L, Schaefer B, Eslam M, Bals R, Janciauskiene S, Carvão J, Neureiter D, Zhou B, Wöran K, Bantel H, Geier A, Dirrichs T, Stickel F, Teumer A, Verbeek J, Nevens F, Govaere O, Krawczyk M, Roskams T, Haybaeck J, Lurje G, Chorostowska-Wynimko J, Genesca J, Reiberger T, Lammert F, Krag A, George J, Anstee QM, Trauner M, Datz C, Gaisa NT, Denk H, Trautwein C, Aigner E, Strnad P | 2020-08-01 | ALT, FibroScan, GGT, SERPINA1 | Gastroenterology |
| Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis. | Ronca V, Mancuso C, Milani C, Carbone M, Oo YH, Invernizzi P | 2020-08-01 | TLR, autoimmunity, biliary epithelial cells, primary biliary cholangitis | Journal of leukocyte biology |
| Management of patients with autoimmune liver disease during COVID-19 pandemic. | Lleo A, Invernizzi P, Lohse AW, Aghemo A, Carbone M | 2020-08-01 | | Journal of hepatology |
| Non-Invasive Assessment and Management of Liver Involvement in Adults With Alpha-1 Antitrypsin Deficiency. | Hamesch K, Strnad P | 2020-07-01 | AATD, SERPINA1, alpha-1 antitrypsin deficiency, elastography, genetic liver disease, liver fibrosis, liver stiffness, rare liver disease | Chronic obstructive pulmonary diseases (Miami, Fla.) |
| Editorial: gut microbiota profile in patients with autoimmune hepatitis-a clue for adjunctive probiotic therapy? Authors' reply. | Liwinski T, Schramm C | 2020-07-01 | | Alimentary pharmacology & therapeutics |
| Genotype correlates with the natural history of severe bile salt export pump deficiency. | van Wessel DBE, Thompson RJ, Gonzales E, Jankowska I, Sokal E, Grammatikopoulos T, Kadaristiana A, Jacquemin E, Spraul A, Lipiński P, Czubkowski P, Rock N, Shagrani M, Broering D, Algoufi T, Mazhar N, Nicastro E, Kelly DA, Nebbia G, Arnell H, Björn Fischler, Hulscher JBF, Serranti D, Arikan C, Polat E, Debray D, Lacaille F, Goncalves C, Hierro L, Muñoz Bartolo G, Mozer-Glassberg Y, Azaz A, Brecelj J, Dezsőfi A, Calvo PL, Grabhorn E, Sturm E, van der Woerd WJ, Kamath BM, Wang JS, Li L, Durmaz Ö, Onal Z, Bunt TMG, Hansen BE, Verkade HJ | 2020-07-01 | ABCB11, Natural history, PFIC2, Severe BSEP deficiency, Surgical biliary diversion | Journal of hepatology |
| Metamizole: An underrated agent causing severe idiosyncratic drug-induced liver injury. | Sebode M, Reike-Kunze M, Weidemann S, Zenouzi R, Hartl J, Peiseler M, Liwinski T, Schulz L, Weiler-Normann C, Sterneck M, Lohse AW, Schramm C | 2020-07-01 | acute liver failure, drug-induced liver injury, elevated liver enzymes, metamizole, side effects | British journal of clinical pharmacology |
| Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists. | Abenavoli L, Procopio AC, Fagoonee S, Pellicano R, Carbone M, Luzza F, Invernizzi P | 2020-06-10 | chenodeoxycholic acid, liver, obeticholic acid, scaffold, ursodeoxycholicacid | Diseases (Basel, Switzerland) |
| Glycerol Phenylbutyrate Therapy in Progressive Familial Intrahepatic Cholestasis Type 2. | Almes M, Jobert A, Lapalus M, Mareux E, Gonzales E, Jacquemin E | 2020-06-01 | | Journal of pediatric gastroenterology and nutrition |
| A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis. | Liwinski T, Casar C, Ruehlemann MC, Bang C, Sebode M, Hohenester S, Denk G, Lieb W, Lohse AW, Franke A, Schramm C | 2020-06-01 | | Alimentary pharmacology & therapeutics |
| Let's not forget our COVID-19-free cirrhotic patients! | Viganò M, Carbone M | 2020-06-01 | | Liver international : official journal of the International Association for the Study of the Liver |
| Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis. | Bossen L, Rebora P, Bernuzzi F, Jepsen P, Gerussi A, Andreone P, Galli A, Terziroli B, Alvaro D, Labbadia G, Aloise C, Baiocchi L, Giannini E, Abenavoli L, Toniutto P, Marra F, Marzioni M, Niro G, Floreani A, Møller HJ, Valsecchi MG, Carbone M, Grønbaek H, Invernizzi P | 2020-06-01 | macrophage activation markers, non-invasive markers, primary biliary cholangitis, prognostic markers | Liver international : official journal of the International Association for the Study of the Liver |
| New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney disease. | Barten TRM, Bernts LHP, Drenth JPH, Gevers TJG | 2020-06-01 | Autosomal dominant polycystic kidney disease, autosomal dominant polycystic liver disease, estrogen, hepatic cystogenesis, liver cyst, mTOR, metformin, polycystic liver disease, somatostatin, tolvaptan | Expert opinion on therapeutic targets |
| Switching vs. add-on strategy in PBC treatment: Lessons from UDCA and bezafibrate experience. | Corpechot C, Rousseau A, Chazouillères O | 2020-06-01 | | Journal of hepatology |
| 2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta-analysis. | Thiele M, Hugger MB, Kim Y, Rautou PE, Elkrief L, Jansen C, Verlinden W, Allegretti G, Israelsen M, Stefanescu H, Piscaglia F, García-Pagán JC, Franque S, Berzigotti A, Castera L, Jeong WK, Trebicka J, Krag A | 2020-06-01 | Aixplorer, Decompensated liver disease, compensated advanced chronic liver disease, liver vein catheterization, supersonic shear imagine | Liver international : official journal of the International Association for the Study of the Liver |
| Population-based study of autoimmune hepatitis and primary biliary cholangitis in Germany: rising prevalences based on ICD codes, yet deficits in medical treatment. | Sebode M, Kloppenburg A, Aigner A, Lohse AW, Schramm C, Linder R | 2020-05-01 | | Zeitschrift fur Gastroenterologie |
| Primary Sclerosing Cholangitis: Burden of Disease and Mortality Using Data from the National Rare Diseases Registry in Italy. | Carbone M, Kodra Y, Rocchetti A, Manno V, Minelli G, Gerussi A, Ronca V, Malinverno F, Cristoferi L, Floreani A, Invernizzi P, Conti S, Taruscio D | 2020-04-29 | autoimmune liver disease, cholestatic liver disease, epidemiology, primary sclerosing cholangitis, rare diseases, registry | International journal of environmental research and public health |
| A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis. | Hammoutene A, Biquard L, Lasselin J, Kheloufi M, Tanguy M, Vion AC, Mérian J, Colnot N, Loyer X, Tedgui A, Codogno P, Lotersztajn S, Paradis V, Boulanger CM, Rautou PE | 2020-03-01 | Alcohol, Autophagy, Diabetes, Fibrosis, Inflammation, LSECs, Metabolic syndrome, NASH | Journal of hepatology |
| The future of autoimmune liver diseases - Understanding pathogenesis and improving morbidity and mortality. | Engel B, Taubert R, Jaeckel E, Manns MP | 2020-02-01 | autoimmune hepatitis, cholangiocarcinoma, primary biliary cholangitis, primary sclerosing cholangitis, regulatory T cells | Liver international : official journal of the International Association for the Study of the Liver |
| Autoimmune Hepatitis: Tolerogenic Immunological State During Pregnancy and Immune Escape in Post-partum. | Bozward AG, Wootton GE, Podstawka O, Oo YH | 2020-01-01 | autoimmune hepatitis, memory T cells, placenta, pregnancy, regulatory T cells, tolerance | Frontiers in immunology |
| New Therapeutic Targets in Autoimmune Cholangiopathies. | Gerussi A, Lucà M, Cristoferi L, Ronca V, Mancuso C, Milani C, D'Amato D, O'Donnell SE, Carbone M, Invernizzi P | 2020-01-01 | FXR agonists, fibrates, gut-liver axis, liver, microbiome, primary biliary cholangitis, primary sclerosing cholangitis | Frontiers in medicine |
| Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies. | Gerussi A, D'Amato D, Cristoferi L, O'Donnell SE, Carbone M, Invernizzi P | 2020-01-01 | Bile acids, FXR agonists, Fibrates, Gut–liver axis, Microbiome, Precision medicine, Primary biliary cholangitis, Primary sclerosing cholangitis | Annals of hepatology |
| Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group. | Than NN, Hodson J, Schmidt-Martin D, Taubert R, Wawman RE, Botter M, Gautam N, Bock K, Jones R, Appanna GD, Godkin A, Montano-Loza AJ, Lammert F, Schramm C, Manns MP, Swain M, Burak KW, Adams DH, Hirschfield GM, Oo YH | 2019-12-01 | Autoimmune hepatitis, B cell depletion therapy, Difficult-to-manage, Prednisolone, Rituximab | JHEP reports : innovation in hepatology |
| Assessment of liver phenotype in adults with severe alpha-1 antitrypsin deficiency (Pi*ZZ genotype). | Kümpers J, Fromme M, Schneider CV, Trautwein C, Denk H, Hamesch K, Strnad P | 2019-12-01 | | Journal of hepatology |
| The challenges of primary biliary cholangitis: What is new and what needs to be done. | Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D, Vierling JM, Adams D, Alpini G, Banales JM, Beuers U, Björnsson E, Bowlus C, Carbone M, Chazouillères O, Dalekos G, De Gottardi A, Harada K, Hirschfield G, Invernizzi P, Jones D, Krawitt E, Lanzavecchia A, Lian ZX, Ma X, Manns M, Mavilio D, Quigley EM, Sallusto F, Shimoda S, Strazzabosco M, Swain M, Tanaka A, Trauner M, Tsuneyama K, Zigmond E, Gershwin ME | 2019-12-01 | Bile acids, Biliary epithelial cells, Biomarkers, Histology, Personalized medicine, Primary biliary cholangitis | Journal of autoimmunity |
| Mild Iron Overload as Seen in Individuals Homozygous for the Alpha-1 Antitrypsin Pi*Z Variant Does Not Promote Liver Fibrogenesis in HFE Knockout Mice. | Guldiken N, Hamesch K, Schuller SM, Aly M, Lindhauer C, Schneider CV, Fromme M, Trautwein C, Strnad P | 2019-11-09 | HFE, SERPINA1, genetic liver disease, iron metabolism, liver fibrosis, rare liver disease, α1-antitrypsin deficiency | Cells |
| Clinical management of autoimmune hepatitis. | Pape S, Schramm C, Gevers TJ | 2019-11-01 | Autoimmune hepatitis, European Association for Study of the Liver, clinical management, induction therapy, prednisolone, prednisone | United European gastroenterology journal |
| Sex differences in clinical presentation and prognosis in patients with primary biliary cholangitis. | Abdulkarim M, Zenouzi R, Sebode M, Schulz L, Quaas A, Lohse AW, Schramm C, Weiler-Normann C | 2019-11-01 | Autoimmune liver disease, male, primary biliary cholangitis, prognosis, sex differences | Scandinavian journal of gastroenterology |
| Depression in patients with autoimmune hepatitis: the need for detailed psychiatric assessment. | Janik MK, Wunsch E, Moskwa M, Raszeja-Wyszomirska J, Krawczyk M, Milkiewicz P | 2019-09-30 | | Polish archives of internal medicine |
| DEFI-ALFA: The French key to the alpha1 mystery? | Fromme M, Oliverius M, Strnad P | 2019-06-01 | | Liver international : official journal of the International Association for the Study of the Liver |
| Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis. | Strnad P, Buch S, Hamesch K, Fischer J, Rosendahl J, Schmelz R, Brueckner S, Brosch M, Heimes CV, Woditsch V, Scholten D, Nischalke HD, Janciauskiene S, Mandorfer M, Trauner M, Way MJ, McQuillin A, Reichert MC, Krawczyk M, Casper M, Lammert F, Braun F, von Schönfels W, Hinz S, Burmeister G, Hellerbrand C, Teufel A, Feldman A, Schattenberg JM, Bantel H, Pathil A, Demir M, Kluwe J, Boettler T, Ridinger M, Wodarz N, Soyka M, Rietschel M, Kiefer F, Weber T, Marhenke S, Vogel A, Hinrichsen H, Canbay A, Schlattjan M, Sosnowsky K, Sarrazin C, von Felden J, Geier A, Deltenre P, Sipos B, Schafmayer C, Nothnagel M, Aigner E, Datz C, Stickel F, Morgan MY, Hampe J, Berg T, Trautwein C | 2019-06-01 | NASH, SERPINA1, alcoholic liver disease, alpha1-antitrypsin deficiency, fibrosis | Gut |
| Inflammatory Phenotype of Intrahepatic Sulfatide-Reactive Type II NKT Cells in Humans With Autoimmune Hepatitis. | Sebode M, Wigger J, Filpe P, Fischer L, Weidemann S, Krech T, Weiler-Normann C, Peiseler M, Hartl J, Tolosa E, Herkel J, Schramm C, Lohse AW, Arrenberg P | 2019-01-01 | CD1d, alpha-galactosylceramide, lipid antigen, tumor necrosis factor-alpha, unconventional T cells | Frontiers in immunology |
| Comparison of non-invasive assessment of liver fibrosis in patients with alpha1-antitrypsin deficiency using magnetic resonance elastography (MRE), acoustic radiation force impulse (ARFI) Quantification, and 2D-shear wave elastography (2D-SWE). | Reiter R, Wetzel M, Hamesch K, Strnad P, Asbach P, Haas M, Siegmund B, Trautwein C, Hamm B, Klatt D, Braun J, Sack I, Tzschätzsch H | 2018-01-01 | | PloS one |
